text stringlengths 102 99.6k | url stringlengths 31 426 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:29:49 2022-09-19 04:34:15 |
|---|---|---|
- In conjunction with the business combination agreement, the parties have commitments for $40 million in new investments by institutional investors, including $20 million in conversion of licensing consideration from Cellectis
- Isleworth has $207 million in trust
- Merger expected to be completed in Q3 of 2022; Combined company expected to be listed on NASDAQ under the ticker symbol INKC.
ST. PETERSBURG, Fla. and AVENTURA, Fla. and NATICK, Mass., April 26, 2022 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) ("Isleworth"), a special purpose acquisition company (NASDAQ: ISLE, ISLEW) and Cytovia Holdings, Inc.("Cytovia"), a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies today announced they have entered into a definitive business combination agreement. Upon consummation of this combination, Isleworth will be renamed Cytovia Therapeutics, Inc. (the "combined company") and its common stock and warrants are expected to remain listed on NASDAQ under the ticker symbols INKC and INKCW, respectively.
The combined company will continue Cytovia's operations and remain focused on developing and manufacturing complementary NK cell and NK engager antibody platforms.
The combined company will be led by Dr. Daniel Teper, the Co-Founder, Chairman, and Chief Executive Officer of Cytovia.
"We are grateful for the strong support from new and existing investors and the team of seasoned entrepreneurs at Isleworth. We expect this transaction to accelerate the execution of Cytovia's vision to advance NK therapeutics towards a cure for cancer" said Dr. Teper. "We are encouraged by our preclinical data recently presented at AACR, which supports advancing development of our iPSC-derived NK cells (iNK) and Flex-NK™ cell engagers for the treatment of Hepatocellular Carcinoma."
Bob Whitehead, Isleworth's CEO, said: "Isleworth evaluated multiple life science companies and was most impressed by the talent and technology assembled by Cytovia. We believe Cytovia is one of the most advanced, innovative cell therapy companies involved with the development of new cancer treatments. Cell therapies in oncology have already brought hope to millions. Cytovia's approaches could conceivably make similar approaches more conveniently 'off-the-shelf' and affordable."
Cytovia's Therapeutic Approach
Cytovia aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in oncology.
The company focuses on harnessing the innate immune system by developing complementary and disruptive NK-cell and NK-engager antibody platforms. Specifically, Cytovia is developing three types of iNK cells: unedited iNK cells, TALEN® gene-edited iNK cells with improved function and persistence, and TALEN® gene-edited iNK cells with chimeric antigen receptors (CAR-iNKs) to improve tumor-specific targeting. The second complementary cornerstone technology is a quadrivalent multispecific antibody platform designed to engage NK cells by targeting the NKp46 activating receptor using a proprietary Flex-NK™ technology.
These two technology platforms are being used to develop treatments for patients with Hepatocellular Carcinoma (HCC) and solid tumors. Clinical studies are expected to initiate by the end of 2022.
Headquartered in Aventura, FL, Cytovia operates R&D laboratories in Natick, MA and a cGMP cell manufacturing facility in Puerto Rico and has scientific partnerships with Cellectis, CytoImmune Therapeutics, the Hebrew University of Jerusalem, INSERM, the New York Stem Cell Foundation, the National Cancer Institute, and the University of California San Francisco (UCSF). Cytovia Therapeutics has recently formed CytoLynx Therapeutics, a strategic partnership focused on research and development, manufacturing, and commercialization activities in Greater China and beyond.
Cytovia Pipeline
Cytovia is the first immune-oncology company with the capabilities to combine gene edited iPSC-derived NK Cell and Flex-NK™ cell engager antibody platforms to develop the next generation of immunotherapies for both hematological and solid tumors.
Cytovia's portfolio includes targets and indications with a balanced risk profile.
GPC3 is a promising novel target for solid tumors, particularly hepatocellular carcinoma, where the unmet medical need is most significant. Cytovia's lead program aims to develop first-in-class HCC therapies targeting GPC3. The initial four product candidates will be evaluated as monotherapies and as combination therapies. CYT-303, Cytovia's GPC3 Flex-NK™ engager, is a tri-specific antibody that binds to HCC tumor cells through GPC3 and to NK cells through NKp46 and CD16a. For patients with either an impaired number or function of NK cells, Cytovia will evaluate the addition of iNK cells, CYT-100, to possibly unlock the full potential of this treatment strategy. Cytovia is also developing CYT-150, gene-edited iNK cells, to improve tumor infiltration and cell persistence, that may also be combined with CYT-303. In addition, CYT-503, a GPC3-targeting CAR-iNK cell therapeutic, is designed to improve specificity for tumor targeting. Cytovia expects to file INDs for CYT-303 and CYT-100, followed by INDs for CYT-150 and CYT-503.
CD38 is a well-established clinical and commercial target for Multiple Myeloma. Cytovia is developing CYT-338 and CYT-538 which are, respectively, CD38-targeting Flex-NK™ cell engagers and CAR-iNK cells for the treatment of Multiple Myeloma in patients that have failed CD38 antibody therapies and agents targeting B-cell maturation antigen (BCMA).
Cytovia is also developing an intracranial EGFR CAR iNK candidate to target both wtEGFR and EGFR vIII to address a significant medical need in the management of the currently untreatable Glioblastoma multiforme.
Cytovia has established collaborations with academic institutions and industry partners including Cellectis for TALEN® gene-editing. TALEN® gene-editing is a technology pioneered and controlled by Cellectis, a clinical-stage biotechnology company using its gene-editing platform to develop life-saving cell and gene therapies. The TALEN® gene-edited patents controlled by Cellectis in the field of iNK and CAR-iNK are licensed from Cellectis by Cytovia and Cytovia holds global development and commercial rights to these patents.
Planned Milestones and Use of Proceeds
Proceeds from private placements (the "PIPE"), funds in Isleworth's trust account (net of redemptions), and proceeds from other prospective financings, in the aggregate amount of up to one hundred million dollars, would provide Cytovia with capital for up to 2 years to further develop its gene-edited iNK and Flex-NK™ cell engager technologies. Cytovia plans to focus on multiple milestones, including:
- Filing the first two INDs for Flex-NK™ CYT-303 and iNK CYT-100
- Initiating Phase I/II clinical trials to evaluate CYT-303 and CYT-100, alone and in combination, for the treatment of HCC
- Obtaining and presenting initial clinical data for CYT-303 and CYT-100 in HCC
- Filing INDs for CYT-150 and CYT-503 and initiating Phase I/II clinical trials
- Continuing to enhance iNK & Flex-NK™ technologies and advance the pipeline with multiple therapeutic candidates
Summary of Transaction
The transaction would value the combined company at a pro forma equity value of $602 million, assuming a $10 per share price, no Isleworth stockholder redemptions and no additional financing obtained prior to the closing of the transaction. As a result of the transaction, the combined company would have up to $227 million in gross proceeds from a combination of approximately $207 million in cash held in Isleworth's trust account (assuming no Isleworth stockholders exercise their redemption rights at closing) and $20 million from PIPE financing of new investors, and without considering the proceeds of any additional prospective financing.
All existing Cytovia equity holders will roll the entirety of their equity holdings into the combined company and are expected to hold approximately half of the issued and outstanding equity of the combined company immediately following the closing (assuming no Isleworth shareholders exercise their redemption rights at closing).
The transaction, which has been approved by each of Isleworth's and Cytovia's Boards of Directors, is expected to be completed in the third quarter of 2022, subject to approval by Isleworth's and Cytovia's shareholders and satisfaction, or the waiver of, customary closing conditions identified in the business combination agreement.
Isleworth and Cytovia have agreed in the business combination agreement to take all necessary action to cause the board of directors of the combined company immediately following the closing to consist of seven directors, of whom two individuals will be designated by Isleworth and five individuals will be designated by Cytovia. Each designee will meet the director qualification and eligibility criteria of the Nominating and Corporate Governance committee of the board of directors of Isleworth, and a number of Cytovia designees will qualify as independent directors as determined by the board of directors of Isleworth such that a majority of the directors as of immediately following the closing will qualify as independent directors.
I-Bankers Securities, Inc. is serving as capital markets advisor and placement agent to Isleworth. Truist Securities is acting as financial advisor, placement agent and capital markets advisor to Cytovia. BTIG LLC is acting as capital markets advisor to Cytovia.
Cooley LLP is serving as legal advisor to Cytovia. ArentFox Schiff LLP is serving as legal advisor to Isleworth. Goodwin Procter is serving as legal advisor to Truist Securities in its role as placement agent.
About Cytovia Therapeutics
Cytovia Therapeutics aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on harnessing the innate immune system by developing complementary and disruptive NK-cell and NK-engager antibody platforms. The company is developing three types of iPSC-derived (or iNK) cells: unedited iNK cells, TALEN® gene-edited iNK cells with improved function and persistence, and TALEN® gene-edited iNK cells with chimeric antigen receptors (CAR-iNKs) to improve tumor-specific targeting. The second complementary cornerstone technology is a quadrivalent multifunctional antibody platform designed to engage natural killer cells by targeting NKp46 using Cytovia's proprietary Flex-NK™ technology.
These two technology platforms are being used to develop treatments for patients with solid tumors such as HCC and Glioblastoma as well as hematological malignancies such as Refractory Multiple Myeloma.
Headquartered in Aventura, FL, Cytovia has research and development laboratories in Natick, MA, and a GMP cell manufacturing facility in Puerto Rico. The company's own R&D work is augmented through scientific partnerships with Cellectis, CytoImmune, the Hebrew University of Jerusalem, INSERM, the New York Stem Cell Foundation and the University of California San Francisco (UCSF).
Cytovia has a strategic partnership with CytoLynx Therapeutics, which is focused on research and development, manufacturing, and commercialization activities in Greater China and beyond.
About Isleworth Healthcare Acquisition Corp.
Isleworth Healthcare Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Isleworth has operating expertise in managing large and high growth businesses and more specifically, in the life sciences industry. Collectively, Isleworth has built, managed, bought and sold companies or technologies all over the world. Al Weiss (Chairman, Director), former President, Worldwide Operations Walt Disney Parks and Resorts, and Bob Whitehead (CEO, Director), a long-standing pharmaceutical executive, in the United States and internationally, and in large and emerging stage companies, lead the team. The team includes Dan Halvorson (EVP & CFO, Director), experienced public and private company executive in financial planning and operations in the life science, technology and artificial intelligence industries; Vipul Patel, MD, (Director), a pioneer in the development and utilization of robotic surgical technologies, and is connected to many emerging stage lifescience companies; Monica Reed, M.D. (Director), an experienced healthcare leader of large regional healthcare systems and community hospitals, and serves on various bioscience boards; Bob Dahl (Director), formerly Managing Director of Healthcare Investments at the Carlyle Group and was previously co-head of healthcare investment banking at Credit Suisse; and Michelle McKenna (Director), an experienced board member who has significant experience in M&A and early stage companies, and as a C-suite executive of the NFL, was responsible for the highly effective Covid-19 contract tracing program across the league.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will, "estimate," "continue," "anticipate," "intend," expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to statements regarding estimates and forecasts of financial and performance metrics, including the benefits of the proposed business combination, the anticipated timing of the proposed business combination, Cytovia's expectations regarding cash runway, projections of market opportunity, operating results, debt levels, potential revenues, business strategies, various addressable markets, anticipated trends, industry environment, developments in markets in which Cytovia operates, the initiation, timing, progress, scope and results of Cytovia's ongoing pre-clinical studies, planned clinical trials and research and development programs, the timing, availability and presentation of pre-clinical and regulatory developments, Cytovia's ability to timely file and obtain approval of investigational new drug applications for its planned clinical trials, the potential benefits of Cytovia's platforms, programs and product candidates, the development and the commercial potential, growth potential and market opportunity for Cytovia's product candidates, if approved, and the drivers, timing, impact and results thereof, the potential and future results of current and planned collaborations, Cytovia's ability to obtain and maintain regulatory approval of any of Cytovia's product candidates, Cytovia's plans to research, discover and develop additional product candidates, including by leveraging other technologies and expanding into additional indications, Cytovia's ability to expand its manufacturing capabilities, and to manufacture its product candidates and scale production, Cytovia's ability to meet certain milestones , and the effects of regulations and Isleworth's or Cytovia's projected future results. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the respective managements of Cytovia and Isleworth and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions this press release relies on. Many actual events and circumstances are beyond the control of Cytovia and Isleworth. These forward-looking statements are subject to a number of risks and uncertainties, including (i) changes in domestic and foreign business, market, financial, political, economic and legal conditions; (ii) the risk that the proposed business combination may not be completed in a timely manner or at all, which may adversely affect the price of Isleworth's securities; (iii) failure to realize the anticipated benefits of the business combination or to obtain additional financing, including financing the parties intend to obtain prior to the consummation of the business combination to meet the minimum cash condition contained in the business combination agreement related to the proposed business combination and to fund operations and future product development; (iv) risks relating to the uncertainty of projected information, including Cytovia's ability to project future capital needs, cash utilization and potential cash inflows, and timing with respect to Cytovia and its product candidates; (v) uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing pre-clinical studies and planned clinical trials candidates; (vi) difficulties arising from Cytovia's third-party licenses, or supply-chain or manufacturing challenges; (vii) unexpected safety or efficacy data observed during pre-clinical or clinical studies; (viii) the failure of the data from Cytovia's pre-clinical trials to be indicative in human trials; (ix) the ability of Cytovia to protect its intellectual property rights; (x) trends in the industry, changes in the competitive landscape, and delays or disruptions due to the COVID-19 pandemic, including the risk that the ongoing COVID-19 pandemic and the associated containment efforts may disrupt Cytovia's business and/or the global healthcare system (including its supply chain) more severely than it has to date or more severely than anticipated; (xi) the effects of competition on Cytovia's future business and the ability of the combined company to grow and manage growth profitably, maintain relationships with collaborators, manufacturers, suppliers, licensors or strategic partners and retain its management and key employees; (xii) changes in the legal and regulatory framework for the industry or unexpected litigation or disputes and future expenditures; (xiii) the risk that the proposed business combination may not be completed by Isleworth's business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Isleworth; (xiv) the failure to satisfy the conditions to the consummation of the proposed business combination in the anticipated manner or on the anticipated timeline, including the approval of the proposed business combination by the stockholders of Isleworth and Cytovia, the satisfaction of the minimum trust account amount following redemptions by Isleworth's public stockholders and the receipt of certain governmental and regulatory approvals; (xv) the effect of the announcement or pendency of the proposed business combination on Cytovia's business relationships, performance, and business generally; (xvi) risks that the announcement and consummation of the proposed business combination disrupts current plans and operations of Cytovia and Isleworth and potential difficulties in Cytovia employee retention as a result of the proposed business combination; (xvii) the outcome of any legal proceedings that may be instituted against Isleworth or Cytovia related to the agreement and plan of merger or the proposed business combination; (xviii) the ability to maintain the listing of Isleworth's securities on the NASDAQ or the combined company's securities on the NASDAQ or another securities exchange; (xix) the price of Isleworth's securities, including volatility resulting from changes in the competitive and highly regulated industries in which Cytovia plans to operate, variations in performance across competitors, changes in laws and regulations affecting Cytovia's business and changes in the combined capital structure; (xx) any changes to accounting methods of Isleworth; (xxi) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed business combination, and identify and realize additional opportunities; and (xxii) those factors discussed in Isleworth's Annual Report on Form 10-K for the year ended December 31, 2021 under the heading "Risk Factors," and other documents Isleworth has filed, or will file, with the Securities and Exchange Commission (the "SEC"). If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements.
There may be additional risks that neither Isleworth nor Cytovia presently knows, or that Isleworth or Cytovia currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Isleworth's and Cytovia's expectations, plans, or forecasts of future events and views as of the date of this press release. Isleworth and Cytovia anticipate that subsequent events and developments will cause Isleworth's and Cytovia's assessments to change. However, while Isleworth and Cytovia may elect to update these forward-looking statements at some point in the future, Isleworth and Cytovia specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Isleworth's and Cytovia's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.
Additional Information About the Proposed Business Combination and Where To Find It
The proposed business combination will be submitted to shareholders of Isleworth and Cytovia for their consideration. Isleworth intends to file a registration statement on Form S-4 (the "Registration Statement") with the SEC which will include preliminary and definitive proxy statements to be distributed to Isleworth's shareholders in connection with Isleworth's solicitation of proxies for the vote by Isleworth's shareholders in connection with the proposed business combination and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to Cytovia's shareholders in connection with the completion of the proposed business combination. After the Registration Statement has been filed and declared effective, Isleworth will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the proposed business combination. Isleworth's shareholders and other interested persons are urged to read, once available, the preliminary proxy statement/information statement/prospectus and any amendments thereto, the definitive proxy statement/information statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with Isleworth's solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the proposed business combination, because these documents will contain important information about Isleworth, Cytovia and the proposed business combination. Shareholders may also obtain a copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the proposed business combination and other documents filed with the SEC by Isleworth, without charge, at the SEC's website located at www.sec.gov or by directing a request to 360 Central Avenue, First Central Tower, Suite #800, St. Petersburg, Florida 33701.
Participants in the Solicitation
Isleworth, Cytovia and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitations of proxies from Isleworth's shareholders in connection with the proposed business combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of Isleworth's shareholders in connection with the proposed business combination will be set forth in Isleworth's proxy statement/information statement/prospectus when it is filed with the SEC. You can find more information about Isleworth's directors and executive officers in Isleworth's 2021 Form 10-K. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests will be included in the proxy statement/information statement/prospectus when they become available. Shareholders, potential investors and other interested persons should read the proxy statement/information statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.
Non-Solicitation
This press release does not constitute an offer to sell or exchange or the solicitation of an offer to buy or exchange any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction
INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
View original content to download multimedia:
SOURCE Cytovia Therapeutics | https://www.kxii.com/prnewswire/2022/04/26/isleworth-healthcare-acquisition-corp-cytovia-therapeutics-announce-agreement-business-combination-create-publicly-listed-company-focused-empowering-natural-killer-cell-therapeutics-fight-cancer/ | 2022-04-27T03:23:22Z |
First quarter results reflect strong marketing contribution and support revised full year outlook amidst growing sector activity
CALGARY, AB, May 5, 2022 /PRNewswire/ - Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL) (NYSE: PBA) announced today its financial and operating results for the first quarter 2022.
Highlights
- Record Quarterly Results – delivered first quarter earnings of $481 million and record quarterly adjusted EBITDA of $1 billion, reflecting higher natural gas liquids and crude oil prices and margins, and rising volumes on key systems.
- Guidance Raised – 2022 adjusted EBITDA guidance range has been revised to $3.45 to $3.6 billion (previously $3.35 to $3.55 billion).
- Peace Pipeline Expansion Updates – the Phase VIII expansion has been reactivated and the Phase VII expansion is undergoing final commissioning and is expected to enter commercial service on June 1, 2022 ahead of schedule and under budget.
- New NEBC Producer Commitment – Pembina has entered into a 20-year midstream services agreement, for the transportation and fractionation of liquids, with a premier northeast British Columbia Montney producer.
- New Gas Processing Joint Venture – as previously disclosed, Pembina has entered into definitive agreements with affiliates of KKR & Co., Inc. (collectively, "KKR") to combine their respective western Canadian natural gas processing assets into a single, new joint venture entity. Closing of the transaction is expected in the third quarter.
- Alberta Carbon Grid – during the first quarter, the Government of Alberta announced that the Alberta Carbon Grid has been successfully chosen to move to next stage of the Province's carbon capture, utilization and storage process in the industrial heartland.
Financial and Operational Overview
Financial and Operational Overview by Division
Financial & Operational Highlights
Adjusted EBITDA
Change in First Quarter Adjusted EBITDA ($ millions)(1)
In the first quarter, Pembina reported record quarterly adjusted EBITDA of $1 billion, representing a 20 percent increase over the same period in the prior year. The first quarter was positively impacted by stronger marketing results due to higher margins on NGL and crude oil sales and lower realized losses on commodity-related derivatives, combined with a higher share of profit from Aux Sable. Adjusted EBITDA also benefited from higher volumes in combination with higher tolls on the Peace Pipeline system; higher recoverable costs on the Horizon Pipeline related to extensive slope mitigation; contributions from the Prince Rupert Terminal coming into service in March 2021; and a higher share of profit from Veresen Midstream, due to the Hythe Developments entering service in March 2021 and higher volumes at the Dawson Assets. These positive factors were partially offset by lower contracted volumes on the Nipisi and Mitsue pipeline systems, due to the expiration of contracts; a lower contribution from Ruby Pipeline; and higher general and administrative costs, due to higher long-term incentives driven by an increase in Pembina's share price compared to the prior period and Pembina's performance relative to peers.
Earnings
Change in First Quarter Earnings ($ millions)(1)(2)
In the first quarter, Pembina recorded earnings of $481 million, which represents a 50 percent increase relative to the same period in the prior year. In addition to the factors impacting adjusted EBITDA, as noted above, earnings were positively impacted by lower impairments and a higher unrealized gain on commodity-related derivatives for certain gas processing fees tied to AECO prices. First quarter earnings were negatively impacted by higher income tax expense and a lower share of profit from Ruby Pipeline.
Cash Flow From Operating Activities
Cash flow from operating activities of $655 million for the first quarter represents an increase of 44 percent over the same period in the prior year. The increase was primarily driven by an increase in operating results after adjusting for non-cash items, higher distributions from equity accounted investees, and a change in non-cash working capital, partially offset by increases in taxes paid, share-based compensation payments, and net interest paid. On a per share (basic) basis, cash flow from operating activities increased by 43 percent due to the same factors.
Adjusted Cash Flow From Operating Activities
Adjusted cash flow from operating activities of $700 million represents a 20 percent increase over the same period in the prior year. The increase was due to the factors impacting cash flow from operating activities, discussed above, net of the change in non-cash working capital, taxes paid, and share-based compensation payments, partially offset by higher current tax expense and an increase in accrued share-based payments. On a per share (basic) basis, adjusted cash flow from operating activities increased by 20 percent due to the same factors.
Volumes
Total volumes of 3,369 mboe/d for the first quarter represent a decrease of approximately three percent over the same period in the prior year. The decrease was the result of lower volumes in both the Pipelines and Facilities divisions due to contract expirations, offset by higher volumes on certain systems and new assets placed into service, as well as other factors as discussed in further detail below.
Divisional Highlights
- Pipelines had reportable segment earnings before tax in the first quarter of $361 million, representing an eight percent increase over the same period in the prior year. The increase was largely due to higher volumes on the Peace Pipeline system, as higher crude oil and NGL market prices resulted in increased upstream activities, in combination with higher tolls, largely due to inflation; higher recoverable costs from Horizon Pipeline System, due to extensive slope mitigation; and lower impairment charges. These factors were partially offset by a lower share of profit from Ruby, and the expiration of contracts on the Nipisi and Mitsue pipeline systems.
Pipelines reported adjusted EBITDA for the first quarter of $521 million, representing a two percent decrease compared to the same period in the prior year. The decrease was due to the same items impacting reportable segment earnings before tax, discussed above, net of the decrease in impairments, as well as a lower contribution from Ruby due to contract expirations that occurred in mid-2021.
Pipelines volumes of 2,493 mboe/d in the first quarter represent a four percent decrease compared to the same period in the prior year. The decrease largely was driven by lower contracted volumes on the Nipisi and Mitsue pipeline systems and on the Ruby Pipeline, combined with lower volumes on the Alberta Ethane Gathering System due to third party outages, partially offset by higher volumes on the Peace Pipeline and the Drayton Valley Pipeline.
- Facilities had reportable segment earnings before tax in the first quarter of $246 million, which represents a 32 percent increase over the same period in the prior year. Certain gas processing fees that are tied to AECO prices were positively impacted by the increase in the AECO price, resulting in an increase in the realized and unrealized gain on commodity-related derivatives compared to the prior period. The first quarter of 2022 was also positively impacted by a full quarter contribution from the Prince Rupert Terminal, which was placed into service in March 2021, as well as a higher share of profit from Veresen Midstream due to the Hythe Developments going into service in March 2021 and higher volumes at the Dawson Assets. These positive factors were partially offset by higher non-recoverable operating expenses.
Facilities reported adjusted EBITDA of $281 million for the first quarter, representing a four percent increase over the same period in the prior year. The increase was primarily due to the same items impacting reportable segment earnings before tax, discussed above, net of the unrealized gains on commodity-related derivatives.
Facilities volumes of 876 mboe/d in the first quarter represent a two percent decrease compared to the same period in the prior year. The quarterly decrease is largely due to lower volumes from NGL services, partially offset by higher volumes at Veresen Midstream at the Dawson Assets and from the Hythe Developments going into service in March 2021.
- Marketing & New Ventures had first quarter reportable segment earnings before tax of $221 million, representing a 230 percent increase over the same period in the prior year. Improvements in commodity market prices, including NGL, crude oil and condensate, contributed to a significant quarter-over-quarter increase in results for the marketing business. Contributions were made by NGL marketing where higher margins resulted when seasonable inventories built up during the second and third quarters of 2021 were sold during the first quarter of 2022 in a higher price environment. In addition, crude oil marketing realized strong blending margins due to the rapidly rising crude oil price environment.
Reportable segment earnings before tax benefited from higher margins due to higher NGL and crude oil market prices; a lower realized loss on commodity-related derivatives compared to the same period in the prior year; and a higher share of profit from Aux Sable as a result of higher NGL margins, partially offset by the impact of a narrower AECO-Chicago price differential. First quarter reportable segment earnings before tax were negatively impacted by a higher unrealized loss on commodity-related derivatives.
Marketing & New Ventures reported first quarter adjusted EBITDA of $268 million, which represents a 198 percent increase compared to the first quarter of 2021. The increase was due to the same items impacting reportable segment earnings before tax, discussed above, net of the unrealized loss on commodity-related derivatives.
Marketed NGL volumes of 206 mboe/d in the first quarter represent a seven percent decrease compared to the same period in the prior year. Marketed NGL volumes decreased largely due to lower propane sales during the first quarter of 2022 compared to the first quarter of 2021 when Pembina monetized storage positions that were built up during the second and third quarters of 2020, combined with lower ethane sales caused by third-party outages.
Executive Overview
The first quarter of 2022 delivered a tremendous start to the year. Financial and operating results, including record quarterly adjusted EBITDA, reflect a strong contribution from Pembina's marketing business, growing volumes on many key systems and new assets recently placed into service. Our growing optimism over the future of the Western Canadian Sedimentary Basin ("WCSB") remains intact and the positive discussions we have been having with customers over the past year are translating into contracting success and long-term commitments for future volumes to support higher utilization of Pembina's existing asset base as well as accretive and capital efficient new growth projects.
Physical volumes on Pembina's conventional pipeline systems continue to grow and serve as a good proxy for Pembina's broader business and the WCSB in general. Physical volumes in the first quarter of 2022 increased nearly five percent compared to the first quarter of 2021 and that trend has continued into April, with physical volumes reaching an all-time monthly high.
Pembina is continuing to realize the financial benefits of growing volumes, however incremental volumes are also leading to constraints on certain segments of the Peace Pipeline. Therefore, we are pleased with the upcoming placement into service of the Phase VII Peace Pipeline Expansion ("Phase VII"), the reactivation of the Phase VIII Peace Pipeline Expansion ("Phase VIII") and continued construction progress on the Phase IX Peace Pipeline Expansion ("Phase IX"), each of which is discussed in more detail below and collectively will allow Pembina to continue to provide industry-leading transportation service to our producing customers in a highly capital efficient manner.
The first quarter was also highlighted by the announcement that Pembina and KKR will combine their respective western Canadian natural gas processing assets into a single, new joint venture entity. We also were pleased to announce our intention to increase Pembina's common share dividend $0.0075 per share per month, or 3.6 percent upon closing of this transaction, which we expect in the third quarter of 2022.
Guidance Update
Pembina has raised its 2022 adjusted EBITDA guidance range to $3.45 to $3.6 billion (previously $3.35 to $3.55 billion). Relative to Pembina's initial guidance, the revised outlook for 2022 primarily reflects stronger marketing results, as a result of higher expected NGL and crude oil prices, partially offset by higher realized hedging losses. In addition, the revised outlook reflects the removal of Ruby Pipeline adjusted EBITDA from April 1 through the remainder of 2022 pending resolution of the Chapter 11 process, as well as the impact of a higher long-term share-based incentive expense given the increase in Pembina's share price. Current guidance does not include the impact of the Newco transaction.
Cash flow from operating activities is expected to exceed dividends and the capital investment program in 2022. As previously disclosed, Pembina expects to allocate a portion of the excess towards common share repurchases, with the balance available for incremental capital investment, debt repayment, or additional distribution to shareholders. As of the current date and including shares repurchased in December 2021, Pembina has completed $58 million towards its 2022 target.
Business Update
Northeast British Columbia ("NEBC") Producer Commitments
Pembina has entered into a 20-year midstream services agreement for the transportation and fractionation of liquids from ConocoPhillips Canada's ("CPC") Montney development in NEBC. Under the arrangement, which was preceded by the previously announced exclusivity agreement, and subject to certain exclusions, CPC has dedicated liquids production from the majority of its acreage within the liquids-rich NEBC region of the Montney resource play. Any new firm transportation and fractionation services provided by Pembina in respect of liquids production will be supported by long-term, take-or-pay agreements at competitive market rates.
"ConocoPhillips Canada continues to pursue innovative solutions to improve netbacks and overall returns," said ConocoPhillips Canada president Bij Agarwal. "We value our established mutually beneficial working relationship with Pembina and look forward to working together to realize the full potential of our significant Montney asset."
Pembina is in the process of building out its network of pipeline capacity with its phased Peace Pipeline expansions, which will provide CPC and NEBC region producers with liquids egress when required. Under the dedication, further infrastructure development remains contingent upon CPC requesting service, as well as any environmental and regulatory approvals that may be required. Beyond the Phase VII, Phase VIII and Phase IX expansions, no significant additional capital expenditures are expected to initially be required to transport incremental volumes. Longer-term capital requirements will be aligned with the scope and timing of CPC's development.
In addition, as previously disclosed, Pembina recently executed a new agreement with a second Montney producer, which commits to Pembina volumes from a multiphase development of the producer's NEBC Montney acreage, on a take-or-pay basis, upon the acreage being developed. The agreement provides the producer with certainty of transportation egress from this key area for their future development and access to the remainder of Pembina's integrated value chain.
Finally, Pembina has finalized commercial terms with a third leading Montney producer regarding significant long-term NEBC volume commitments and expects commercial agreements to be signed by mid-2022.
"These agreements are exciting opportunities to further strengthen Pembina's relationship with premier NEBC producers in a strategically important region. They highlight Pembina's advantages in the face of increasing competition for Montney volumes and demonstrate the value our customers continue to place on our already in-place assets, strong track record of safety and reliability, competitive fees and integrated service offering," said Pembina's Jaret Sprott, Senior Vice President & Chief Operating Officer.
Pembina is poised to benefit from a promising outlook for NEBC development. As a result of these long-term commitments and the agreements that have been executed, or are anticipated to be executed later this year, Pembina expects to have secured the transportation rights to a significant portion of forecasted future growth in the NEBC Montney, which collectively will support improved utilization of its existing assets as well as capital efficient expansion projects into the future.
Peace Pipeline Expansions
Phase VIII Peace Pipeline Expansion
As a result of the commitments secured and ongoing conversations with other customers, Pembina is pleased to be reactivating the previously deferred Phase VIII, which will enable segregated pipeline service for ethane-plus and propane-plus NGL mix from the central Montney area at Gordondale, Alberta, into the Edmonton, Alberta area for market delivery. Based on the significant long-term commitments from leading NEBC producers discussed above, we have clear visibility to the demand for incremental capacity in this region and as a result we are confident in the decision to reactivate Phase VIII at this time.
The scope of Phase VIII has been optimized to align with current system constraints and forecasted future demand and redeploys certain infrastructure from the original Phase VII project scope. Phase VIII will include new 10 and 16-inch pipelines, totaling approximately 150 kilometers, in the Gordondale to La Glace corridor of Alberta, as well as additional new mid-point pump stations and terminal upgrades located throughout the Peace Pipeline system. This project will add approximately 235,000 barrels per day ("bpd") of incremental capacity between Gordondale, Alberta and La Glace, Alberta, as well as approximately 65,000 bpd of capacity between La Glace, Alberta and the Namao hub near Edmonton, Alberta.
The project has an estimated cost of approximately $530 million, which relative to the original $500 million cost estimate, reflects the optimized scope and the net effect of cost increases due to market factors and cost savings arising from value engineering. Phase VIII is anticipated to be placed into service in the first half of 2024. Approximately $75 million had been spent on this project at the end of 2021, with an incremental $100 million expected to be spent in 2022.
Completion of the Phase VIII and Phase IX expansions will enable full segregation of LVP and HVP products along the Peace Pipeline system, thereby enabling further system optimization opportunities due to the reduction of batching and need for quality management. This optimization, along with other continuous improvement activities, could create material incremental capacity with minimal capital spending.
Phase VII Peace Pipeline Expansion
Construction and line fill of Phase VII are complete and final commissioning is underway. Phase VII is expected to be approximately $150 million under budget and is expected to enter commercial service on June 1, 2022. Phase VII was constructed to provide transportation for the growing condensate supply in the WCSB and will divert condensate off of the existing LaGlace-Kakwa-Fox Creek corridor, creating additional firm capacity for Pembina's customers.
Pembina continues to have the ability to add approximately 200,000 bpd of capacity to its market delivery pipelines from Fox Creek, Alberta to Namao, Alberta through the relatively low-cost addition of pump stations on these mainlines, bringing the total capacity of the Peace and Northern pipelines to 1.3 million bpd.
Alliance Pipeline Open Season
Recent contracting success continues to highlight the value of Alliance's reliable and highly competitive access to mid-western U.S. gas markets, and as a conduit to the Gulf Coast and its robust liquefied natural gas market.
During the first quarter of 2022, Alliance offered six open seasons to the market. One of the open seasons was for Canadian long-term firm service which resulted in an incremental 75 MMcf/d of long-term firm service, with service commencing in November 2022, for a volume averaged weighted term of 7.6 years. The remaining open seasons were for Canadian short-term firm service (terms of 364 days or less), which secured contracts at a volume weighted average toll of approximately 120 percent of long-term firm Alliance tolls in Canada for November 2022 onward.
Recent open seasons have resulted in Alliance being contracted over 90 percent for the current gas year and 75 percent for the next gas year.
Projects and New Developments
Pipelines
- As discussed above, the Phase VII Peace Pipeline Expansion is expected to enter commercial service on June 1, 2022 ahead of schedule and under budget and Pembina has reactivated the Phase VIII Peace Pipeline Expansion.
- The Phase IX Peace Pipeline Expansion includes new 6-inch and 16-inch pipelines debottlenecking the corridor north of Gordondale, Alberta, as well as upgrades at one pump station. In addition, this expansion will see existing pipelines, which are currently batching, converted to single product lines. Phase IX also includes a pump station in the Wapiti-to-Kakwa corridor. Clearing activities are complete and mainline pipe delivery and construction are expected to commence in June. The Phase IX Peace Pipeline Expansion remains on-time and on-budget with an estimated cost of approximately $120 million and an expected in-service date in the fourth quarter of 2022.
- As described further below, on March 31, 2022, Ruby Pipeline, LLC voluntarily filed for relief under Chapter 11 of the U.S. Bankruptcy Code.
Facilities
- On March 1, 2022, Pembina announced that it has entered into definitive agreements with KKR to combine their respective western Canadian natural gas processing assets into a single, new joint venture entity ("Newco"). Pembina will hold a 60 percent interest in Newco and serve as its operator and manager, while KKR's global infrastructure funds will hold the remaining 40 percent interest in Newco.
Pembina will contribute to Newco its field-based gas processing assets, which include the Cutbank Complex, the Saturn Complex, the Resthaven Facility, the Duvernay Complex and the Saskatchewan Ethane Extraction Plant, as well as its 45 percent interest in Veresen Midstream. Pembina's Empress, Younger and Burstall assets will be excluded from the transaction and Pembina will retain its current ownership position in respect of such assets.
KKR will contribute its 55 percent interest in Veresen Midstream to Newco, as well as the 49 percent interest in Energy Transfer Canada ULC ("ETC") that it currently owns. Newco has also agreed to acquire the remaining 51 percent interest in ETC from an affiliate of Energy Transfer LP, aligning ownership of those assets and driving additional efficiencies within Newco. The contribution of Pembina's and KKR's assets to Newco, and Newco's acquisition of the remaining 51 percent interest in ETC, are cross-conditional upon each other and will occur concurrently. As part of the transaction, Pembina and KKR intend to dispose of Newco's non-operated interest in the Key Access Pipeline System following closing of the transaction, subject to receiving acceptable purchase terms through the sale process. Closing is expected to occur in the third quarter of 2022.
- Construction of the Empress Cogeneration Facility is progressing and the project remains ahead of schedule and on-budget with an estimated cost of approximately $120 million and an expected in-service date in the fourth quarter of 2022.
- Subsequent to quarter end, after careful consideration Pembina made the decision to not proceed with the previously deferred expansion of Prince Rupert Terminal at this time. This decision was informed by a refreshed evaluation of market dynamics that included customer demand, shipping costs, and North American and international pricing. Given the outlook for strong domestic propane prices and new propane demand sources under development within the WCSB, Pembina believes it can provide customers with a more capital efficient offering that still achieves high netbacks. Pembina's advantaged unit train capabilities along with its current Prince Rupert Terminal provide customers a diversified portfolio of markets, without the additional international egress from an expansion. Pembina will continue to evaluate and enhance its portfolio of propane sales options and will consider future expansion opportunities as market conditions evolve.
Marketing & New Ventures
- Pembina and TC Energy intend to jointly develop the Alberta Carbon Grid, a world-scale carbon transportation and sequestration system, which will enable Alberta-based industries to effectively manage their greenhouse gas emissions, contribute positively to Alberta's lower-carbon economy and create sustainable long-term value for Pembina and TC Energy stakeholders. During the first quarter, the Government of Alberta announced that the Alberta Carbon Grid has been successfully chosen to move to next stage of the Province's carbon capture, utilization and storage ("CCUS") process in the industrial heartland. As an open-access system, the Alberta Carbon Grid will be a significant component of Alberta's emerging CCUS industry, connecting key sequestration locations and delivery points across the province to serve multiple industries. When fully constructed, the system is designed with the potential capability of transporting and sequestering more than 20 million tonnes of CO2 annually, which would be equivalent to removing 7.5 million cars off the road each year. The project is part of Pembina's ongoing commitment to energy diversification and will support federal emissions targets to reduce CO2 and other greenhouse gas emissions by at least 40 percent compared to 2005 levels by 2030.
- Pembina has entered into a partnership agreement with the Haisla First Nation to develop the proposed Cedar LNG Project, a floating LNG facility strategically positioned to leverage Canada's abundant natural gas supply and British Columbia's growing LNG infrastructure to produce industry-leading low–carbon, low-cost Canadian LNG for overseas markets. Cedar LNG's application for an Environmental Assessment Certificate was recently submitted to the British Columbia Environmental Assessment Office, moving the project into the 180-day application review phase. Cedar LNG has also entered into agreement for the front-end engineering and design of the Cedar LNG's proposed floating liquefaction, storage and offloading unit, and begun commercial discussions.
Financing Activity
- On March 8, 2022, the Toronto Stock Exchange ("TSX") accepted the renewal of Pembina's normal course issuer bid (the "NCIB") that allows the Company to repurchase, at its discretion, up to approximately 27.5 million common shares through the facilities of the TSX, the New York Stock Exchange and/or alternative Canadian trading systems or as otherwise permitted by applicable securities law, subject to certain restrictions on the number of common shares that may be purchased on a single day. Common shares purchased by the Company will be cancelled. The NCIB commenced on March 10, 2022 and will terminate on March 9, 2023 or on such earlier date as the Company has purchased the maximum number of common shares permitted pursuant to the notice of intention under the normal course issuer bid or at such time Pembina determines to no longer make purchases thereunder. During the quarter 600,000 common shares were repurchased for cancellation at an average price of $46.43 per share and a total cost of $28 million. As previously disclosed, Pembina repurchased $17 million of common shares in 2021. An additional $13 million of common shares were repurchased subsequent to the quarter, in April.
- On March 14, 2022, Pembina's $50 million senior unsecured medium term notes, Series 3A, matured and were fully repaid.
- Ruby Pipeline, L.L.C. ("Ruby Pipeline"), a wholly-owned subsidiary of Ruby, had U.S. $475 million principal amount of unsecured notes that matured on April 1, 2022 (the "2022 Notes"). Although Ruby Pipeline has sufficient liquidity to operate its business, it lacked sufficient liquidity to satisfy its obligations under the 2022 Notes on the maturity date of April 1, 2022. Accordingly, on March 31, 2022, Ruby Pipeline filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The risks and uncertainties surrounding the Chapter 11 proceedings raise substantial doubt as to Ruby Pipeline's ability to continue as a going concern.
Pembina does not have any financial commitments or obligations in respect of the debts or obligations of Ruby Pipeline, including in respect of the 2022 Notes, nor is Pembina contractually obligated to provide any further contributions or funding to Ruby.
Dividends
- Pembina declared and paid dividends of $0.21 per common share in January, February and March 2022 for the applicable record dates.
- In connection with the Newco transaction with KKR, upon closing, and subject to approval and declaration by its Board of Directors, Pembina also intends to increase its common share dividend by $0.0075 per share per month, or 3.6 percent. The increase, if implemented, would reflect the expected immediate cash flow accretion from creation of the joint venture.
- Pembina declared and paid quarterly dividends per Class A Preferred Share of: Series 1: $0.306625; Series 3: $0.279875; Series 5: $0.285813; Series 7: $0.27375; Series 9: $0.268875; and Series 21: $0.30625 to shareholders of record as of February 1, 2022. Pembina also declared and paid quarterly dividends per Class A Preferred Share of: Series 15: $0.279; Series 17: $0.301313; and Series 19: $0.29275 to shareholders of record on March 15, 2022. Pembina also declared and paid quarterly dividends per Class A Preferred Share of Series 23: $0.328125; and Series 25: $0.325 to shareholders of record on January 32, 2022.
First Quarter 2022 Conference Call & Webcast
Pembina will host a conference call on Friday, May 6, 2022 at 8:00 a.m. MT (10:00 a.m. ET) for interested investors, analysts, brokers and media representatives to discuss results for the first quarter of 2022. The conference call dial-in numbers for Canada and the U.S. are 647-792-1240 or 800-437-2398. A recording of the conference call will be available for replay until May 13, 2022 at 11:59 p.m. ET. To access the replay, please dial either 647-436-0148 or 888- 203-1112 and enter the password 1397681.
A live webcast of the conference call can be accessed on Pembina's website at www.pembina.com under Investors / Presentation & Events, or by entering:
https://produceredition.webcasts.com/starthere.jsp?ei=1501650&tp_key=057312b160 in your web browser. Shortly after the call, an audio archive will be posted on the website for a minimum of 90 days.
Annual Meeting of Common Shareholders
The Company will hold its Annual Meeting of Common Shareholders ("AGM") on Friday, May 6, 2022 at 2:00 p.m. MT (4:00 p.m. ET). The AGM will be held as a virtual-only meeting, which will be conducted via live webcast at
https://web.lumiagm.com/#/431537915. Participants are recommended to register for the virtual webcast at least 10 minutes before the presentation start time. For further information on Pembina's virtual AGM, kindly visit www.pembina.com.
About Pembina
Pembina Pipeline Corporation is a leading energy transportation and midstream service provider that has served North America's energy industry for more than 65 years. Pembina owns an integrated network of hydrocarbon liquids and natural gas pipelines, gas gathering and processing facilities, oil and natural gas liquids infrastructure and logistics services, and a growing export terminals business. Through our integrated value chain, we seek to provide safe and reliable infrastructure solutions which connect producers and consumers of energy across the world, support a more sustainable future and benefit our customers, investors, employees and communities. For more information, please visit www.pembina.com.
Purpose of Pembina:
To be the leader in delivering integrated infrastructure solutions connecting global markets:
- Customers choose us first for reliable and value-added services;
- Investors receive sustainable industry-leading total returns;
- Employees say we are the 'employer of choice' and value our safe, respectful, collaborative and inclusive work culture; and
- Communities welcome us and recognize the net positive impact of our social and environmental commitment.
Pembina is structured into three Divisions: Pipelines Division, Facilities Division and Marketing & New Ventures Division.
Pembina's common shares trade on the Toronto and New York stock exchanges under PPL and PBA, respectively. For more information, visit www.pembina.com.
Forward-Looking Statements and Information
This document contains certain forward-looking statements and forward looking information (collectively, "forward-looking statements"), including forward-looking statements within the meaning of the "safe harbor" provisions of applicable securities legislation, that are based on Pembina's current expectations, estimates, projections and assumptions in light of its experience and its perception of historical trends. In some cases, forward-looking statements can be identified by terminology such as "continue", "anticipate", "schedule", "will", "expects", "estimate", "potential", "planned", "future", "outlook", "strategy", "protect", "trend", "commit", "maintain", "focus", "ongoing", "believe" and similar expressions suggesting future events or future performance.
In particular, this document contains forward-looking statements, including certain financial outlooks, pertaining to, without limitation, the following: Pembina's corporate strategy and the development of new business initiatives and growth opportunities, including the anticipated benefits therefrom and the expected timing thereof; expectations about industry activities and development opportunities, including our operating segment outlooks and general market conditions for 2022 and thereafter; expectations about future demand for Pembina's infrastructure and services; expectations relating to new infrastructure projects, including the benefits therefrom and timing thereof; Pembina's sustainability, climate change and environmental, social and governance plans, initiatives and strategies, including expectations relating to Pembina's greenhouse gas emissions reduction target; Pembina's revised 2022 annual guidance, including the Company's expectations regarding its adjusted EBITDA; expectations relating to the joint venture transaction between Pembina and KKR, including the terms thereof, including the assets to be contributed by Pembina and KKR, the expected closing date and the anticipated benefits thereof to Pembina; the post-closing business and assets of Newco, including Pembina's role as manager and operator of Newco; the post-closing ownership of Newco; the acquisition by Newco of the remaining 51% interest in ETC, including the terms and expected timing thereof; the proposed disposition by Newco of the KAPS project, including the expected timing thereof; Pembina's future common share dividends, including Pembina's intention to increase the amount thereof following closing of the joint venture transaction with KKR; planning, construction and capital expenditure estimates, schedules, locations; expected capacity, incremental volumes, completion and in-service dates; rights, activities and operations with respect to the construction of, or expansions on, existing pipelines systems, gas services facilities, processing and fractionation facilities, terminalling, storage and hub facilities and other facilities or energy infrastructure, as well as the impact of Pembina's growth projects on its future financial performance and stakeholders; expectations regarding Pembina's commercial agreements, including the expected timing and benefit thereof; statements regarding the Company's intention to repurchase common shares, including the timing and magnitude thereof; expectations, decisions and activities related to the Company's projects and new developments; the impact of current and expected market conditions on Pembina; and statements regarding the Company's capital allocation strategy, including the 2022 capital expenditure program and expected future cash flows.
The forward-looking statements are based on certain assumptions that Pembina has made in respect thereof as at the date of this news release regarding, among other things: oil and gas industry exploration and development activity levels and the geographic region of such activity; the success of Pembina's operations; prevailing commodity prices, interest rates, carbon prices, tax rates and exchange rates; the ability of Pembina to maintain current credit ratings; the availability of capital to fund future capital requirements relating to existing assets and projects; future operating costs; geotechnical and integrity costs; that any third-party projects relating to Pembina's growth projects will be sanctioned and completed as expected; the ability of Pembina and KKR to satisfy the conditions to closing of the joint venture transaction in a timely manner and substantially on the terms described herein; the ability of Newco to satisfy the conditions to closing of the acquisition of the remaining 51% interest in ETC in a timely manner and substantially on the terms described herein; that any required commercial agreements can be reached; that all required regulatory and environmental approvals can be obtained on the necessary terms and in a timely manner; that counterparties will comply with contracts in a timely manner; that there are no unforeseen events preventing the performance of contracts or the completion of the relevant projects; prevailing regulatory, tax and environmental laws and regulations; maintenance of operating margins; the amount of future liabilities relating to lawsuits and environmental incidents; and the availability of coverage under Pembina's insurance policies (including in respect of Pembina's business interruption insurance policy).
Although Pembina believes the expectations and material factors and assumptions reflected in these forward-looking statements are reasonable as of the date hereof, there can be no assurance that these expectations, factors and assumptions will prove to be correct. These forward-looking statements are not guarantees of future performance and are subject to a number of known and unknown risks and uncertainties including, but not limited to: the regulatory environment and decisions and Indigenous and landowner consultation requirements; the impact of competitive entities and pricing; reliance on third parties to successfully operate and maintain certain assets; labour and material shortages; reliance on key relationships and agreements; the strength and operations of the oil and natural gas production industry and related commodity prices; the ability of the Pembina and KKR to receive, in a timely manner, the necessary regulatory and other third-party approvals in connection with closing of the joint venture transaction; the ability of Pembina and KKR to satisfy, in a timely manner, the other conditions to the closing of the joint venture transaction; the ability of Newco to satisfy, in a timely manner, the conditions to closing of the acquisition of the remaining 51% interest in ETC; the failure to realize the anticipated benefits and/or synergies of the joint venture transaction following closing due to integration issues or otherwise; expectations and assumptions concerning, among other things: customer demand for Newco's assets and services; non-performance or default by counterparties to agreements which Pembina or one or more of its affiliates has entered into in respect of its business; adverse actions by governmental or regulatory authorities, including changes in tax laws and treatment, changes in project assessment regulations, royalty rates, climate change initiatives or policies or increased environmental regulation; the ability of Pembina to acquire or develop the necessary infrastructure in respect of future development projects; fluctuations in operating results; adverse general economic and market conditions in Canada, North America and Internationally, including changes, or prolonged weaknesses, as applicable, in interest rates, foreign currency exchange rates, commodity prices, supply/demand trends and overall industry activity levels; risks related to the current and potential adverse impacts of the COVID-19 pandemic; constraints on the, or the unavailability of, adequate infrastructure; the political environment in North American and elsewhere, and public opinion; the ability to access various sources of debt and equity capital, and on acceptable terms; adverse changes in credit ratings; counterparty credit risk; technology and cyber security risks; natural catastrophes; the conflict between Ukraine and Russia and its potential impact on, among other things, global market conditions and supply and demand, energy and commodity prices; interest rates, supply chains and the global economy generally; and certain other risks detailed in Pembina's Annual Information Form and Management's Discussion and Analysis, each dated February 24, 2022 for the year ended December 31, 2021 and from time to time in Pembina's public disclosure documents available at www.sedar.com, www.sec.gov and through Pembina's website at www.pembina.com. In addition, the closing of the joint venture transaction may not be completed or may be delayed if Pembina's and KKR's respective conditions to the closing are not satisfied on the anticipated timelines or at all. Accordingly, there is a risk that the joint venture transaction will not be completed within the anticipated timeline, on the terms currently proposed and disclosed in this news release or at all.
In respect of the forward-looking statements concerning the anticipated increase in Pembina's common dividend following completion of the joint venture transaction with KKR, Pembina has made such forward-looking statements in reliance on certain assumptions that it believes are reasonable at this time, including assumptions in respect of: prevailing commodity prices, interest rates, margins and exchange rates; that future results of operations will be consistent with past performance, as applicable, and management expectations in relation thereto, including in respect of Newco's future results of operations; the continued availability of capital at attractive prices to fund future capital requirements relating to existing assets and projects, including, but not limited to, future capital expenditures relating to expansion, upgrades and maintenance shutdowns; future cash flows and operating costs; that counterparties to material agreements will continue to perform in a timely manner; that there are no unforeseen events preventing the performance of contracts; that there are no unforeseen material construction or other costs related to current growth projects or current operations; and that there are no unforeseen material construction or other costs related to current growth projects or current operations. Pembina will also be subject to requirements under applicable corporate laws in respect of declaring dividends at such time.
This list of risk factors should not be construed as exhaustive. Readers are cautioned that events or circumstances could cause results to differ materially from those predicted, forecasted or projected by forward-looking statements contained herein. The forward-looking statements contained in this document speak only as of the date of this document. Pembina does not undertake any obligation to publicly update or revise any forward-looking statements or information contained herein, except as required by applicable laws. Management approved the revised 2022 adjusted EBITDA guidance contained herein as of the date of this news release. The purpose of our revised 2022 adjusted EBITDA guidance is to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.
Non-GAAP and Other Financial Measures
Throughout this news release, Pembina has disclosed certain financial measures and ratios that are not defined in accordance with GAAP and which are not disclosed in Pembina's financial statements. Non-GAAP financial measures either exclude an amount that is included in, or include an amount that is excluded from, the composition of the most directly comparable financial measure determined in accordance with GAAP. Non-GAAP ratios are financial measures that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components. These non-GAAP financial measures and ratios are used by management to evaluate the performance and cash flows of Pembina and its businesses and to provide additional useful information respecting Pembina's financial performance and cash flows to investors and analysts.
In this news release, Pembina has disclosed the following non-GAAP financial measures and non-GAAP ratios: net revenue, adjusted earnings before interest, taxes, depreciation and amortization ("adjusted EBITDA"), adjusted cash flow from operating activities, and adjusted cash flow from operating activities per common share. These non-GAAP financial measures and ratios disclosed in this news release do not have any standardized meaning under International Financial Reporting Standards ("IFRS") and may not be comparable to similar financial measures or ratios disclosed by other issuers. The measures and ratios should not, therefore, be considered in isolation or as a substitute for, or superior to, measures of Pembina's financial performance, or cash flows specified, defined or determined in accordance with IFRS, including revenue, earnings, cash flow from operating activities and cash flow from operating activities per share.
Except as otherwise described herein, these non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period. Specific reconciling items may only be relevant in certain periods.
Below is a description of each non-GAAP financial measure and non-GAAP ratio disclosed in this news release, together with, as applicable, disclosure of the most directly comparable financial measure that is determined in accordance with GAAP to which each non-GAAP financial measure relates and a quantitative reconciliation of each non-GAAP financial measure to such directly comparable GAAP financial measure. Additional information relating to such non-GAAP financial measures, including disclosure of the composition of each non-GAAP financial measure, an explanation of how each non-GAAP financial measure provides useful information to investors and the additional purposes, if any, for which management uses each non-GAAP financial measure; an explanation of the reason for any change in the label or composition of each non-GAAP financial measure from what was previously disclosed; and a description of any significant difference between forward-looking non-GAAP financial measures and the equivalent historical non-GAAP financial measures, is contained in the "Non-GAAP & Other Financial Measures" section of the management's discussion and analysis of Pembina dated May 5, 2022 for the three months ended March 31, 2022 (the "MD&A"), which information is incorporated by reference in this news release. The MD&A is available on SEDAR at www.sedar.com, EDGAR at www.sec.gov and Pembina's website at www.pembina.com.
Net Revenue
Net revenue is a non-GAAP financial measure which is defined as total revenue less cost of goods sold including product purchases. The most directly comparable financial measure to net revenue that is determined in accordance with GAAP and disclosed in Pembina's financial statements is revenue.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization
Adjusted EBITDA is a non-GAAP financial measure and is calculated as earnings before net finance costs, income taxes, depreciation and amortization (included in operations and general and administrative expense) and unrealized gains or losses on commodity-related derivative financial instruments. The exclusion of unrealized gains or losses on commodity-related derivative financial instruments eliminates the non-cash impact of such gains or losses.
Adjusted EBITDA also includes adjustments to earnings for losses (gains) on disposal of assets, transaction costs incurred in respect of acquisitions, dispositions and restructuring, impairment charges or reversals in respect of goodwill, intangible assets, investments in equity accounted investees and property, plant and equipment, certain non-cash provisions and other amounts not reflective of ongoing operations. In addition, Pembina's proportionate share of results from investments in equity accounted investees with a preferred interest is presented in adjusted EBITDA as a 50 percent common interest. These additional adjustments are made to exclude various non-cash and other items that are not reflective of ongoing operations.
Adjusted EBITDA per common share is a non-GAAP ratio which is calculated by dividing adjusted EBITDA by the weighted average number of common shares outstanding.
2022 Adjusted EBITDA Guidance
The equivalent historical non-GAAP measure to 2022 adjusted EBITDA guidance is adjusted EBITDA for the year ended December 31, 2021.
Adjusted EBITDA from Equity Accounted Investees
In accordance with IFRS, Pembina's jointly controlled investments are accounted for using equity accounting. Under equity accounting, the assets and liabilities of the investment are presented net in a single line item in the Consolidated Statement of Financial Position, "Investments in Equity Accounted Investees". Net earnings from investments in equity accounted investees are recognized in a single line item in the Consolidated Statement of Earnings and Comprehensive Income "Share of Profit from Equity Accounted Investees". The adjustments made to earnings, in adjusted EBITDA above, are also made to share of profit from investments in equity accounted investees. Cash contributions and distributions from investments in equity accounted investees represent Pembina's share paid and received in the period to and from the investments in equity accounted investees.
To assist in understanding and evaluating the performance of these investments, Pembina is supplementing the IFRS disclosure with non-GAAP proportionate consolidation of Pembina's interest in the investments in equity accounted investees. Pembina's proportionate interest in equity accounted investees has been included in adjusted EBITDA.
Adjusted Cash Flow from Operating Activities and Adjusted Cash Flow from Operating Activities per Common Share
Adjusted cash flow from operating activities is a non-GAAP measure which is defined as cash flow from operating activities adjusting for the change in non-cash operating working capital, adjusting for current tax and share-based compensation payment, and deducting preferred share dividends paid. Adjusted cash flow from operating activities deducts preferred share dividends paid because they are not attributable to common shareholders. The calculation has been modified to include current tax and share-based compensation payment as it allows management to better assess the obligations discussed below. Adjusted cash flow from operating activities per common share is a non-GAAP financial ratio which is calculated by dividing adjusted cash flow from operating activities by the weighted average number of common shares outstanding.
View original content to download multimedia:
SOURCE Pembina Pipeline Corporation | https://www.wibw.com/prnewswire/2022/05/05/pembina-pipeline-corporation-reports-strong-results-first-quarter-2022-raises-2022-guidance-provides-business-update/ | 2022-05-05T21:48:52Z |
OREGON CITY, Ore., July 25, 2022 /PRNewswire/ - Following a competitive procurement process, Clackamas County has selected Fengate PCL Progress Partners (FP3) as the preferred proponent to design, build, finance, operate and maintain a much-needed new courthouse through a public-private partnership.
The FP3 consortium comprises:
- Developer: Fengate Asset Management (Fengate) and PCL Investments Inc.
- Design-Build Contractor: PCL Construction Services Inc. (PCL)
- Services Provider: Honeywell
- Design Services: DLR Group
Fengate is managing this investment as part of the firm's infrastructure strategy on behalf of its investors, including an investment fund owned by the LiUNA Pension Fund of Central and Eastern Canada.
The current Clackamas County courthouse is in urgent need of replacement. Built in 1936 to serve 50,000 residents, the facility can no longer handle the demands of a population of 420,000 that continues to grow. The gap between space availability and judicial needs of the growing population in the County has led to delays in trials and incarceration and affected child support hearings and civil litigation trials.
The current facility has been determined functionally obsolete and seismically unsound, causing safety concerns. A capacity shortage highlights the need for separate building circulation zones: there is currently a lack of separate paths for victims, witnesses, and prisoners/defendants. Jurors have no sequestration room on site, increasing potential improper communications.
The new Clackamas County Courthouse will be built on the County's Red Soils Campus in Oregon City and by moving here, courthouse users will be able to quickly access County departments including Social Services; Behavioral Health; Public Health; Juvenile; Veterans Services; and the Family Justice Center. Currently, residents need to drive to multiple buildings to access the various functions of County government. The County owns this land and utility infrastructure is already installed as a part of the master plan for the campus. The new 241,073 sq. ft. courthouse will feature 16 courtrooms, 17 judicial chambers, space for the District Attorney's Office, secure loading and staging areas, enhanced prisoner transfer facilities, jury assembly and grand jury spaces, safe corridors for courthouse users, and secure holding cells for violent offenders.
"We are honored to be selected to deliver this new, safe and secure courthouse with the features and services that the growing population of Clackamas County needs," said Mac Bell, Managing Director, Infrastructure Investments, Fengate. "We look forward to working closely with the County and bringing our team's deep experience to design, build, finance, operate and maintain the new facility for the community."
"We're thrilled to have the chance to partner with DLR, Fengate and Honeywell on this project," said Tyler Kautz, district manager for PCL Construction's Pacific Northwest group. "This public-private partnership project delivery model provides a unique opportunity to look at the goals for Clackamas County in order to build a courthouse that is not only iconic at completion but has long-term sustainability and lower operations lifecycle cost in mind."
In May 2021, Clackamas County Commissioners approved a plan to pursue a public-private partnership for the new courthouse, the first of its kind for Oregon, as this approach provides the best value in keeping with the County's commitment to affordability. The public-private partnership approach was determined to be the most cost-effective plan based on extensive analysis of alternatives and the new courthouse building will be built without any additional tax increases.
FP3 will design and build the new courthouse, then operate and maintain the facility over a 30-year period. FP3 is dedicated to fostering and enhancing the construction industry through supporting local and regional small and historically underutilized businesses by providing education, support, relationship building, networking and opportunities. The consortium's goal is to meet or exceed subcontracting goals utilizing local Disadvantaged Minority-Owned/Women-Owned/Emerging Small Businesses/Service-Disabled Veterans Business (D/M/W/ESB/SDVBE), Small Business Utilization goals and Construction Career Pathways Project (C2P2) initiatives. FP3 is committed to engaging in a substantial good faith effort to provide opportunities to Oregon certified local and D/M/W/ESB/SDVBEs, Small Businesses and C2P2s in the surrounding community and foster ongoing relationships with these businesses.
The County owns the courthouse and the State and the County will not make any payments until the building is completed and ready for occupancy. Upon completion, the State's contribution will be applied as a lump sum payment towards the private financing with the remainder repaid by the County over the remaining 30-year term of the project agreement. For more information, please visit the Clackamas County website.
About Fengate
Fengate is a leading alternative investment manager focused on infrastructure, private equity and real estate strategies. With offices in Ontario and Texas and team members across North America, Fengate is one of the most active real asset investors in North America and the firm has been investing in and developing public-private partnerships and infrastructure since 2006. Learn more at www.fengate.com
About PCL Investments
PCL Investments is the development and equity arm of the PCL family of companies, one of North America's most prolific public-private partnership (P3) general contractors. PCL Investments supports PCL's P3 bids through committed capital ensuring interests are aligned between clients and PCL.
About PCL Construction
PCL is a group of independent construction companies that carries out work across the United States, Canada, the Caribbean, and in Australia. These diverse operations in the civil infrastructure, heavy industrial, and buildings markets are supported by a strategic presence in more than 30 major centers. Together, these companies have an annual construction volume of more than $6 billion USD, making PCL one of the largest contracting organizations in North America. Watch us build at www.PCL.com.
About Honeywell
Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.
About DLR Group
DLR Group is an integrated design firm delivering architecture, engineering, interiors, planning, and building optimization for new construction, renovation, and adaptive reuse. Our promise is to elevate the human experience through design. This promise inspires sustainable design for a diverse group of public and private sector clients; local communities; and our planet. DLR Group is 100 percent employee-owned and fully supports the initiatives and goals of the 2030 Challenge, and is an initial signatory to the China Accord and the AIA 2030 Commitment.
Media contact:
Amy Holmes
Vice President, Marketing and Communications
Fengate Asset Management
amy.holmes@fengate.com | +1 647 297 5369
View original content to download multimedia:
SOURCE Fengate Asset Management | https://www.kxii.com/prnewswire/2022/07/25/fengate-pcl-progress-partners-selected-clackamas-county-courthouse-replacement-project/ | 2022-07-25T19:07:36Z |
MILWAUKEE, Sept. 6, 2022 /PRNewswire/ -- Ademi LLP is investigating ChannelAdvisor (NYSE: ECOM) for possible breaches of fiduciary duty and other violations of law in its transaction with CommerceHub.
Click here to learn how to join the action: https://www.ademilaw.com/case/channeladvisor-corporation or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges ChannelAdvisor's financial outlook and prospects are excellent and yet ChannelAdvisor holders will receive only $23.10 per share. The transaction agreement unreasonably limits competing bids for ChannelAdvisor by imposing a significant penalty if ChannelAdvisor accepts a superior bid. ChannelAdvisor insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of ChannelAdvisor's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for ChannelAdvisor.
If you own ChannelAdvisor common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/channeladvisor-corporation.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content to download multimedia:
SOURCE Ademi LLP | https://www.kxii.com/prnewswire/2022/09/06/shareholder-alert-ademi-llp-investigates-whether-channeladvisor-corporation-has-obtained-fair-price-its-transaction-with-commercehub/ | 2022-09-06T16:04:34Z |
WASHINGTON, Sept. 1, 2022 /PRNewswire/ -- Verdant Microgrid, LLC, ("Verdant") a leading clean energy development company, today announces the completion of its newest energy storage microgrid at the ThermalVac Technologies, Inc., a premier brazing, heat treating and metals finishing facility headquarters in Orange, California.
This project deploys state-of-the-art energy storage technology in a demand-reduction mode that will reduce the peak draw of electric power from the customer's utility. This results in fewer demand charges from the utility to the customer and significant cost savings.
Verdant collaborated with Eos Energy Enterprises of Edison, NJ, Stronghold Engineering, Inc. of Parris, CA and Gridswitch Asset Management Services of Moon, PA to deploy 4 containerized Znyth™ aqueous zinc energy storage batteries to provide approximately 500 kW of energy storage for 4 hours per day. These U.S. manufactured batteries are completely recyclable and use earth abundant, non-conflict minerals in their construction and operation. The deployment of the Eos batteries in California is supported by that state's Self Generation Incentive Program ("SGIP") – a landmark first for the technology.
"This exciting project is another great example of the changing energy market in the U.S.," said Robert Babcock, Chief Executive of Verdant. "The customer benefits from advanced battery technology through reduced demand charges on their site, which also provides several hours of resiliency in case of a power outage. Eos' batteries are made in America, are fully recyclable, nonflammable and provide a wide range of operating parameters that allows us to match the complicated customer load profile to minimize their demand charges," continued Babcock.
"Eos was thrilled to provide the primary energy storage equipment to Verdant for this project," said William Mao, Chief Commercial Officer of Eos. He added, "This project also represents our first deployment of our energy storage systems under California's SGIP program, and we look forward to doing many more similar projects with the Verdant team in the future."
Verdant's affiliate, Gridswitch Asset Management Services, provided construction management services; coordinating the logistics and installation teams that implemented and commissioned the project. Gridswitch will also provide its GridCareSM long-term asset and operations management service to Verdant, including through-life performance warranty support required by SGIP. "Gridswitch will assure the performance and health of the ThermalVac battery installation through our state-of-the-art Operations Center outside of Pittsburgh," said Paul Tobin, CEO of Gridswitch. "GridCareSM includes a comprehensive suite of remote monitoring and reporting and predictive maintenance tools which will provide Verdant and other project stakeholders with real-time insights on the health and efficiency of the system."
About Verdant
Verdant Microgrid, LLC was founded in 2019 by energy industry experts who have deployed and operated over 30 gigawatts of clean power generation over the last 30 years. Formed primarily to address the commercial and industrial market, Verdant develops, builds, owns and operates microgrids ranging from 500 kilowatts to 50 megawatts utilizing solar, energy storage, advanced CHP and other clean technologies as a unified on-site energy source.
About Gridswitch Asset Management Services
GridSwitch provides turnkey design, development and long-term operational services for Microgrids and other renewable energy generation assets throughout the Engineering, Procurement, Construction and Operations phases of a microgrid development. Founded in June 2021 and based in Pittsburgh, GridSwitch partners with specialist developers such as Verdant Microgrid and financial owners of renewable energy assets seeking a centralized and standardized way of managing and optimizing the productivity and performance of their energy portfolio.
About Eos Energy Enterprises
Eos Energy Enterprises, Inc. is accelerating the shift to clean energy with positively ingenious solutions that transform how the world stores power. Our breakthrough Znyth™ aqueous zinc battery was designed to overcome the limitations of conventional lithium-ion technology. Safe, scalable, efficient, sustainable—and manufactured in the U.S—it's the core of our innovative systems that today provide utility, industrial, commercial, and residential customers with a proven, reliable energy storage alternative. Eos was founded in 2008 and is headquartered in Edison, New Jersey. For more information about Eos (NASDAQ: EOSE), visit eose.com.
For more information, contact:
Robert Babcock
Verdant Microgrid, LLC
917-744-2712
Rob@VerdantMicrogrid.com
Paul Tobin
GridSwitch Asset Management
412-445-2789
tobinpjr@gridswitch.com
Eos Energy Enterprises, Inc.
732-225-8400
info@eose.com
View original content:
SOURCE Verdant Microgrid, LLC | https://www.wibw.com/prnewswire/2022/09/01/verdant-microgrid-llc-announces-completion-new-microgrid-thermalvac-technologies-inc-orange-california/ | 2022-09-01T22:54:09Z |
KRAMATORSK, Ukraine (AP) — As Russia asserted progress in its goal of seizing the entirety of contested eastern Ukraine, President Vladimir Putin tried to shake European resolve Saturday to punish his country with sanctions and to keep supplying weapons that have supported Ukraine’s defense.
The Russian Defense Ministry said Lyman, the second small city to fall to Russia this week, had been “completely liberated” by a joint force of Russian soldiers and Kremlin-backed separatists, who have waged war for eight years in the industrial Donbas region bordering Russia.
Ukraine’s train system has ferried arms and evacuated citizens through Lyman, a key railway hub in the country’s east. Control of it also would give Russia’s military another foothold in the region; it has bridges for troops and equipment to cross the Siverskiy Donets river, which has so far impeded the Russian advance into the Donbas.
The Kremlin said Putin held an 80-minute telephone call Saturday with the leaders of France and Germany in which he warned against the continued transfers of Western weapons to Ukraine and blamed the conflict’s disruption to global food supplies on Western sanctions.
German Chancellor Olaf Scholz and French President Emmanuel Macron urged an immediate cease-fire and a withdrawal of Russian troops, according to the chancellor’s spokesperson. Both urged Putin to engage in serious direct negotiations with Ukrainian President Volodymyr Zelenskyy to end the fighting, the spokesperson said.
A Kremlin readout of the call between Macron, Putin and Scholz said the Russian leader affirmed “the openness of the Russian side to the resumption of dialogue.” The three leaders, who had gone weeks without speaking during the spring, agreed to stay in contact, according to the readout.
But Russia’s recent progress in Donetsk and Luhansk, the two provinces that make up the Donbas, could further embolden Putin. Since failing to occupy Kyiv, Ukraine’s capital, Russia has set out to seize the last parts of the region not controlled by the separatists.
“If Russia did succeed in taking over these areas, it would highly likely be seen by the Kremlin as a substantive political achievement and be portrayed to the Russian people as justifying the invasion,” the British Ministry of Defense said in a Saturday assessment.
Russia has intensified efforts to capture the larger cities of Sievierodonetsk and nearby Lysychansk, which are the last major areas under Ukrainian control in Luhansk province. Zelenskyy called the situation in the east “difficult” but expressed confidence his country would prevail with help from Western weapons and sanctions.
“If the occupiers think that Lyman or Sievierodonetsk will be theirs, they are wrong. Donbas will be Ukrainian,” he said.
The governor of Luhansk reported that Ukrainian fighters repelled an assault on Sievierodonetsk but Russian troops still pushed to encircle them. Speaking on Ukrainian TV later Saturday, Gov. Gov. Serhii Haidai said the Russians had seized a hotel on the outskirts of Sievierodonetsk.
Sievierodonetsk Mayor Oleksandr Striuk said Friday that some 1,500 civilians in the city with a prewar population of around 100,000 have died there during the war, including from a lack of medicine or because of diseases that could not be treated.
The advance of Russian forces raised fears that residents would experience the same horrors as people in the southeastern port city Mariupol in the weeks before it fell. Residents who had not yet fled faced the choice of risking it now or staying behind.
Just south of Sievierodonetsk, AP reporters saw elderly and ill civilians bundled into soft stretchers and slowly carried down apartment building stairs Friday in Bakhmut, a city in northeast Donetsk province.
Svetlana Lvova, the manager of two buildings in Bakhmut, tried to convince reluctant residents to leave but said she and her husband would not evacuate until their son, who was in Sieverodonetsk, returned home.
“I have to know he is alive. That’s why I’m staying here,” Lvova, 66, said.
On Saturday, people who managed to flee Lysychansk described intensified shelling, especially over the past week, that left them unable to leave basement bomb shelters at all.
Yanna Skakova said she left the city on Friday with her 18-month-old and 4-year-old sons. She cried as she sat on a train bound for western Ukraine. She said her husband stayed behind to take care of their house and animals.
“It’s too dangerous to stay there now,” she said, wiping away tears.
A nearly three-month siege of Mariupol ended last week when Russia claimed complete control of the city. Mariupol became a symbol of mass destruction and human suffering, as well as of Ukrainian determination to defend the country.
Mariupol’s port has reportedly resumed operations after Russian forces finished clearing mines in the Azov Sea off the once-vibrant city. Russian state news agency Tass reported that a vessel bound for the southern Russian city of Rostov-on-Don entered Mariupol’s seaport early Saturday.
The Kremlin said that Putin had emphasized to Macron and Scholz that Russia was working to “establish a peaceful life in Mariupol and other liberated cities in the Donbas.”
Germany and France brokered a 2015 peace agreement between Ukraine and Russia that would have given a large degree of autonomy to Moscow-backed rebel regions in eastern Ukraine. However, the agreement stalled long before Russia’s invasion in February. Any hope that Paris and Berlin would anchor a renewed peace agreement now appears unlikely with both Kyiv and Moscow taking uncompromising stands.
Ukrainian authorities have reported that Kremlin-installed officials in seized cities have started airing Russian news broadcasts, introduced Russian area codes, imported Russian school curriculum and taken other steps to annex the areas.
Russian-held areas of Ukraine’s southern Kherson region have switched to Moscow time and “will no longer switch to daylight-saving time, as is customary in Ukraine,” Russia’s state RIA Novosti agency quoted Krill Stremousov, a Russian-installed local official, as saying Saturday.
The war in Ukraine has caused global food shortages because the country is a major exporter of grain and other commodities. Moscow and Kyiv have traded accusations over which side was responsible for keeping shipments tied up in ports, with Russia saying Ukrainian sea mines prevented safe passage and Ukraine citing a Russian naval blockade.
The press service of the Ukrainian Naval Forces said two Russian missile carriers “capable of carrying up to 16 missiles” were ready for action in the Black Sea. It said that only shipping routes which had been established through multilateral treaties could be considered safe.
As Ukraine attempts to fend off the Russian invasion, the country’s officials have pressed Western nations for more sophisticated and powerful weapons. The U.S. Defense Department would not confirm a Friday CNN report saying the Biden administration was preparing to send long-range rocket systems to Ukraine.
Russia’s ambassador to the United States, Anatoliy Antonov, on Saturday branded such a move as “unacceptable” and called on the Biden administration to “abandon statements about the military victory of Ukraine.”
A Telegram post published on the Russian embassy’s official channel cited Moscow’s top diplomat in Washington as saying “the unprecedented pumping of weapons into Ukraine significantly increases the risks of an escalation of the conflict.”
Moscow is also trying to spook Sweden and Finland’s determination to join NATO. Russia’s Defense Ministry said its navy successfully launched a new hypersonic missile from the Barents Sea. The ministry said the recently developed Zircon hypersonic cruise missile had struck its target about 1,000 kilometers away.
If confirmed, the launch could spell trouble for NATO voyages in the Arctic and North Atlantic. Zircon, described as the world’s fastest non-ballistic missile, can be armed with either a conventional or a nuclear warhead, and is said to be impossible to stop with current anti-missile defense systems.
Moscow’s claims, which could not be immediately verified, came a week after Defense Minister Sergey Shoigu announced that Russia would form new military units in the west of the country in response to Sweden and Finland’s bids to join NATO. | https://www.tdtnews.com/news/article_b4915a34-dec2-11ec-a23b-97c2578f5b90.html | 2022-05-29T05:35:13Z |
IMAGE Studios® Ranks No. 238 on the 2022 Inc. 5000 Annual List, Among America's Fastest-Growing Private Companies
SALT LAKE CITY, Aug. 26, 2022 /PRNewswire/ -- Today, Inc. revealed that IMAGE Studios® is No. 238 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segment— independent businesses.
"The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated," says Scott Omelianuk, editor-in-chief of Inc. "Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today."
"IMAGE has experienced transformative growth and brand evolution in the last few years. The Inc. 5000 list is just the tip of the iceberg, as we close in on our 200th location mark, we are poised to continue the surge we've been creating industry wide. We are a unique real estate investment opportunity, taking salon suites to a whole new level as we expand our footprint nationwide," says Jason Olsen, Founder and CEO of IMAGE Studios®.
Taylor Lamont, COO of IMAGE Studios® stated, "I love seeing our team's accomplishments recognized and celebrated - ranking 238 out of the 5000 fastest-growing companies in America is an incredible honor. The exponential growth we've achieved is a testament to the infrastructure, support, and experience we offer. Over the last decade, thousands of small business owners have started their journey with us and IMAGE Studios® continues to be a leader in salon suites."
There are currently 190 IMAGE Studios® Salon Suites in development throughout the US and this number increases month over month. IMAGE Studios® is an exclusive salon suite that creates modern, high-end salon suites at affordable rates for salon professionals – this makes it possible for salon professionals to easily launch their new business and become successful entrepreneurs. IMAGE Studios® provides this unique opportunity by bringing together like-minded professionals under one roof, along with the guidance of mentors who are invested in the success of their business owners.
Media Contact - noah@imagestudios360.com
View original content:
SOURCE Image Studios | https://www.wibw.com/prnewswire/2022/08/26/is-image-studios-salon-suites-leading-surge-beauty-industry/ | 2022-08-26T12:22:27Z |
Current CFO and Board Member, Tom Casey, to Retire After Transition Period
SAN FRANCISCO, July 27, 2022 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today announced that Drew LaBenne has been named LendingClub's next Chief Financial Officer (CFO). To ensure a seamless transition, he will assume the responsibilities on September 1, 2022, from current CFO, Tom Casey, who will be retiring but will continue to support LendingClub in a non-executive capacity through the end of 2022. Mr. Casey will also be retiring from LendingClub's Board of Directors.
As CFO, LaBenne will lead LendingClub's finance organization and financial activities including accounting, financial planning and analysis, treasury, tax, and investor relations.
"Drew has extensive retail and commercial banking experience at some of the largest and most well-respected banks in the world. He is also completely aligned with the multiple ways we can use technology to deliver better outcomes for consumers in managing their money," said LendingClub CEO, Scott Sanborn. "His acumen and experience make him uniquely qualified to help lead LendingClub as we combine the innovation of a fintech with the operating discipline of a digital bank."
Mr. LaBenne was previously the CFO of Bakkt (NYSE: BKKT), a digital asset marketplace. Prior to that he was CFO of Amalgamated Bank and Managing Director and CFO of JP Morgan Chase's Business Banking division. LaBenne also spent 17 years at Capital One Financial where he held numerous positions including CFO of Retail Banking and played a key role in growing the banking franchise.
"I have been watching LendingClub's ongoing and very successful transformation from afar since it became a national digital bank last year," added Mr. LaBenne. "The company is combining the best of both worlds – the growth and agility of a fintech with the profitability and resilience of a bank. I am excited to be joining a company that is redefining what banking can do for its customers."
LendingClub's current CFO and member of the Board of Directors, Tom Casey, will be retiring from both positions effective August 31, 2022, after a well-planned transition process. Sanborn added, "In his six years at the Club, Tom has captained our return to profitability and scale, helped our transformation to a digital bank, built an incredible finance model and organization and helped shape the strategy that the company will build on for many years to come. I would like to thank Tom both personally and on behalf of the company for his incredible contributions to LendingClub."
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $75 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members, while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
CONTACT:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.kxii.com/prnewswire/2022/07/27/lendingclub-names-drew-labenne-new-chief-financial-officer/ | 2022-07-27T21:48:10Z |
A Web3 Task Collaboration Platform to Create, Collaborate and Reward
SINGAPORE, Aug. 9, 2022 /PRNewswire/ -- Leveling the limitations of geography, language, and race, Web3 enables people to flexibly collaborate. It begs the question of how to efficiently allocate social resources. Therefore TaskOn was built to be a platform that boosts completion for various Web3 tasks in a decentralized way. It efficiently aligns the mutual interests of task initiators and implementers to scalable facilitate collaboration.
Nowadays Web3 citizens are heavily involved in various whitelists, airdrops, NFT giveaways and other bounty campaigns. For these crypto enthusiasts, a handy tool is essential to getting the job done. Participation allows anyone to be an early adopter or shareholder of high potential projects. TaskOn brings your unique talents to bear and may even be like a part or full time job with reasonable rewards. In addition, everyone is actually creating their unique living NFTs. Every task completion action will change your living NFT as you explore more in Web3, and make sure you are fairly rewarded.
The other side of the coin is TaskOn provides solutions that can effectively solve thousands of Web3 projects' development problems, especially the very early-stage entrepreneurial teams with the least cost. No doubt, it can be considered as growth hack for burgeoning projects. With its comprehensive task formats, TaskOn can meet the demand of various projects to gain initial users, build a strong community and improve user engagement. In consideration of projects' desire to expand their brand awareness, TaskOn is also building up its user and KOL database. It doesn't just store that data, but also filters out the most valuable influencers and users to meet customized inquiries. More importantly, TaskOn is the ideal platform to find the right talent for each project, whether that be on a temporary or long-term basis.
TaskOn is now open for everyone to use cost free. Log on to the website to explore or create your customized campaign today. Everyone is encouraged to create, collaborate together, and of course be rewarded fairly.
About TaskOn
TaskOn is a platform that boosts the completion for various Web3 tasks in a decentralized way. It helps task initiators and implementers to collaborate efficiently and better align mutual interests. Everyone is encouraged to create, collaborate and be rewarded.
Website: taskon.xyz
Twitter: https://twitter.com/taskonxyz
Discord: https://discord.gg/AyyXaX9c4S
View original content to download multimedia:
SOURCE TaskOn | https://www.mysuncoast.com/prnewswire/2022/08/09/taskon-launch-boosts-web3-collaboration/ | 2022-08-09T13:49:07Z |
Which Nike trail running shoes are best?
Running in wooded areas or on rocky trails is a great way to stay in shape and get some fresh air. But before you head outside, you’re going to need a reliable pair of running shoes.
Nike is a top brand that makes some of the best trail running shoes. If you’re looking for a solid pair, the Nike Pegasus Trail 3 GORE-TEX Trail Running Shoes are stylish, durable and comfortable.
What to know before you buy Nike trail running shoes
Surface
If you’re just starting as an outdoor runner, you might not know what kind of shoes to buy. First of all, you should consider what type of surface you’ll be running on most of the time.
Trail running shoes are designed for rugged terrain where there’s a risk of encountering debris and moisture. Naturally, they tend to be more robust and durable than standard running shoes designed for urban environments or roadways.
Size and fit
While running, it’s crucial to be comfortable, especially if you’re long-distance running on rocky trails. If your shoes are too big, they can cause you to trip and possibly lead to injury. On the other hand, shoes that are too tight can cause foot swelling and pain. Focus on finding a pair with a snug fit that also has some room in the toe area.
Protection
Running on rugged terrain is more dangerous than running on a paved road, and you’ll likely encounter water and debris, such as twigs and rocks. If any of these enter your shoes, the outcome could range from discomfort while running to an injury.
To protect your feet, it’s a good idea to get water-resistant trail running shoes made with durable materials. Durable shoes will provide you with stability and protection while running on rocky trails, and they should also last you several months before they need replacing.
What to look for in quality Nike trail running shoes
Weight
Trail running shoes are more durable and heavier than road running shoes, but they still need to be lightweight. The more robust they are, the more protection they provide against debris and moisture. However, robust shoes can also make it more difficult to move, especially on rocky trails.
If speed and time are a concern, you’re going to want the most lightweight shoe possible. If you don’t mind taking your time, it’s not a bad idea to go with something that offers more protection.
Cushioning
A trail running shoe’s durability is the most important aspect, but don’t underestimate the importance of sufficient cushioning in the sole areas. Trail runners need extra cushioning for stability and support on rugged terrain where surfaces are uneven.
Heel-to-toe drop
Heel-to-toe drop refers to the distance from the highest point of the back heel’s cushioned area to its highest point at the front of the shoe. It ranges from 0 to 12 millimeters and is a matter of preference. Shoes with a lower heel-to-toe drop provide a more stable landing platform, while higher ones have more cushioning and offer more comfort.
How much you can expect to spend on Nike trail running shoes
Nike trail running shoes can cost as low as $60-$100. However, if you want more durable shoes with advanced features, you can expect to spend anywhere from $100-$160.
Nike trail running shoes FAQ
Are waterproof shoes necessary?
A. Even if you live somewhere with a relatively dry climate, waterproof shoes are still a good idea for trail running because moisture from mud and other debris can still enter your shoe.
How long do trail running shoes last?
A. It depends on how often you use your shoes and the distance you travel. In any case, you should consider replacing them every six to 18 months.
What are the best Nike trail running shoes to buy?
Top Nike trail running shoes
Nike Pegasus Trail 3 GORE-TEX Trail Running Shoes
What you need to know: These shoes provide the ultimate protection for trail runners and are suitable for all types of terrain.
What you’ll love: Your feet will be well-protected and dry behind the Gore-Tex layer and gaiter on the collar that helps prevent moisture and debris from entering. They have a durable foam insole for superior comfort and a band around the ankle for a secure fit.
What you should consider: Some users find them on the heavy side, and they may be too narrow for those with wide feet.
Where to buy: Sold by Dick’s Sporting Goods
Top Nike trail running shoes for the money
Nike Juniper Trail Running Shoes
What you need to know: These shoes are excellent for beginners and experienced runners alike. Additionally, they are ideal for running for extended periods on rugged terrain.
What you’ll love: They have a round-toe design and durable rubber outsole for extra traction on rocky trails. Elastic wraps around the ankle areas provide a secure fit, and the mesh upper makes for a lightweight and breathable running shoe.
What you should consider: It doesn’t have a contoured fit that adjusts to the shape of the wearer’s foot, so those with supinated or pronated feet might find them uncomfortable.
Where to buy: Sold by Amazon, Dick’s Sporting Goods and Kohl’s
Worth checking out
Nike Air Zoom Terra Kiger 7 Trail Running Shoes
What you need to know: If you are looking for a sturdy, comfortable shoe with a funky color scheme, then this pair is for you.
What you’ll love: They have a mesh upper, so they’re lightweight and breathable. They are also durable, as they feature traction lugs and a rock plate at the heel for extra traction and stability on rugged surfaces. Additionally, they are highly responsive and have a cushioned collar for added comfort.
What you should consider: There’s a brief break-in period, so they might feel uncomfortable out of the box.
Where to buy: Sold by Backcountry
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Kevin Luna writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | https://cw33.com/reviews/br/sports-fitness-br/footwear-br/best-nike-trail-running-shoes/ | 2022-04-09T14:12:32Z |
BEIJING, Aug. 23, 2022 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a leading Internet company, today announced that it will change the ratio of its American Depositary Share ("ADS") to Class A ordinary share ("Share") from one (1) ADS representing ten (10) Shares to one (1) ADS representing fifty (50) Shares, effective September 2, 2022 (the "ADS Ratio Change").
For Cheetah Mobile's ADS holders, the change in the ADS ratio will have the same effect as a one-for-five reverse ADS split. Effective September 2, 2022, ADS holders of Cheetah Mobile will be required on a mandatory basis to surrender their old ADS to the depositary bank for cancellation at the rate of five (5) old ADSs for one (1) new ADS. Holders in the Direct Registration System and in the Depository Trust Company will have their ADSs automatically exchanged and need not take any actions. Only whole ADSs will be distributed. The depositary bank will attempt to sell any fractional ADSs and distribute the cash proceeds. The ADS Ratio Change will have no impact on Cheetah Mobile's underlying ordinary shares.
About Cheetah Mobile Inc.
Cheetah Mobile is a leading internet company. It has attracted hundreds of millions of monthly active users through an array of internet products such as Clean Master, Security Master and several casual games. The Company provides advertising services to advertisers worldwide as well as value-added services including the sale of premium membership and in-app virtual items to its users. Cheetah Mobile is also committed to leveraging its cutting-edge artificial intelligence technologies to power its products and make the world smarter. It has been listed on the New York Stock Exchange since May 2014.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about Cheetah's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement. All information provided in this press release is as of the date of this press release, and Cheetah does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
Cheetah Mobile Inc.
Tel: +86 10 6292 7779
Email: ir@cmcm.com
View original content:
SOURCE Cheetah Mobile | https://www.mysuncoast.com/prnewswire/2022/08/23/cheetah-mobile-announces-ads-ratio-change/ | 2022-08-23T09:59:57Z |
UNITED NATIONS (AP) — A top official in the global campaign against the use of land mines urged Russia on Monday to stop its troops in Ukraine from laying the weapons that too often kill and maim civilians.
Alicia Arango Olmos, Colombia’s ambassador to the United Nations in Geneva and this year’s president of the state parties to the 1997 convention banning the production and use of land mines, expressed deep concern at media reports that Russia is using land mines in its war in Ukraine.
She pointed to Human Rights Watch, which said on March 29 that Ukrainian explosive ordnance disposal technicians located banned anti-personnel mines in the eastern Kharkiv region a day earlier. The rights group said Russia is known to possess the type of mines that were discovered, but Ukraine doesn’t have them.
Arango Olmos said at a news conference Monday — the International Day for Mine Awareness and Assistance in Mine Action — that Ukraine is one of the 164 state parties to the convention, but Russia is not.
She said her appeal to Russia is: “Anti-personnel mines only cause victims, they don’t resolve any type of problem.”
“So please, Russians, please stop using it, because many of the people that are victims of land mines have nothing to do with what’s happening between Ukraine and Russia,” Arango Olmos said.
Prince Mired of Jordan, the special envoy trying to make the land-mine convention universal, said about 80% of the world’s nations are parties to the convention. He said 33 countries have not joined, among them some that may collectively hold tens of millions of anti-personnel mines in military warehouses and unfortunately have buried millions more in the ground.
Some countries that are not parties have “the power to significantly turn the tide and eliminate this horrendous weapon such as China, India, Pakistan, Russia and the United States,” he said. “A coordinated and concerted effort is needed at the highest level in order to achieve further accessions. This will not be easy, but it’s possible.” | https://cw33.com/news/international/ap-international/russia-urged-to-stop-using-land-mines-in-its-war-in-ukraine/ | 2022-04-05T13:42:45Z |
NEW YORK and HOUSTON, Aug. 5, 2022 /PRNewswire/ -- DarkPulse, Inc. (OTC Markets: DPLS) ("DarkPulse" and the "Company"), a technology company focused on the manufacture, sale, installation and monitoring of their patented laser sensing systems which provide a data stream of critical metrics for assessing the health and security of infrastructure, today announced that Gulf Automation Services & Oilfield Supplies Company, LLC ("GASOS") has become the exclusive agent for the Company's DarkPulse BOTDA EREBOS™ sensing systems in Abu Dhabi, UAE. In offering these products, GASOS will concentrate on customers in the critical infrastructure/ key resources markets, with a focus on oil and gas pipeline health monitoring applications and offshore drilling operations. In addition, GASOS can provide the Company with services including sales and marketing, manpower, training and technical services.
In view of the singular importance of the petroleum sector in the UAE's overall development and emerging need for technology inputs, Bin Hamoodah decided in 1972 to establish a new, 100% local company called Gulf Automation Services & Oilfield Supplies. This company was formed with a view to serve as a focal point for providing requisite technology and services to the oil and gas sector. GASOS has since provided many pioneering services to the oil and gas industry. First, through sponsorship of world renowned oil service companies; second by marketing oilfield related equipment and services; and, last, by introduction of fire-fighting, safety and protection related equipment and services. The GASOS name has now become synonymous with both the current and future projects in the UAE.
"GASOS is the premier agent throughout the Gulf States with a decade's long history of successful contract awards in the multiple billions of dollars," said Dennis O'Leary, DarkPulse Chairman and CEO. "In addition to typical agency services, GASOS, as a part of its process, will assist the Company with meeting balance sheet requirements typical of very large contract awards. GASOS, through their extensive network of major technical services companies bring additional resources to our efforts within the region. In considering which agent we would engage, GASOS was the clear choice."
In the early eighties, as Dubai was developing to be a major trading hub between Europe, Far East and Africa, GASOS decided to set up a base in the city. Bin Hamoodah set up the Dubai branch of the company called GASOS in 1984 to provide professional and focused service to clients in the region. The branch caters to clients in Dubai and the UAE's Northern Emirates and also handles export enquires from other Gulf countries and Africa. GASOS is a major supplier of equipment and spares to various organizations in Kuwait, Oman and Several African countries.
More information about the company's and their services visit: www.GASOS.com.
DarkPulse, Inc. uses advanced laser-based monitoring systems to provide rapid and accurate monitoring of temperatures, strains and stresses. The Company's technology excels when applied to live, dynamic critical infrastructure and structural monitoring, including pipeline monitoring, perimeter and structural surveillance, aircraft structural components and mining safety. The Company's fiber-based monitoring systems can assist markets that are not currently served, and its unique technology covers extended areas and any event that is translated into the detection of a change in strain or temperature. In addition to the Company's ongoing efforts with respect to the marketing and sales of its technology products and services to its customers, the Company also continues to explore potential strategic alliances through joint venture and licensing opportunities to further expand its global market position.
For more information, visit www.DarkPulse.com
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. All statements other than statements of historical facts included in this news release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Media contact:
DarkPulse, Inc.
media@DarkPulse.com
1.800.436.1436
View original content to download multimedia:
SOURCE DarkPulse, Inc. | https://www.mysuncoast.com/prnewswire/2022/08/05/darkpulse-inc-signs-agency-agreement-with-gulf-automation-services-amp-oilfield-supplies-company-llc-gasos/ | 2022-08-05T15:17:03Z |
Warren Buffett-backed electric carmaker shrugs off China’s lockdowns
By Laura He, CNN Business
BYD, the Warren Buffett-backed Chinese electric vehicle maker, had a bumper month in the world’s largest car market, despite strict Covid lockdowns that have disrupted production and sales for many of its major rivals.
The company reported Tuesday that its sales of electric vehicles and plug-in hybrids soared 313% in April from the same month a year ago. The Shenzhen-based carmaker sold a record number of 106,000 units last month in mainland China.
BYD was already off to a strong start to the year.
Sales for all its vehicles jumped 423% in the first quarter of this year, according to preliminary figures released last month. It is the second largest carmaker in China in terms of pure-EV sales, just behind Tesla.
The stellar performance in April showed that BYD is “totally resilient from the Shanghai City lockdown and [the] sector’s supply chain disruption,” wrote Citi analysts on Tuesday.
That’s thanks to its “vertical integrated supply chain,” they added. Apart from vehicles, BYD is a major manufacturer of both batteries and automotive chips, which it uses in its own cars and also sells to other auto makers.
This integrated business model made the company less vulnerable to supply chain disruptions during China’s ongoing lockdowns, while rivals had to cut back production because of chip and battery shortages.
Rivals hit
Nio said Sunday that it delivered only 5,074 vehicles in April, down 49% from March. The company had to suspend production for a few days last month as Covid restrictions hit suppliers in Shanghai, Jiangsu, and Jilin.
At least 27 Chinese cities are under some degree of Covid lockdown, affecting around 180 million residents, according to CNN’s latest calculations last week.
Li Auto also recorded a 62% plunge in car deliveries for April, compared with March, citing “supply chain problems.” In a statement on Sunday, Shen Yanan, co-founder and president of the company, said that some of its suppliers had stopped production entirely as Covid cases surged in the country.
“This had a great impact on our production for this month, resulting in delays in the delivery of new cars,” he said.
Tesla, which ranks first among pure-electric brands in China, hasn’t revealed its April sales data yet, but it will be closely watched given that it had to suspend production in Shanghai for a few weeks, starting March 28.
Elon Musk’s EV maker reported strong sales for March — it delivered 65,814 cars from its Shanghai factory, up 85% from a year earlier.
The company restarted production on April 19 — according to state-owned Xinhua, and even wrote a letter to the Shanghai government expressing its gratitude, according to Reuters.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/money/cnn-business-consumer/2022/05/04/warren-buffett-backed-electric-carmaker-shrugs-off-chinas-lockdowns/ | 2022-05-04T15:19:15Z |
Defending champ Krejcikova loses to French foe in 1st round
By HOWARD FENDRICH
AP Tennis Writer
PARIS (AP) — Barbora Krejcikova arrived at the French Open as the defending champion in singles and doubles. She also was coming off a three-month absence from the tour because of an injured right elbow, so even her own expectations were rather modest.
Krejcikova was right to be apprehensive — and on Monday, she become only the third woman in the professional era to exit in the first round at Roland Garros a year after earning the trophy.
The second-seeded Krejcikova got off to a terrific start before everything fell apart in a 1-6, 6-2, 6-3 loss to Diane Parry, a 19-year-old from France who is ranked 97th and entered the day with a 1-5 career record in Grand Slam matches.
Parry received raucous backing from spectators shouting for her at Court Philippe Chatrier, where the noise echoed under the retractable roof pulled shut because of rain.
“It’s a dream for me. It was always a dream to play on this court, with the French crowd to support me. They clearly pushed me to victory today,” Parry said. “I’m the happiest person right now.”
This was Krejcikova’s first match since February and the rust showed.
The only other women to lose in the first round a year after winning the title at Roland Garros were Anastasia Myskina in 2005 and Jelena Ostapenko in 2018 — both of whom, like Krejcikova, had been surprising champions.
Since the professional era began in 1968, Krejcikova is just the seventh reigning women’s champion to be bounced in the first round at all of the Grand Slam tournaments.
Against Parry, Krejcikova double-faulted on the match’s very first point, and then looked every bit someone ready to display her best tennis. The next 15 points in a row went Krejcikova’s way as she raced to a 4-0 lead.
“It’s never easy to start on this kind of court against the defending champion,” Parry said. “You can get a bit tight, which happened in the first set. But then I managed to relax.”
Did she ever.
After Krejcikova wrapped up that opening set, things turned around as Parry played more confidently.
Krejcikova’s mistakes mounted: By the end, she had accumulated 45 unforced errors, 19 in the third set alone. Parry finished with 26 in all.
___
AP Sports Writer Chris Lehourites in London contributed to this report.
___
More AP sports: https://apnews.com/hub/sports and https://twitter.com/AP_Sports | https://localnews8.com/sports/ap-national-sports/2022/05/23/defending-champ-krejcikova-loses-in-1st-round-of-french-open/ | 2022-05-23T16:01:22Z |
TORONTO, May 16, 2022 /PRNewswire/ - Rhyolite Resources Ltd. (TSXV: RYE) ("Rhyolite" or the "Company") is pleased to announce that its inaugural 3,000-metre diamond core drilling program at the Brothers Project in Suriname has identified a gold mineralized shear zone 3.5 km in length. The shear zone is open on strike at both ends and is open down dip. Highlight assay results include 10 metres (m) of 1.8 g/t gold (Au) in hole BRDD-001, 6m of 4.6 g/t Au in hole BRDD-004, 8m of 2.4 g/t Au in hole BRDD-009, 1m of 20.5 g/t Au in hole BRDD-013. The drill program was completed in late March 2022.
Fred Stanford, Chief Executive Officer of Rhyolite, commented: "These initial holes were drilled to test for gold mineralization at shallow depths. It is early days in this exploration program, but it was more than encouraging to find 10m of 1.8 g/t Au in the first hole drilled on the large 9,600-hectare Brothers Project located on a significant, emerging gold belt in the Guiana Shield. The team will make use of the geological and structural understandings that were enhanced by this drill program, as well as additional geophysics and geochemical work to refine the targeting for the next drilling campaign at the Brothers Project.
"While this targeting work is ongoing at the Brothers Project, an inaugural diamond drilling campaign is scheduled to commence at the Suku Passi Project during the next dry season which typically starts in August."
No previous diamond drilling had been conducted on the district-scale Brothers Project. The focus of the initial 20-hole drilling program was to test a variety of target types to identify priority prospects along with host rocks, structure and alteration. Planned follow-up exploration will include trenching and field sampling in the southern part of Brothers that hosts volcanic-sedimentary lithologies resembling the world-class Rosebel and Merian gold mines in Suriname.
Standard protocol of chain of custody, standards, blanks and duplicates were used. Oriented core of HQ size was done and structural data entered in a database software. Filab Assay Lab in Suriname was used for 50-gram fire assays. Check assays of pulps and rejects are in progress.
Qualified Person
Dr. Dennis LaPoint, PhD, is a Qualified Person (QP) under National Instrument 43-101 "Standards of Disclosure for Mineral Projects" and has approved the technical information contained in this news release. Dr. LaPoint is not considered to be independent for the purposes of National Instrument 43-101.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the use of proceeds of the Offering. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive regulatory approvals; the ability to attract financing on these terms or at all; the price of commodities; and the results of current exploration. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:
SOURCE Rhyolite Resources Ltd. | https://www.kxii.com/prnewswire/2022/05/16/rhyolite-identifies-35-km-gold-mineralized-shear-zone-guiana-shield-greenstone-belt-suriname/ | 2022-05-16T21:48:12Z |
In the aftermath of George Floyd's killing, several nooses were left around Saginaw, Michigan. Nearly two years later, a man is facing federal hate crime charges for it, the Justice Department says.
Kenneth David Pilon, 61, was charged this week with six counts of interfering with federally protected activities, a misdemeanor hate crime, court documents show. If convicted, each count carries a punishment that varies from a fine or imprisonment of up to one year, or both.
As nationwide protests against police brutality took place after Floyd was killed by a Minneapolis police officer, Pilon allegedly tried to stop people from supporting Black Lives Matter during multiple incidents in the span of nearly five weeks.
CNN has reached out to Pilon and an attorney representing him for comment. He has not yet been arraigned, and is not currently in police custody, Special Agent Mara R. Schneider of the FBI Detroit division told CNN.
On June 14, 2020, Pilon allegedly called nine different Starbucks stores in Saginaw, Bay City, Birch Run, Flint, Ann Arbor, Allen Park and Oak Park. He told employees answering the phone to tell staffers wearing Black Lives Matter T-shirts that "the only good n***er is a dead n***er," court documents say.
During one of those calls Pilon told an employee: "I'm gonna go out and lynch me a n***er," the court document said.
A couple days before the incident, Starbucks reversed its position that had prohibited employees from wearing paraphernalia, such as T-shirts or pins, supporting the "Black Lives Matter" movement and announced it was giving 250,000 T-shirts to employees.
Pilon "made these communications for the purpose of issuing a threat and with knowledge that the communications would be viewed as a threat," authorities said in an affidavit.
According to the affidavit, later that week, Pilon went to a Goodwill store and left a noose along with a note that read, "An accessory to be worn with your 'BLM' t-shirt. Happy protesting!"
Authorities said at least four other nooses and notes were found at multiple locations, including a Walmart parking lot, inside a beverage cooler at a 7-Eleven store, a Kroger parking lot and inside a private vehicle.
In the United States, the hangman's noose has come to symbolize brutality and the country's history of lynchings and hatred toward Black people.
In recent years, nooses have been found hanging outside the National Museum of African-American History and Culture in Washington, on college campuses and on a fence at an Oakland, California, elementary school.
Threat 'brought hate' to our home, family says
Donald Simon found one of the nooses on the morning of July 12, 2020, when he got into his truck outside his Saginaw home. He was planning to drive to a nearby gas station and get coffee there, but he never made it.
When he opened the truck's door, Simon's ex-wife Regina told CNN he spotted the noose and a note inside the vehicle, and went back inside their home.
"It took us to our knees, I think we just kind of went numb and went to autopilot," said Regina Simon, adding that her husband eventually felt so much anger.
"Our truck is about, not even 10 feet from my front door. That bothered me -- you came on my property and brought hate to a house that does not hate," she said.
Regina Simon, who is Mexican and White, and her ex-husband, who is Black, said they think they were targeted because the family had been playing on their front yard with their dog a day before the incident. Regina Simon had been wearing a Black Lives Matter T-shirt, they said.
In the days that followed, Regina Simon said she posted a photo of the noose on Facebook, spoke with the NAACP, decorated her front yard with Black Lives Matter signs and balloons, and organized a protest because the family wanted to show they were not scared or intimidated.
"We marched through our neighborhood to let people know that our neighborhood isn't gonna stay on for this," she said.
Regina Simon said the family didn't know Pilon and never had contact with him. They hope, if Pilon is found guilty, a judge orders Pilon to do mental health therapy.
"Anybody that lives a life full of hate like this, that's got to be a miserable life," she said, referring to Pilon.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/news/a-man-was-charged-with-hate-crimes-after-allegedly-making-racist-threats-leaving-nooses-around/article_c0737c30-f9da-548b-a502-4f35e96d0f1a.html | 2022-04-28T21:01:19Z |
The company will present the preclinical data of five novel drug candidates at AACR 2022 (on April 8-13).
Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008.
SHANGHAI and HONG KONG, April 10, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced the publication of five posters that will be presented during the upcoming 2022 American Association for Cancer Research Annual Meeting (AACR 2022), taking place from April 8th to April 13th in New Orleans in person or via virtual attendance.
(https://www.aacr.org/professionals/meetings/myaacr-support/ )
"The preclinical studies that we are presenting at AACR 2022 provide a window into five innovative programs in Antengene's pipeline," said Bo Shan, Ph.D., Chief Scientific Officer of Antengene. "These programs target areas that we believe are very important in cancer drug development: Tumor microenvironment (TME) regulators (ATG-037), pathway inhibitors (ATG-018, ATG-022 and ATG-008), and ADCs (ATG-022). These studies have been instrumental in guiding our clinical development plans for each program, including selection of combination partners and biomarkers, that could be used to predict efficacy or improve the proportion of patients who respond to treatment. We are very pleased to share these results with the oncology community."
Details of the posters and corresponding abstracts are shown below:
ATG-037, a highly potent small molecule CD73 inhibitor has superior activity of reversing immunosuppression in higher-AMP environments compared with anti-CD73 antibodies
Abstract: 2576
Session: Cell Cycle, Replication Inhibitors, and Immunotherapy Agents
Date and Time: 9:00 AM – 12:30 PM CST, April 12, 2022
Venue: Poster Section 21
This study was designed to compare the T-cell rescue activity of ATG-037, a highly potent and selective oral small molecule inhibitor of CD73, and two CD73 blocking antibodies. CD73 is an enzyme that is highly expressed in the tumor microenvironment and enables the degradation of AMP into adenosine, resulting in immunosuppression and cancer progression. In vitro assays were used to assess each compound's ability to inhibit CD73 enzyme activity and reverse AMP/adenosine mediated T-cell suppression. ATG-037 demonstrated more potent and complete inhibitory activity of cell surface CD73 in this study.
As shown in Figure, the authors found that ATG-037 had a stronger ability to restore T-cell function in higher-AMP environments compared with other clinical anti-CD73 antibodies. These data highlight the potential therapeutic advantages of small molecule inhibitors of CD73 over blocking antibodies. ATG-037 is being evaluated by Antengene in a Phase I trial as monotherapy and in combination with anti-PD-1 antibody in patients with locally advanced or metastatic solid tumors.
The novel ATR inhibitor ATG-018 is efficacious in preclinical cancer models
Abstract: 2604
Session: DNA Damage Response and Repair
Date and Time: 9:00 AM – 12:30 PM CST, April 12, 2022
Venue: Poster Section 22
In this study, the preclinical pharmacology data set supporting the development of ATG-018, a small molecule ATR inhibitor, was reviewed. Inhibiting ATR kinase (ataxia telangiectasia and Rad3 related kinase) leads to increased accumulation of double-strand breaks, particularly meaningful for tumor cells which rely on DNA damage response (DDR). ATG-018 was tested in a panel of 142 tumor cell lines and three CDX mouse models to assess anti-tumor efficacy and to identify potential predictive biomarkers. ATG-018 was a potent inhibitor of in vitro ATR activity inhibition and cell proliferation without significant impact on normal peripheral blood mononuclear cell (PBMCs) viability.
In addition, a series of genetic alterations were discovered that correlated with ATG-018 sensitivity and could be potential predictive biomarkers. As shown in Figure, the authors found that ATG-018 demonstrated potent in vivo efficacy in solid tumor/hematologic cancer models with certain DDR-related mutations. These data showed the potential of ATG-018 in synthetic lethality with homologous recombination deficiencies and promising application in a wide range of indications. With single-agent activity and no impact on PBMCs viability, ATG-018 may be well positioned for use in mono- or combination therapy in a wide range of tumors that rely on DDR. Development of a set of predictive biomarkers could enable its use as a precision-medicine. Antengene intends to file the first IND for ATG-018 in 2022.
ATG-022, an antibody-drug conjugate targeting Claudin 18.2, demonstrated potent in vivo efficacy in gastric cancer patient-derived xenografts
Abstract: 1143
Session: Preclinical and Clinical Pharmacology
Date and Time: 9:00 AM – 12:30 PM CST, April 11, 2022
Venue: Poster Section 25
In this preclinical study, ATG-022, an antibody-drug conjugate targeting Claudin18.2 (CLDN18.2), was evaluated in several gastric cancer patient-derived xenograft (PDX) models, to assess whether it had potential across a range of CLDN18.2 expression levels. Human CLDN18.2 is ectopically expressed in a large number of gastric and pancreatic cancers. Monoclonal antibody targeting CLDN18.2 demonstrated a promising clinical benefit when used in combination with chemotherapy. However, it showed suboptimal efficacy in patients with low CLDN18.2 levels.
In this study presented in the AACR, ATG-022 is reported to show high affinity (sub-nanomolar grade) against CLDN18.2 and demonstrated potent in vitro and in vivo antitumor effects, with in vivo efficacy observed in CLDN18.2 low expression PDX models. As shown in Figure, ATG-022 demonstrated much better in vivo efficacy compared with benchmark ADC. In addition, ATG-022 was highly specific for CLDN18.2, with virtually no effect on cells expressing CLDN18.1. In addition, ATG-022 has almost no impact on body weight, a proxy for safety. The authors concluded that ATG-022 shows promise for treating gastric cancer patients with a broad range of CLDN18.2 expression levels, a significant unmet need. Antengene is conducting preclinical studies for ATG-022.
Synergistic effects of the combination of Kras (G12C) with SHP2, ERK 1/2, mTORC1/2 or XPO1 inhibition for the treatment of Kras (G12C) mutated cancer
Abstract: 2679
Session: Signaling Pathway Inhibitors
Date and Time: 9:00 AM – 12:30 PM CST, April 12, 2022
Venue: Poster Section 25
This preclinical study was conducted to identify combination therapy regimen that could overcome the short progression free survival that is a characteristic of KRAS G12C inhibitors (linked to acquired resistance). The study evaluated the anti-tumor activity of ATG-012, a KRAS G12C inhibitor, with four other agents that are involved in the multiple pathways impacted by RASi: i) an SHP2 inhibitor (ET0038), ii) an ERK 1/2 kinase inhibitor (ATG-017), iii) an mTORC1/2 kinase inhibitor (ATG-008) or iv) the XPO-1 inhibitor, Selinexor, in preclinical solid tumor CDX models.
While ATG-012 monotherapy induced dose-dependent tumor growth inhibition at day 27, as shown in Figure, the authors also found strong in vivo synergism in 2-agent combinations. In particular, ATG-012 and clinical stage ERK inhibitor (ATG-017) demonstrate strong in vitro and in vivo synergism, suggesting potential clinical application which may overcome the rapid resistance of KRAS inhibitors. These data open the door to a range of combination partners for ATG-012 that could be fine-tuned to address drug resistance and potentially improve progression-free survival by matching tumor type/histology and combination partner for patients with the KRAS G12C mutation. Antengene is conducting preclinical studies for ATG-012.
Identification of MUC5B mutation as a positive predictive biomarker for mTORC1/2 inhibition by ATG-008 in lung cancer
Abstract: 4032
Session: Molecular Pharmacology
Date and Time: 9:00 AM – 12:30 PM CST, April 13, 2022
Venue: Poster Section 26
This study was designed to evaluate whether MUC5B could serve as a positive predictive biomarker for mTORC1/2 inhibition by ATG-008 (Onatasertib) in lung cancer. ATG-008 is a dual mTOR complex 1/2 kinase inhibitor. The mTOR complex regulates cell growth, metabolism, proliferation and survival. While the mTOR pathway is frequently deregulated in cancers, efficacy of mTOR inhibitors in lung cancer has been modest. In the study, 31 lung cancer cell lines were treated with ATG-008 to determine dose response and to correlate the gene mutation, amplification and expression with sensitivity to ATG-008.
As shown in Figure, the authors found that the presence of the MUC5B mutation correlates with more potent anti-tumor efficacy of ATG-008 in vitro and in vivo in lung cancer CDX models. The mucin MUC5B has a critical protective role in normal lung and has been identified as prognostic marker in multiple tumor types. One observation highlighted in the poster is that MUC5B is also mutated in melanoma, endometrial, colorectal, esophogastric and cervical cancers, vastly expanding the potential clinical utility of MUC5B mutation as the predictive biomarker for ATG-008. ATG-008 is being evaluated by Antengene in multiple Phase I and II clinical trials.
About Antengene
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for selinexor/ATG-010/XPOVIO® in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs.
Forward-looking statements
The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, see the section titled "Risk Factors" in our periodic reports filed with the Hong Kong Stock Exchange and the other risks and uncertainties described in the Company's Annual Report for year-end December 31, 2020, and subsequent filings with the Hong Kong Stock Exchange.
For more information, please contact:
Investor Contacts:
Donald Lung
E-mail: Donald.Lung@antengene.com
Mobile: +86 18420672158
PR Contacts:
Peter Qian
E-mail: Peter.Qian@antengene.com
Mobile: +86 13062747000
View original content to download multimedia:
SOURCE Antengene Corporation Limited | https://www.mysuncoast.com/prnewswire/2022/04/11/antengene-announces-publication-five-posters-2022-american-association-cancer-research-aacr-annual-meeting/ | 2022-04-11T01:19:22Z |
Company implements planned leadership succession process
Entergy board of directors elects Chief Financial Officer Andrew Marsh as next CEO
NEW ORLEANS, Aug. 17, 2022 /PRNewswire/ -- Entergy Corporation announced today that Leo P. Denault, chairman and chief executive officer, will retire in 2023 following 23 years of service to the company and a 40-year career in the energy industry. As part of an orderly and planned leadership succession process, the Entergy board of directors elected Andrew "Drew" Marsh, executive vice president and chief financial officer, to succeed Denault as CEO, effective Nov. 1. Denault will continue to lead the board as executive chairman until his retirement. He will work closely with Marsh and the senior leadership team to support a smooth and organized transition that builds on the company's momentum in areas of customer solutions, renewable energy generation, infrastructure resilience and operational excellence.
"Leo Denault has shaped Entergy's purpose, culture and transformation with a relentless focus on creating long-term, sustainable value for customers, employees, communities and owners," said Stuart Levenick, Entergy's lead independent director. "Leo has built and led an experienced team that has consistently executed an orderly business strategy with solid underlying fundamentals, including a robust customer base, a strong financial position, a constructive regulatory environment, strong community partnerships, a talented, diverse workforce, and a world-class storm restoration organization. He has strengthened the business and positioned Entergy well for the future. While Leo will continue to serve Entergy for several more months, the entire board expresses its deep gratitude for his years of dedication, service and values-driven leadership. We are confident that Drew will carry the torch and continue serving all of Entergy's stakeholders well by creating sustainable value today and for future generations."
"When I think about Entergy's forward momentum and some of the milestones we've recently achieved, like the creation of our first-ever chief customer officer and the successful completion of our planned, multi-year strategy to exit the merchant power generation business, I realized this would be a logical time and a natural transition point for me in my career," said Leo Denault, Entergy chairman of the board and CEO. "Throughout my time at Entergy, I have endeavored to put our customers, the communities we serve and the company on a path that delivers long-term, sustainable value for all without leaving anyone behind. I'm immensely pleased and humbled by the many accomplishments our 12,000 strong team has achieved together."
Denault concluded, "Having worked closely alongside Drew for many years building Entergy's vision for the future, I have seen firsthand his strategic leadership, in-depth knowledge of all aspects of the business, and astute financial acumen. The future for Entergy is bright and there are significant opportunities ahead. I know Drew is the right person to successfully lead the company forward on the path we've built together."
Leo Denault, 62, was appointed chairman and CEO in 2013. Soon after, he guided the company through its 100-year milestone and later launched the company's forward-thinking vision, We Power Life. Denault led Entergy's transformation into a pure-play electric utility and set the company on the path to become the premier utility – one focused on delivering a cleaner, brighter and more sustainable future for everyone. As CEO of one of the cleanest large-scale U.S. utilities, Denault and his team have executed a strategic capital plan to modernize its power generation portfolio to ever cleaner and more resilient energy sources while maintaining some of the lowest electricity rates in the nation. Under Denault's leadership, Entergy has grown its service footprint to 3 million customers and has been recognized as a driving force behind the industrial expansion and job creation across the company's four states.
Prior to being named chairman and CEO, Denault served as executive vice president and chief financial officer beginning in 2004. He played a critical role in 2005 ensuring Entergy – the only Fortune 500 company with headquarters in New Orleans – returned to the city following Hurricane Katrina, the largest natural disaster in U.S. history at the time. He also helped restore confidence to the financial markets and helped rebuild the company's New Orleans utility, Entergy New Orleans, which was forced to file for bankruptcy after suffering a nearly total loss of its customers following the storm. Under his leadership as CFO, Entergy delivered the highest earnings per share and highest operating cash flow in company history in 2011 and 2010, respectively.
Among his numerous recognitions, Denault was honored as a Global Energy Awards finalist for the S&P Platts Global 2021 Chief Executive of the Year and by the Climate Leadership Conference with a 2021 Individual Leadership Award for accelerating Entergy's carbon reduction strategy to net-zero emissions by 2050 and advancing climate resilience initiatives throughout communities in the Entergy region. As CFO, he was named to Institutional Investor magazine's "2010 All-American Executive Team" and was ranked as the best CFO in the power industry in 2010 and 2009. Denault has also been recognized as a corporate champion for low-income customers and serves on the board of directors for Jobs for America's Graduates, a school-to-career program dedicated to removing barriers to graduation and/or employment for young people.
Andrew "Drew" Marsh, 50, joined Entergy in 1998 and served in a series of financial planning and strategy roles, including vice president, planning and financial communications, where he oversaw a large organization responsible for executing commercial operations for the Entergy utility operating companies. He was named executive vice president and chief financial officer in 2013. As CFO, Marsh has maintained Entergy's firm financial standing, ensuring the company is well-positioned to achieve its strategic business objectives. In addition to his role at Entergy, he is a member of the Nuclear Electric Insurance Limited board of directors, KIPP New Orleans Schools board of directors, and Posse New Orleans advisory board. He has a bachelor's degree in mechanical engineering from the University of Notre Dame and a master's degree in management from Kellogg Graduate School of Management at Northwestern University.
"I am both grateful and honored by the confidence the board has placed in me, and I'm honored to follow in my colleague and friend Leo Denault's footsteps," said Drew Marsh. "I will uphold Entergy's values and the strategy that he has instilled in our leadership team. I look forward to advancing our We Power Life vision as we continue our journey of becoming the premier utility for everyone."
Kimberly Fontan, 49, who has served as senior vice president and chief accounting officer since 2019, will succeed Marsh as executive vice president and chief financial officer. Prior to her current role, she served as vice president, system planning; vice president, regulatory services; and vice president, regulatory affairs. Fontan joined Entergy in 1996 as a staff accountant. She has held various roles of increasing scope and responsibility, including jurisdictional finance director for Entergy Louisiana, LLC and Entergy Gulf States Louisiana, L.L.C., and controller, utility operations, in addition to the roles previously noted. In addition to her role at Entergy, she serves on the board of the New Orleans Center for Creative Arts.
Fontan has a bachelor's degree in business administration with an emphasis in accounting from The University of Southern Mississippi and an MBA from Loyola University New Orleans. She is a certified public accountant and a member of both the American Institute of Certified Public Accountants and the Mississippi Society of Certified Public Accountants.
Members of Entergy's senior leadership team will be:
- Rod West, group president, utility operations, will continue his current responsibilities overseeing Entergy's five utility businesses in Arkansas, Louisiana, Mississippi, New Orleans and Texas. He will continue to direct Entergy's engagement with state and local government regulators, economic development and the organization responsible for delivering quality customer experiences.
- Kimberly Fontan, chief accounting officer, has been appointed executive vice president and chief financial officer, where she will be responsible for corporate finance, treasury, accounting, internal audit, investor relations, and corporate development and planning.
- Marcus Brown, executive vice president and general counsel, will continue in his current role with responsibility for all legal, ethics and compliance, federal policy, regulatory and government affairs, communications, and corporate security and governance matters affecting Entergy Corporation and its subsidiaries.
- Chris Bakken, executive vice president and chief nuclear officer, has been appointed executive vice president of Entergy infrastructure, where he will have oversight responsibility for both the utility operations and the nuclear operations. In this expanded role, Bakken will draw from his extensive leadership career in nuclear energy to oversee operational excellence, reliability, resilience and an improved quality of service from Entergy's diverse power generation portfolio.
- Peter Norgeot Jr., executive vice president and chief operating officer, continues in his role with responsibility for safety and human performance, power generation, power delivery, system planning, capital projects, system resilience, and compliance with federal standards for critical infrastructure protection. Norgeot will report to Bakken.
- Kimberly Cook-Nelson, senior vice president, nuclear corporate services, has been named executive vice president of nuclear operations and chief nuclear officer, with responsibility for the safe and reliable operations of Entergy's four emissions-free nuclear plants located in Arkansas, Louisiana and Mississippi. Cook-Nelson will report to Bakken.
- Julie Harbert, senior vice president, corporate business services, will continue in her current role with responsibility for information technology, supply chain, finance operations, human resource operations, real estate, facilities, aviation, and continuous improvement.
- Kathryn Collins, senior vice president and chief human resources officer, will continue in her current role overseeing human resources strategy, including talent management, business partnerships, compensation, benefits, labor relations, organizational health, and diversity workforce strategies.
With decades of combined leadership experience, Entergy's senior leadership team has the breadth and depth to lead the company forward. These leadership appointments will be effective Nov. 1.
About Entergy
Entergy (NYSE: ETR), a Fortune 500 company headquartered in New Orleans, powers life for 3 million customers through its operating companies across Arkansas, Louisiana, Mississippi and Texas. Entergy is creating a cleaner, more resilient energy future for everyone with our diverse power generation portfolio, including increasingly carbon-free energy sources. With roots in the Gulf South region for more than a century, Entergy is a recognized leader in corporate citizenship, delivering more than $100 million in economic benefits to local communities through philanthropy and advocacy efforts annually over the last several years. Our approximately 12,000 employees are dedicated to powering life today and for future generations. Learn more at entergy.com and follow @Entergy on social media. #WePowerLife
View original content to download multimedia:
SOURCE Entergy Corporation | https://www.kxii.com/prnewswire/2022/08/17/entergy-chairman-ceo-leo-denault-announces-plans-retire-2023/ | 2022-08-17T14:30:27Z |
San Diego teen Anna Davis wins Augusta Women’s Amateur
By DOUG FERGUSON
AP Golf Writer
AUGUSTA, Ga. (AP) — Anna Davis is the winner of the Augusta National Women’s Amateur. The 16-year-old from San Diego County was bogey-free on the back nine at Augusta National and closed with a 69. That still didn’t look to be enough. LSU junior Latanna Stone birdied the 16th hole for a two-shot lead with two holes to play. Stone made double bogey on the 17th hole with a long three-putt. And then she chipped too strong on the 18th and made bogey. Stone finished one shot behind with LSU teammate Ingrid Lindblad. Lindblad also made bogey on the 18th. | https://localnews8.com/sports/ap-national-sports/2022/04/02/san-diego-teen-anna-davis-wins-augusta-womens-amateur/ | 2022-04-02T22:14:04Z |
Company to Broadcast Conference Call
COLUMBUS, Ohio, Aug. 16, 2022 /PRNewswire/ -- Big Lots, Inc. (NYSE: BIG) today announced it will report the results for the second quarter of fiscal 2022 on Tuesday, August 30, 2022. The company will host a conference call at 8:00 a.m. Eastern Time on Tuesday, August 30, 2022.
A live webcast of the call will be available through the Investor Relations section of its website at http://www.biglots.com/corporate/investors/ or by phone by dialing 877.407.3088 (Toll Free) or 201.389.0927 (Toll).
An archive will be available on the Investor Relations section of the company's website at http://www.biglots.com/corporate/investors/ through midnight Tuesday, September 13, 2022. In addition, a replay of the call will be available through September 13 by dialing 877.660.6853 (Toll Free) or 201.612.7415 (Toll) and enter the Replay Conference ID: 13732156.
About Big Lots, Inc.
Headquartered in Columbus, Ohio, Big Lots, Inc. (NYSE: BIG) is a leading home discount retailer and a Fortune 500 company, operating 1,445 stores in 48 states, as well as a best-in-class ecommerce platform with expanded capabilities via BOPIS, curbside pickup, Instacart and same day delivery across thousands of items. The company's product assortment is focused on home essentials: Furniture, Seasonal, Soft Home, Food, Consumables and Hard Home. Ranked one of the fastest-growing eCommerce businesses by Digital Commerce 360 and the recipient of Home Textiles Today's 2021 Retail Titan Award, Big Lots' mission is to help people Live BIG and Save Lots. The company strives to be the BIG difference for a better life by delivering exceptional value to customers through the ultimate treasure hunt shopping experience, building a "best places to grow" culture, rewarding shareholders with consistent growth and top-tier returns and doing good in local communities. For more information about the company, visit biglots.com.
Cautionary Statement Concerning Forward-Looking Statements
Certain statements in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and such statements are intended to qualify for the protection of the safe harbor provided by the Act. The words "anticipate," "estimate," "expect," "objective," "goal," "project," "intend," "plan," "believe," "will," "should," "may," "target," "forecast," "guidance," "outlook" and similar expressions generally identify forward-looking statements. Similarly, descriptions of objectives, strategies, plans, goals or targets are also forward-looking statements. Forward-looking statements relate to the expectations of management as to future occurrences and trends, including statements expressing optimism or pessimism about future operating results or events and projected sales, earnings, capital expenditures and business strategy. Forward-looking statements are based upon a number of assumptions concerning future conditions that may ultimately prove to be inaccurate. Forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance and are applicable only as of the dates of such statements. Although the company believes the expectations expressed in forward-looking statements are based on reasonable assumptions within the bounds of knowledge, forward-looking statements, by their nature, involve risks, uncertainties and other factors, any one or a combination of which could materially affect business, financial condition, results of operations or liquidity.
Forward-looking statements that the company makes herein and in other reports and releases are not guarantees of future performance and actual results may differ materially from those discussed in such forward-looking statements as a result of various factors, including, but not limited to, developments related to the COVID-19 coronavirus pandemic, current economic and credit conditions, the cost of goods, the inability to successfully execute strategic initiatives, competitive pressures, economic pressures on customers and the company, the availability of brand name closeout merchandise, trade restrictions, freight costs, the risks discussed in the Risk Factors section of the company's most recent Annual Report on Form 10-K, and other factors discussed from time to time in other filings with the SEC, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. This release should be read in conjunction with such filings, and you should consider all of these risks, uncertainties and other factors carefully in evaluating forward-looking statements.
You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. The company undertakes no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures the company makes on related subjects in public announcements and SEC filings.
View original content to download multimedia:
SOURCE Big Lots, Inc. | https://www.wibw.com/prnewswire/2022/08/16/big-lots-report-second-quarter-results-august-30-2022/ | 2022-08-16T11:36:47Z |
UNDER EMBARGO UNTIL 27 July 1700 GMT-5
QUITO, Ecuador, July 26, 2022 /PRNewswire/ -- Ecuador's Minister of Environment, Water and Ecological Transition, Gustavo Manrique, is hosting a special event today to mark Earth Overshoot Day 2022 (July 28), featuring the Minister of Foreign Affairs and Human Mobility, authorities from different countries in the region, representatives of non-governmental organizations, businesses, scientists and academics. Global Footprint Network founder Mathis Wackernagel will be participating as the guest of honor.
"Earth Overshoot Day demonstrates that the current system of production and consumption is not compatible with the intention to continue to inhabit this planet. To better protect our natural resources and manage our demand for them, it is necessary to embrace a new development model based on sustainability and regeneration. From Ecuador, we call on the world to commit to this cause," explains Minister Gustavo Manrique.
Ecuador's unique tradition puts nature at its center. In 2008, it made history when it became the first country in the world to grant nature legally-enforceable constitutional rights to ''exist, flourish and evolve" through an overwhelming popular vote. Ecuador ranks as one of the countries whose Overshoot Day arrives the latest in the year (December 6 this year), which means its Ecological Footprint per person is only slightly higher than the worldwide average biocapacity per person.
The date of Earth Overshoot Day is calculated each year by Global Footprint Network, using National Footprint and Biocapacity Accounts data. This day reminds us that the persistence of overshoot, now for over half a century, has led to huge declines in biodiversity, excess greenhouse gases in the atmosphere, and heightened competition for food and energy. Symptoms are becoming more prominent with unusual heat waves, forest fires, droughts, and floods.
The economic pressures are already playing out. Global Footprint Network research shows that more than 3 billion people live in countries which produce less food than they consume and generate less than world average income. This means they have inadequate food capacity and face a huge disadvantage in accessing food on global markets. If we include all resources, not just food, the number of people exposed to this double challenge climbs to 5.8 billion people.
"Resource security is turning into an essential parameter of economic strength. There is no advantage in waiting for others to act first. Rather, it is in the interest of every city, company, or country to protect its own ability to operate in the inevitable future of more climate change and resource constraints," says Mathis Wackernagel.
"Cities hold the key to clean infrastructure transformation: Quito for its conservation of protected areas, Santiago de Chile for its electric buses, or Bogota for its bike paths show how local governments give their cities a better chance to have a solid future," says Sebastian Navarro, Secretary General of CC35, the Coalition of Capital Cities of the Americas on Climate Change.
Turning the trends around is not just possible, but it economically benefits those who lead the charge. Possibilities include:
- Cutting food waste in half worldwide would #MoveTheDate of Earth Overshoot Day 13 days.
- Upgrading urban bicycle infrastructure worldwide, like the Netherlands, has the potential to move it 9 days.
- Producing power by cost-competitive on-shore wind, as practiced in Denmark and Germany, could move it at least 10 days.
More details, key facts behind Earth Overshoot Day, and translations at: https://www.overshootday.org/newsroom/press-release-july-2022-english/
Marta Antonelli, Ph.D.- Italian, English, (GMT+2)
marta.antonelli@footprintnetwork.org +41-78-656-28-44
Alessandro Galli, Ph.D.- Italian, English, (GMT+2)
alessandro@footprintnetwork.org +39-347-903-49-77
Laetitia Mailhes- French, English, (GMT+2)
laetitia.mailhes@footprintnetwork.org +33-650-979-012
Amanda Diep- English, (GMT-7)
amanda.diep@footprintnetwork.org +1-(510)-839-8879-Ext4
View original content:
SOURCE GLOBAL FOOTPRINT NETWORK | https://www.mysuncoast.com/prnewswire/2022/07/26/earth-overshoot-day-2022-ecuadors-minister-environment-water-ecological-transition-calls-seizing-ecological-power-shape-our-future/ | 2022-07-26T22:30:32Z |
NYSE AMERICAN: SVM
VANCOUVER, BC, Aug. 11, 2022 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for the three months ended June 30, 2022 ("Q1 Fiscal 2023"). All amounts are expressed in US Dollars, and figures may not add due to rounding.
- Mined 300,104 tonnes of ore and milled 298,176 tonnes of ore, up 30% and 23% compared to the prior year quarter;
- Sold approximately 1.9 million ounces of silver, 1,100 ounces of gold, 19.1 million pounds of lead, and 6.9 million pounds of zinc, representing increases of 17%, 10%, and 14% in silver, gold and lead sold, and a decrease of 5% in zinc sold, compared to the prior year quarter;
- Revenue of $63.6 million, up 8% compared to $58.8 million in the prior year quarter;
- Net income attributable to equity shareholders of $10.2 million, or $0.06 per share, compared to $12.2 million, or $0.07 per share in the prior year quarter;
- Adjusted earnings attributable to equity shareholders of $13.5 million, or $0.08 per share, compared to $15.8 million, or $0.09 per share in the prior year quarter. The adjustments were made to remove impacts from impairment charges, share-based compensation, foreign exchange, mark-to-market equity investments, and the share of associates' operating results.
- Cash flow from operations of $40.2 million, up 10% or $3.7 million compared to $36.5 million in the prior year quarter;
- Cash cost per ounce of silver, net of by-product credits, of negative $1.57 compared to negative $1.43 in the prior year quarter;
- All-in sustaining cost per ounce of silver, net of by-product credits, of $9.25 compared to $7.46 in the prior year quarter;
- Spent and capitalized $3.1 million on exploration drilling, $9.7 million on underground development and $1.2 million on the construction of the new mill and tailings storage facility;
- Paid $2.2 million of dividends to the Company's shareholders;
- Spent $0.9 million to buy back 334,990 common shares of the Company under its Normal Course Issuer Bid, and subsequent to the quarter, bought back further 404,970 common shares of the Company for $1.0 million; and
- Strong balance sheet with $215.8 million in cash and cash equivalents and short-term investments, up $2.9 million or 1% compared to $212.9 million as at March 31, 2022. The Company holds further equity investment portfolio in associates and other companies with a total market value of $147.4 million as of June 30, 2022.
CONSOLIDATED FINANCIAL RESULTS
Net income attributable to equity holders of the Company in Q1 Fiscal 2023 was $10.2 million or $0.06 per share, compared to $12.2 million or $0.07 per share in the three months ended June 30, 2021. ("Q1 Fiscal 2022").
In Q1 Fiscal 2023, the Company's consolidated financial results were mainly impacted by i) an increase of 17%, 10%, and 14%, respectively, in silver, gold and lead sold; ii) an increase of 6%, 5%, and 20%, respectively, in the realized selling prices for gold, lead and zinc; iii) a foreign exchange gain of $1.7 million arising from the appreciation of the US dollar against the Company's functional currencies, mainly the Chinese yuan and the Canadian dollar; offset by iv) a decrease of 13% in the realized selling price for silver; v) a decrease of 5% in zinc sold; vi) a loss of $2.7 million on equity investments; and vii) an increase of 7% in per tonne production costs.
Revenue in Q1 Fiscal 2023 was $63.6 million, up 8% compared to $58.8 million in Q1 Fiscal 2022.
Income from mine operations in Q1 Fiscal 2023 was $24.9 million, down 2% compared to $25.5 million in the prior year quarter. Income from mine operations at the Ying Mining District was $21.4 million, up 1% compared to $21.2 million in Q1 Fiscal 2022. Income from mine operations at the GC Mine was $3.6 million, down 19% compared to $4.4 million in Q1 Fiscal 2022.
Cash flow provided by operating activities in Q1 Fiscal 2023 was $40.2 million, up 10% or $3.7 million, compared to $36.5 million in Q1 Fiscal 2022.
The Company ended Q1 Fiscal 2023 with $215.8 million in cash, cash equivalents and short-term investments, up 1% or $2.9 million, compared to $212.9 million as at March 31, 2022.
Working capital as at June 30, 2022 was $182.0 million, down 2% compared to $186.3 million as at March 31, 2022.
CONSOLIDATED OPERATIONAL RESULTS
In Q1 Fiscal 2023, the Company mined 300,104 tonnes of ore, up 30% compared to 231,235 tonnes in Q1 Fiscal 2022. Ore milled in Q1 Fiscal 2023 was 298,176 tonnes, up 23% compared to 243,077 tonnes in Q1 Fiscal 2022.
In Q1 Fiscal 2023, the Company produced approximately 1.9 million ounces of silver, 1,100 ounces of gold, 19.1 million pounds of lead, and 6.9 million pounds of zinc, representing increases of 26%, 10% and 20%, respectively, in silver, gold and lead production, and a decrease of 4% in zinc production over Q1 Fiscal 2022. The Company is on track to produce 7.0 million to 7.3 million ounces of silver, 6,300 to 7,900 ounces of gold, 68.4 million to 71.3 million pounds of lead, and 32.0 million to 34.5 million pounds of zinc in Fiscal 2023.
Compared to Q1 Fiscal 2022, the Company's consolidated per tonne costs in the current quarter were mainly impacted by i) inflationary cost pressure resulting in higher material and utility costs; ii) an average 9% increase in employees' pay rates; iii) increased drilling and tunneling resulting in higher costs included in mining costs and sustaining capital expenditures; offset by iv) an average 2% depreciation of the Chinese yuan against the US dollar.
In Q1 Fiscal 2023, on a consolidated basis, a total of 122,930 metres or $4.9 million worth of diamond drilling were completed (Q1 Fiscal 2022 – 107,913 metres or $4.6 million), of which approximately 66,999 metres or $1.8 million worth of underground drilling were expensed as part of mining costs (Q1 Fiscal 2022 – 50,666 metres or $1.3 million) and approximately 55,931 metres or $3.1 million worth of drilling were capitalized (Q1 Fiscal 2022 – 57,247 metres or $3.3 million). In addition, approximately 11,682 metres or $4.1 million worth of preparation tunnelling were completed and expensed as part of mining costs (Q1 Fiscal 2022 – 6,955 metres or $2.8 million), and approximately 24,958 metres or $9.7 million worth of tunnels, raises, ramps and declines were completed and capitalized (Q1 Fiscal 2022 – 17,263 metres or $6.8 million).
An application for a mining permit for the Kuanping Project has been submitted and is pending review and approval by the relevant provincial government authorities.
As of June 30, 2022, a total of $1.2 million expenditures have been incurred on the construction of the new 3,000 tonne per day floatation mill (the "New Mill") and the new tailings storage facility (the "TSF"). The preliminary design and engineering survey, the water and soil conservation studies for the New Mill and the TSF, and the feasibility study for the TSF have been completed. The Company also received the construction permit for the New Mill and is in the process of negotiating purchases of major equipment for the New Mill. The Company expects that the final approval of the environmental and safety assessment studies, and the detailed engineering design of the New Mill and the TSF will be granted in the second quarter of Fiscal 2023.
A conference call to discuss these results will be held tomorrow, Friday, August 12, at 9:00 am PDT (12:00 pm EDT). To participate in the conference call, please dial the numbers below.
Canada/USA TF: 888-664-6383
International Toll: 416-764-8650
Conference ID: 38775517
Participants should dial-in 10 – 15 minutes prior to the start time. A replay of the conference call and transcript will be available on the Company's website at www.silvercorp.ca.
Mr. Guoliang Ma, P.Geo., Manager of Exploration and Resources of the Company, is the Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101") and has reviewed and given consent to the technical information contained in this news release.
Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The Company's strategy is to create shareholder value by 1) focusing on generating free cashflow from long life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG. For more information, please visit our website at www.silvercorp.ca.
Silvercorp Metals Inc.
Lon Shaver
Vice President
Phone: (604) 669-9397
Toll Free 1(888) 224-1881
Email: investor@silvercorp.ca
Website: www.silvercorp.ca
This earnings release should be read in conjunction with the Company's Management Discussion & Analysis ("MD&A"), the unaudited condensed consolidated interim financial statements and related notes contains therein for the three months ended June 30, 2022, which have been posted on SEDAR under the Company's profile at www.sedar.com and are also available on the Company's website at www.silvercorp.ca under the Investor section. This earnings release refers to various alternative performance (non-IFRS) measures, such as adjusted earnings and adjusted earnings per share, cash costs and all-in sustaining costs per ounce of silver, net of by-product credits, production costs and all-in sustaining production costs per tonne of ore processed and working capital. These measures are widely used in the mining industry as a benchmark for performance, but do not have standardized meanings under IFRS as an indicator of performance and may differ from methods used by other companies with similar description. The detailed description and reconciliation of these alternative performance (non-IFRS) measures have been incorporated by reference and can be found on page 24, section 11 – Alternative Performance (Non-IFRS) Measures in the MD&A for the three months ended June 30, 2022.
Certain of the statements and information in this news release constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian provincial securities laws (collectively, "forward-looking statements"). Any statements or information that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects", "is expected", "anticipates", "believes", "plans", "projects", "estimates", "assumes", "intends", "strategies", "targets", "goals", "forecasts", "objectives", "budgets", "schedules", "potential" or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements. Forward-looking statements relate to, among other things: the price of silver and other metals; the accuracy of mineral resource and mineral reserve estimates at the Company's material properties; the sufficiency of the Company's capital to finance the Company's operations; estimates of the Company's revenues and capital expenditures; estimated production from the Company's mines in the Ying Mining District and the GC Mine; timing of receipt of permits and regulatory approvals; availability of funds from production to finance the Company's operations; and access to and availability of funding for future construction, use of proceeds from any financing and development of the Company's properties.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation, risks relating to: global economic and social impact of COVID-19; fluctuating commodity prices; calculation of resources, reserves and mineralization and precious and base metal recovery; interpretations and assumptions of mineral resource and mineral reserve estimates; exploration and development programs; feasibility and engineering reports; permits and licences; title to properties; property interests; joint venture partners; acquisition of commercially mineable mineral rights; financing; recent market events and conditions; economic factors affecting the Company; timing, estimated amount, capital and operating expenditures and economic returns of future production; integration of future acquisitions into the Company's existing operations; competition; operations and political conditions; regulatory environment in China and Canada; environmental risks; foreign exchange rate fluctuations; insurance; risks and hazards of mining operations; key personnel; conflicts of interest; dependence on management; internal control over financial reporting; and bringing actions and enforcing judgments under U.S. securities laws.
This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, those referred to in the Company's Annual Information Form under the heading "Risk Factors" and in the Company's Annual Report on Form 40-F, and in the Company's other filings with Canadian and U.S. securities regulators. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, described or intended. Accordingly, readers should not place undue reliance on forward-looking statements.
The Company's forward-looking statements are based on the assumptions, beliefs, expectations and opinions of management as of the date of this news release, and other than as required by applicable securities laws, the Company does not assume any obligation to update forward-looking statements if circumstances or management's assumptions, beliefs, expectations or opinions should change, or changes in any other events affecting such statements. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
View original content to download multimedia:
SOURCE Silvercorp Metals Inc | https://www.kxii.com/prnewswire/2022/08/11/silvercorp-reports-adjusted-earnings-135-million-008-per-share-cash-flow-operations-402-million-q1-fiscal-2023/ | 2022-08-11T22:52:49Z |
NEW YORK (AP) — In a legal case closely watched by libraries and the publishing industry, a federal judge in Maryland struck down a state law requiring publishers to make e-books available on “reasonable terms” to libraries if they were also being offered to the general public.
The Association of American Publishers, the industry’s trade organization, had contended that the bill violated the United States Copyright Act by allowing states to regulate publishing transactions. The Maryland law was passed with overwhelming support a year ago, and included provisions for fines up to $10,000 and higher.
Maryland U.S. District Judge Deborah L. Boardman issued her decision Monday, four months after she had enjoined the Maryland Act, writing at the time that the law’s “practical impact” would force publishers “to offer their products to libraries — whether they want to or not — lest they face a civil enforcement action or criminal prosecution.”
The state effectively conceded in April, with attorneys writing that “that there is no genuine dispute as to any material fact.” But the Association of American Publishers was still seeking a permanent injunction. Boardman ruled Monday that the injunction was unnecessary because the law was “unconstitutional and unenforceable.”
AAP President and CEO Maria A. Pallante praised Monday’s announcement, saying in a statement that Boardman had delivered a “clear decision that protects the exclusive rights that are the basis of the United States Copyright Act and the means by which authors and publishers make so many intellectual and economic contributions to society and the long-term public interest.”
Publishers and libraries have fought for years over providing e-books to library patrons. Publishers have worried that unlimited, or near-unlimited access to free e-books from libraries would damage sales and have responded by restricting their use and raising fees charged to libraries. Libraries have contended that it is part of their mission to make books as available as possible and that encouraging reading, for free or not, benefits everyone.
In New York last year, Governor Kathy Hochul vetoed a bill similar to the Maryland Act that had passed by wide margins in the state legislature. She wrote that “While the goal of this bill is laudable, unfortunately, copyright protection provides the author of the work with the exclusive right to their works.” | https://cw33.com/entertainment-news/ap-entertainment/judge-in-maryland-strikes-down-library-e-book-law/ | 2022-06-14T06:54:21Z |
Several food companies pull products linked to Jif peanut butter recall
By Katherine Dillinger, CNN
Food companies across the US are recalling products in the wake of a Jif peanut butter recall over Salmonella contamination concerns. Among them:
- Fudgeamentals of Melville, New York, is recalling fudge made with Jif.
- Fresh Del Monte is recalling fresh-cut fruit and vegetable products containing Jif peanut butter dip.
- Walnut Creek, Ohio-based Coblentz Chocolate Co. is recalling several peanut butter products linked with the Jif recall.
- Garden Cut LLC of Indianapolis is recalling apple wedges and celery bites sold with peanut butter.
- Mary’s Harvest Fresh Foods of Portland, Oregon is recalling celery and apple peanut butter cups.
- Cargill is recalling certain snacks sold online and through the Wilbur Chocolate store in Lititz, Pennsylvania.
- Plymouth, Minnesota-based Taher is recalling Fresh Seasons Power Packs that contain Jif.
Consumers who have these items should dispose of them or return them to the place of purchase.
J.M Smucker Co. recalled several types of Jif peanut butter May 20 after interviews and lab findings suggested that it may be contaminated. Fourteen salmonella cases have been reported in 12 states, with two people hospitalized. However, the US Centers for Disease Control and Prevention says the true number of illnesses is probably higher.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/health/cnn-health/2022/05/25/several-food-companies-pull-products-linked-to-jif-peanut-butter-recall/ | 2022-05-26T03:09:09Z |
(NEXSTAR) – Prepare to sleep like Rosemary’s baby in your very own horror-themed bungalows.
A couple in California is ready to sell a pair of creepy retro cabins that most horror fans “can only dream of living in,” according to one of the owners.
The property, located in Big Bear Lake, actually consists of two separate units — one that’s currently modeled after the Netflix series “Stranger Things,” and another that’s decked out in horror merch and memorabilia. Some of the more inspired touches in the “Stranger Things” cabin include a recreation of Joyce’s living room and a mini arcade, while the horror-themed cabin features a life-sized statue of Michael Myers from the “Halloween” franchise and a bedroom mural depicting “The Creature From the Black Lagoon.”
“I would have to say my favorite room is the ‘Creature From the Black Lagoon’ bedroom in the horror cabin,” co-owner Jade Valore told Nexstar. “When you turn off the lights in there and turn on the neon light, the room is fully green.”
Valore says she and her husband originally intended to use the cabins for vacation rentals, but local regulations have limited them to renting out only one unit at a time.
“This was created as a destination for people to enjoy and if the city can’t let us see our vision through then we would rather part ways,” she said of their decision to sell.
The listing price for the cabins, however, does not currently include most of the decorations. But Valore told Nexstar she’s open to selling the creepy furnishings and décor, if someone were to make the right offer.
Judging by social media’s reaction to the property, there just might be a few interested buyers who prefer the décor stay right where it is.
“Wouldn’t change a thing,” wrote one Instagram user, commenting on a @ZillowGoneWild post featuring the property.
“This will be the only time I’ll ever say this. Let’s move to California,” said another user.
“It’s like the 80s threw up,” someone else joked.
Valore, while sad to give up the cabins, said she hopes to find a buyer who appreciates the property as much as she does.
“These cabins would be something I would personally live in, and I think that is what a lot of people also can only dream of living in,” she said. “The décor is what these cabins are all about.”
The home is currently listed at $450,000, but Valore didn’t specify how much she wanted for the memorabilia and decorations.
“For the right price I wouldn’t say no,” she said. | https://cw33.com/news/wouldnt-change-a-thing-listing-photos-for-horror-themed-property-delight-social-media/ | 2022-04-04T16:35:54Z |
NEW YORK, July 5, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Okta, Inc. (NASDAQ: OKTA) alleging that the Company violated federal securities laws.
Class Period: March 5, 2021 to March 22, 2022
Lead Plaintiff Deadline: July 19, 2022
No obligation or cost to you.
Learn more about your recoverable losses in OKTA:
https://www.kleinstocklaw.com/pslra-1/okta-inc-loss-submission-form?id=29463&from=4
Okta, Inc. NEWS - OKTA NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Okta, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Okta had inadequate cybersecurity controls; (ii) as a result, Okta's systems were vulnerable to data breaches; (iii) Okta ultimately did experience a data breach caused by a hacking group, which potentially affected hundreds of Okta customers; (iv) Okta initially did not disclose and subsequently downplayed the severity of the data breach; (v) all the foregoing, once revealed, was likely to have a material negative impact on Okta's business, financial condition, and reputation; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Okta you have until July 19, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Okta securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the OKTA lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/okta-inc-loss-submission-form?id=29463&from=4.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:
SOURCE The Klein Law Firm | https://www.kxii.com/prnewswire/2022/07/05/okta-alert-klein-law-firm-announces-lead-plaintiff-deadline-july-19-2022-class-action-filed-behalf-okta-inc-shareholders/ | 2022-07-05T10:02:25Z |
The Iconic Easter Brand Offers New Ways for Fans to Celebrate the Season
BETHLEHEM, Pa., April 8, 2022 /PRNewswire/ -- Spring just got a whole lot sweeter! Ahead of the Easter season, the PEEPS® Brand is teaming up with a wide range of new and returning partners to bring its iconic Marshmallow Chicks and Bunnies to fans in exciting new forms. From colorful collabs with well-known beauty brands, to tasty treats, cuddly new offerings and more, there's a way for every-bunny to express their PEEPSONALITY® this season!
"The PEEPS® Brand is excited to share brand new ways fans can make even more Springtime traditions with PEEPS® through fun and vibrant partnerships," said Caitlin Servian, Brand Manager for PEEPS®. "Our Marshmallow Chicks and Bunnies have truly become an essential part of the Spring and Easter seasons, which is why we continue to explore unexpected collaborations that help to elevate the PEEPS® experience. This allows fans to incorporate the brand into a variety of seasonal celebrations."
Need a makeover this Spring? Bring the classic marshmallow confection right to your fingertips with the new Sally Hansen Insta-Dri® X PEEPS® Collection, which features seven nail polish shades inspired by the fluffy treat. Or try a festive new look with the ColourPop x PEEPS® Collection, featuring the brand's Glossy Lip and Super Shock Shadow products in shades that emulate vibrant PEEPS® colors.
Marshmallow lovers seeking a cuddly companion can snuggle up to a sweet friend this Spring as the PEEPS® Brand returns to Build-A-Bear Workshop! Featuring new Lavender, Orange, and Green PEEPS® Bunnies, a larger-than-life Giant PEEPS® Bunny and PEEPS®-inspired accessories, this collection is an adorable addition to any Easter celebration.
For those seeking the recognizable taste of PEEPS® Marshmallow in new forms, Cold Stone Creamery is offering PEEPS® lovers a few indulgent treats with its PEEPS® Marshmallow Flavored Ice Cream, Creation® and Shake, made with Whipped Topping and Blue Sugar Crystals and topped with a Yellow PEEPS® Marshmallow Chick. Fans can also create lasting memories in the kitchen this Spring by baking one of six new recipes made in collaboration with the baked-good experts at Duncan Hines®.
The PEEPS® Brand is also offering fans the chance to bring their sweetest cravings to life through My PEEPS™, a made-to-order dozen of personalized Marshmallow Chicks including a variety of delicious dipping options. Hop to it, the last order date for guaranteed delivery for Easter is April 11th.
For a first-hand tutorial on how to create PEEPS® recipes or crafts, DIY-ers can tune into the brand's Instagram for PEEPSONALITY® Live! The virtual series is back and better than ever this year with even more festive activities that are perfect for the whole family. Fans can tune into the final episode on April 12 at 6:30PM EST to learn how to make seasonal memories with DIY expert Emily Hutchinson (@the_hutch_oven). Previously aired episodes featuring craft and recipe creators such as Kara Whitten (@kailochic), Chef Rebekah of @realduncanhines and Melody of @melodyinthemaking will also be saved to the brand's IGTV and YouTube channel for viewers to enjoy throughout the season.
Don't forget to express your #PEEPSONALITY by snapping and sharing pictures and videos of how you enjoy PEEPS® Chicks and Bunnies, tagging @PEEPSBRAND on social media. Be sure to follow @PEEPSBRAND to stay up to date on the latest and greatest PEEPS® offerings and check out sweet brand giveaways leading up to Easter.
For even more sweet craft and recipe inspiration, visit www.peepsbrand.com. To purchase PEEPS® Candy and merchandise, fans can shop online at www.peepsandcompany.com.
For high-res visual assets showcasing the PEEPS® collaborations, click here.
About Just Born Quality Confections:
Just Born Quality Confections is a third-generation family-owned candy manufacturer with its purpose to bring sweetness to people's lives. Just Born is the maker of some of America's most beloved and iconic brands – PEEPS®, MIKE AND IKE®, HOT TAMALES® and GOLDENBERG'S® PEANUT CHEWS®. In 1923, the founder, Sam Born, opened a small candy shop in Brooklyn, New York, where he marketed the freshness of his daily-made candy with a sign that declared, "Just Born." Together with Born's brothers-in-law, Irv and Jack Shaffer, the company thrived and, in 1932, moved its operations to Bethlehem, PA where it has grown to become one of the largest candy companies in the US by giving back to the community, being good environmental stewards and creating a culture where people want to work. For more information, please visit www.justborn.com (and see the breadth of candy and high-quality branded items at www.peepsandcompany.com) Follow us: facebook.com/JustBornInc, twitter.com/JustBornInc.
View original content to download multimedia:
SOURCE Just Born Quality Confections | https://www.kxii.com/prnewswire/2022/04/08/express-your-peepsonality-this-spring-with-adorable-peeps-chicks-bunnies/ | 2022-04-08T11:14:53Z |
- A Single Dose of SLS-004 Produced 19% Downregulation of mRNA and ~40% Reduction of Alpha-Synuclein Compared to the Control Group
- These Results Support Advancing SLS-004 into Additional Preclinical Studies in Dementia with Lewy Bodies
NEW YORK, June 9, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced data demonstrating a statistically significant (p<0.01) 19% downregulation of mRNA and a ~40% reduction of alpha synuclein (α-synuclein) in an in vitro study of SLS-004, its gene therapy program utilizing CRISPR-dCas9, in dementia with Lewy bodies (DLB).
DLB is characterized by the accumulation of aggregated α-synuclein protein in Lewy bodies and Lewy neurites. In DLB, the pathological changes are observed in the neocortex and limbic systems with a distinguishing feature of cholinergic dysfunction, which is different from other Lewy body disorders such as Parkinson's disease. Cholinergic neurons are differentially vulnerable in various neuropathologic entities that cause dementia, including DLB. Available evidence points to early and substantial degeneration of these neurons in DLB.
"This current in vitro study extends the existing CRISPR program for Parkinson's disease to DLB as both disorders are synucleinopathies although affecting different neurons in separate regions of the brain. Our team's observation of a meaningful efficacy with a new CRISPR technology focused on cholinergic neurons in striatum for DLB is exciting indeed, as it reinforces our earlier findings in a Parkinson's disease model," said Raj Mehra, Ph.D., Chairman and CEO of Seelos. "Results producing statistically significant reductions in mRNA and α-synuclein are clinically meaningful. We plan to advance into additional preclinical studies in DLB and Parkinson's and expect additional data in the second half of this year."
The goal of this in vitro study was to extend the existing SNCA-targeted epigenome therapy system (SLS-004) by modifying the viral vector to target specific cholinergic neurons in the cortex that are afflicted in DLB and validate the specificity and efficacy in human-induced pluripotent stem cells (hiPSC) derived neuronal systems.
The parental line SNCA-Tri hiPSC-derived system for the proof-of-concept model was utilized for the current study. hiPSC were differentiated utilizing earlier protocols used in SLS-004. Multiple batches of each differentiated neuronal type were evaluated, and successful differentiation of each batch was established.
The preliminary findings showed that following two weeks of differentiation into cholinergic neurons, there was a statistically significant (p<0.01) 19% downregulation of mRNA and a ~40% reduction of α-synuclein protein compared to the no treatment/repressor groups.
Seelos plans to advance the study of SLS-004 in DLB in additional preclinical studies and disclose further developments of this new CRISPR-based therapeutic technology in the future.
In July 2021, Seelos released positive preclinical in vivo data with SLS-004 in downregulation of overexpressed α-synuclein in a Parkinson's disease model and plans to release additional data in the second half of 2022.
Dementia with Lewy bodies (DLB) is one of the two types of dementia that has Lewy body inclusions as hallmarks of pathology, the other being Parkinson's disease dementia. DLB's initial symptoms of decreased mental functioning in patients often appear similar to the onset of Alzheimer's disease. However, unlike Alzheimer's, progression of DLB can cause various movement issues as well as visual and auditory hallucinations.
DLB a progressive neurodegenerative disorder in which cognition, behavioral symptoms, and Parkinsonian symptoms worsen over time, shortening life expectancy and often requiring nursing home placement. There are currently no treatments with evidence of disease-modifying effects in DLB. Current treatment options are primarily symptomatic and targeted toward specific disease manifestations, including cognitive or behavioral symptoms, disabling Parkinson's symptoms, sleep behavior disorder and other symptoms.
SLS-004 is a novel epigenome-editing approach to modulate expression of SNCA gene mediated by modification of DNA-methylation. SLS-004 utilizes an all-in-one lentiviral vector harboring dCas9-DNA methyltransferase 3A (DNMT3A) to enrich DNA-methylation within CpGs island at the SNCA intron 1 region. The system resulted in a precise and fine-tuned downregulation (30%) of SNCA overexpression in hiPSC-derived dopaminergic neurons from a PD patient with the triplication of the SNCA locus (SNCA-Tri). Most importantly, the reduction of SNCA expression mediated by the developed system was sufficient to ameliorate disease related cellular phenotypes. The in vitro studies achieved several key milestones including the establishment that DNA hypermethylation at SNCA intron 1 allows an effective and sufficient tight downregulation of SNCA expression levels and suggests the potential of this target sequence combined with the CRISPR-dCas9 technology as a novel epigenetic-based therapeutic approach for PD.
Statements made in this press release, which are not historical in nature, constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements include, among others, those regarding the Company's plans to advance into additional pre-clinical studies in DLB and Parkinson's, its expectations to disclose additional developments and data, including its plans to release data for a Parkinson's disease model in the second half of this year, the safety and efficacy of SLS-004 and its ability to downregulate or reduce SNCA mRNA and SNCA protein expression. These statements are based on Seelos' current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks associated with Seelos' business include, but are not limited to, the risk of not successfully executing its preclinical and clinical studies and not gaining marketing approvals for its product candidates, the risk that prior clinical results may not be replicated in future studies and trials (including the risk that the results from the preclinical study of SLS-004 are not replicated or are materially different from the results of future studies and trials), the risks that clinical study results may not meet any or all endpoints of a clinical study and that any data generated from such studies may not support a regulatory submission or approval, the risks associated with the implementation of Seelos' business strategy, the risks related to raising capital to fund its development plans and ongoing operations, risks related to Seelos' current stock price, risks related to the global impact of COVID-19, as well as other factors expressed in Seelos' periodic filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Anthony Marciano
Chief Communications Officer
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Avenue
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com
https://seelostherapeutics.com/
https://twitter.com/seelostx
https://www.linkedin.com/company/seelos
Mike Moyer Managing Director
LifeSci Advisors, LLC
250 West 55th St., Suite 3401
New York, NY 10019
(617) 308-4306
mmoyer@lifesciadvisors.com
View original content to download multimedia:
SOURCE Seelos Therapeutics, Inc. | https://www.kxii.com/prnewswire/2022/06/09/seelos-therapeutics-announces-data-demonstrating-statistically-significant-downregulation-mrna-reduction-alpha-synuclein-an-vitro-gene-therapy-study-sls-004-utilizing-crispr-dcas9-dementia-with-lewy-bodies/ | 2022-06-09T12:34:10Z |
Five teenagers and a 9-year-old were shot Saturday night in Louisville, Kentucky, police said.
The shooting happened on the Big Four Bridge, a former railroad span that is now used by pedestrians and cyclists near Waterfront Park, the Louisville Metropolitan Police Department said.
"We know the park was filled with a lot of people. We're asking for anybody that witnessed or observed anything to please give us a call," Major Brian Kuriger said.
Just after 9:00 p.m., officers responded to reports of people shot and discovered three teenagers who had been wounded, police said. The teens were transferred to a hospital and at least one of them was listed in critical condition with life-threatening injuries.
Two other teens later arrived at the hospital on their own with gunshot wounds.
On Monday, police said a 9-year-old was also grazed by a bullet in the shooting.
The victims' ages ranged from 9 to 16, according to Elizabeth Ruoff, the Louisville police spokesperson.
Albany and Dougherty County officials welcomed a new fire tanker to the fleet of trucks available for firefighting duties. Tanker 8 will be stationed at the Newton Road fire station. The county, which contracts with the city for fire protection in unincorporated areas, purchased the tanker t… Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/news/5-teenagers-and-a-9-year-old-were-shot-near-a-park-in-louisville-kentucky/article_a3810b2d-0a27-5ff6-8b15-4051cfc7e1ff.html | 2022-06-14T01:48:38Z |
SAN JOSE, Calif., June 29, 2022 /PRNewswire/ -- Visby Medical™, a leading medical diagnostic company, today announced that it expanded its over-subscribed Series E financing round to include an additional $35 million for a total of over $135 million raised in the round. The additional investment was led by Lightrock, who joined existing Series E investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and J Ventures.
The additional investment will be used to enable Visby Medical to scale production capacity, further expand the product menu to include advanced respiratory health tests, antimicrobial resistance panels, and deliver the power of PCR diagnostics to consumers at-home.
"At Visby Medical, we are revolutionizing patient care by developing diagnostics that healthcare providers can use to test for any infection at anytime, anywhere," said Visby Medical Founder and CEO Adam de la Zerda, PhD. "Especially during these times of market slowdown, our investors have shown significant confidence in Visby's innovative technology and mission. This funding will enable us to further our goal to provide the world's first instrument-free handheld PCR platform to accurately and rapidly test for a variety of serious infections to anyone who needs it."
Visby's patented gold standard PCR diagnostic technology is being developed in multiple therapeutic areas and is aimed to address a critical and growing global need: to combat the significant rise in infectious diseases. The FDA-cleared Visby Medical Sexual Health Click Test is already being used in U.S. CLIA-waived settings, such as Urgent Care and women's health clinics, to detect gonorrhea, chlamydia and trichomonas via self-collected vaginal swabs and deliver results in less than 30 minutes, eliminating the need for presumptive treatment.
Ashish Puri, Partner at Lightrock, said, "Visby Medical have produced a diagnostics tool capable of transforming patient care, enabling accurate results over the course of patients' visit. The innovation behind this versatile product has the potential to decentralise lab testing, producing major benefits for communities around the world and opening up access to affordable healthcare results. Lightrock invests in businesses using scalable technologies to deliver real and significant impacts and Visby aligns perfectly with that vision."
About Visby Medical™
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company's proprietary technology development program culminated in the world's first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company's FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.
For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn; Facebook, and Twitter.
Media Contact:
press@visby.com
Investor Contact:
Mark Ibison
Chief Financial Officer, Visby Medical
mark.ibison@visby.com
View original content to download multimedia:
SOURCE Visby Medical | https://www.mysuncoast.com/prnewswire/2022/06/29/visby-medical-expands-series-e-round-over-135-million/ | 2022-06-29T10:54:54Z |
SAN FRANCISCO, Sept. 14, 2022 /PRNewswire/ -- Vivian Health, an IAC (NASDAQ: IAC) company and the leading healthcare jobs marketplace serving healthcare professionals first, today announced an agreement with Lume, a banking platform for healthcare workers, which allows Vivian to leverage Lume's technology to create new banking and financial services for the more than 800,000 registered clinicians on the Vivian platform. As part of the agreement, Lume co-founders Christopher Chang and Shantanu Joshi will join Vivian Health to lead product and engineering efforts focusing on developing new financial products and value-added services that directly benefit healthcare professionals, furthering Vivian's mission of building the most aligned solution for America's healthcare workers.
"Chris and Shantanu's entrepreneurial energy, passion for building products which truly serve those who serve others, and Lume's core technology offering will significantly accelerate Vivian's ability to provide millions of healthcare professionals the most candidate-centric experience in healthcare hiring," said Parth Bhakta, co-founder and CEO of Vivian Health. "Chris and Shantanu will help build the foundation of Vivian's rewards and loyalty offering to healthcare professionals, and they will ultimately help retain more of America's healthcare workforce in an era of persistent staff shortages and a shrinking labor force. The Lume team knows firsthand the unique challenges and barriers that healthcare workers face today, and together, we are poised to create better experiences, fundamentally aligned with clinicians' interests, that can ultimately help alleviate systemic staff shortages in healthcare."
Founded in 2019 and backed by Y-Combinator, Lume is a new kind of banking experience built from the ground up for nurses and those working in the healthcare industry. Lume features such as on-demand pay, student loan and debt refinancing, and personalized job recommendations are all designed to help healthcare workers live better lives.
"It was clear ever since our first meeting with Parth that we were both on a mission to build a best-in-class experience for clinicians and we aligned on a strategy to do that. It very much felt like a natural partnership," said Mr. Chang.
"Having previously run a healthcare staffing firm ourselves, we were already deeply familiar with Vivian's customers, product offerings, and vision. We're incredibly excited to hit the ground running by bringing banking and financial products to every nurse on the Vivian platform," added Mr. Joshi.
As the first jobs marketplace built for healthcare professionals, Vivian offers healthcare employers nationwide, including both staffing agencies and large health systems, a fast and effective way to fill a variety of healthcare jobs across permanent roles, per-diem shifts, local contracts, and travel positions. Vivian has seen significant adoption among healthcare professionals, with over 800,000 registered clinicians using its jobs marketplace. Much of this growth has come through organic channels and word-of-mouth. Vivian Health recently announced a $60 million equity investment led by Thoma Bravo, a leading software investment firm, with participation from IAC and Collaborative Fund, to further accelerate its growth.
Vivian Health, an IAC company (NASDAQ: IAC), is the leading healthcare job marketplace that serves healthcare professionals first. Vivian Health empowers a broad range of healthcare professionals to find jobs they love across many types of healthcare work, including permanent roles, per-diem shifts, local contracts, and travel positions. Built on intelligent matching, transparent information, and the widest selection of job opportunities, Vivian Health offers healthcare job seekers an unrivaled solution for finding their next role. For employers, Vivian Health helps fill roles 50% faster than traditional recruiting practices and at a fraction of the cost, saving them millions of dollars, and helping alleviate labor shortages in healthcare. Vivian Health is headquartered in San Francisco with offices in Denver. To learn more about Vivian Health, visit www.vivian.com
Lume is a technology platform dedicated to helping healthcare professionals build wealth. The platform offers multiple financial solutions and products all designed to help healthcare providers and clinicians eliminate loans and debt and maximize their hard-earned income. Learn more at uselume.com.
Media Contact
vivian@theblissgrp.com
View original content to download multimedia:
SOURCE Vivian Health | https://www.kxii.com/prnewswire/2022/09/14/vivian-health-acquires-use-lume-technology-further-empower-support-healthcare-workers/ | 2022-09-14T14:41:10Z |
Massillon Tigers football star Freddie Lenix Jr. commits to Kent State
MASSILLON — Freddie Lenix Jr. of Massillon is not highly active on social media. So when it comes to announcing his college of choice, just like his on-field performance last year, you might not see it coming.
Lenix confirmed to The Canton Repository that he committed to Kent State on Wednesday afternoon. Lenix plans to play running back at the next level.
As he much as valued the relationship he had with the coaches he met, his education played a part in why he chose to be a future Golden Flash.
"To me, it's the academics," Lennix said. "I got a couple of friends that go there, and they told me that the academics here are amazing, and what I need help on, they are going to let me focus on that, making sure I'm good I know what I suppose to know."
Lenix also plays cornerback and was highly recruited in that position. He attracted the attention of quite a few schools after testing well at Massillon's Division I College Showcase on May 12. The following day, he received offers from several teams in the Mid-American Conference. Lenix also had offers from Marshall, Morgan State, and a few Division II schools.
"As soon as everything started to low-key go off, I was like, wow," Lenix said. "Everything is starting to happen. I just have to lock in more."
Northeast Ohio High School Football:'He loved the young men he coached': Akron high school football legend Tim Flossie dies at 73
Lenix is the third Tiger to commit before the 2022 regular season. Marcus Moore committed to Akron and Ardell Banks committed to Toledo in April. Willtrell Hartson, Massillon's other top running back, is still undecided but is thrilled for Lenix in choosing to stay close to home.
"It keeps him out of trouble and it's close to home," Hartson said. "He will be close to his family in case he needs anything, and he'd still be around here. That's good for him, and he will do his thing.
Lenix stepped in at running back after Hartson went down with an injury midway through last season. Lenix finished the season with 779 yards rushing and 11 touchdowns on 100 carries. He had a breakout game Week 10 against rival McKinley and was even better In the regional quarterfinals, with a season-best 226 yards and two TDs in the Tigers' win over Westerview South High School. Massillon finished 11-3.
Lenix is not satisfied and still believes he has something to prove. He is one of Massillon's top returning players on both ends of the field and is expected to split carries with Hartson this season. Lenix is on USA Today Networks's Greater Akron/Canton list of top players in the 2023-25 classes.
"I'm bringing everything that everyone likes to see," Lenix said. "Have fun, tuck the ball like always, and I know if I do something wrong, Willtrell will back me up."
Massillon opens the regular season at home against Cincinnati Moeller on Friday, Aug. 19.
Stark County Football:Pro Football Hall of Fame East-West All-Star Football Game rosters feature All-Ohio players | https://www.cantonrep.com/story/sports/high-school/fridaynightohio/2022/07/20/kent-state-football-recruiting-news-freddie-lenix-jr-massillon-tigers-commits-college-prospect-mac/10108147002/ | 2022-07-20T20:49:49Z |
Amazon, Rite Aid cap purchase of emergency contraceptives
NEW YORK (AP) — Amazon is limiting how many emergency contraceptives consumers can buy, joining other retailers who put in place similar caps following the Supreme Court decision overruling Roe v. Wade.
Amazon’s limit, which temporarily caps purchase of the contraceptives at three units per week, went into effect on Monday, a spokesperson for the e-commerce giant confirmed to The Associated Press. The company did not share further details on what emergency contraceptive products were limited for purchase, but a listing showed the cap applied to Plan B, the popular “morning after” pill.
A similar policy went into effect Monday at the drugstore chain Rite Aid, which has limited the purchase of Plan B pills to three units per customer due to increased demand, a company spokesperson said. The limit applies to both in-store and online purchases.
Emergency contraception is different from abortion pills used to end a pregnancy. Plan B, which can be obtained without a prescription, contains a concentrated dose of the same drug found in many regular birth control pills. If a woman takes Plan B within 72 hours of unprotected sex, she can lower the risk of pregnancy significantly.
Emergency contraception has been attacked by some abortion foes who believe life begins when an egg is fertilized. The federally approved label says it may prevent a fertilized egg from attaching to the womb. But researchers with the American College of Obstetricians and Gynecologists have said its unlikely to have that effect.
A large Missouri hospital chain briefly stopped providing Plan B due to confusion over whether the state’s abortion ban could put doctors at risk of criminal charges for providing it. St. Luke’s Health Kansas City said Wednesday, however, that it would resume offering the medication.
Retailers limiting purchases is standard practice that helps retailers prevent stockpiling and reselling at higher prices.
“Retailers are being cautious. They are trying to manage it,” said Neil Saunders, managing director at GlobalData Retail. “But I don’t think there are chronic shortages.”
Walmart, Amazon’s top competitor, has capped online purchases of Plan B to 10 units, though it’s unclear when the purchase limit began. The retailer doesn’t have in-store limits at this time, but managers may make changes to help ensure availability based on the demand.
“Many of our products have online purchase limits in place,” a Walmart spokesperson said. “During times of fluctuating demand, these limits may change.”
Meanwhile, CVS Health said it removed its own caps on emergency contraceptives after it installed a temporary limit following Friday’s high court ruling. The company said it had been seeking to preserve access to the products following a “sharp increase” in sales, which have since returned to normal levels.
“We continue to have ample supply of emergency contraceptives to meet customer needs,” CVS Health spokesman Matthew Blanchette said.
The pharmacy chain Walgreens is still able to meet demand for in-store purchases and curbside pickup of over-the-counter emergency contraception pills. But spokeswoman Emily Mekstan said the company is restocking its ship-to-home business, which saw a jump in demand. CVS Health and Walgreens are the two biggest U.S. drugstore chains. They run around 19,000 locations combined.
Spokespeople for Target and Kroger said they didn’t have anything to share on potential limits on contraceptive purchases.
______
AP staff writers Anne D’Innocenzio in New York and Tom Murphy in Indianapolis contributed to this report.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/06/30/amazon-rite-aid-cap-purchase-emergency-contraceptives/ | 2022-06-30T12:22:38Z |
CHICAGO, Aug. 22, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, is calling on global college students interested in pursuing careers in finance and markets to register for its annual University Trading Challenge which will be held during October 2022. Registration for the global educational competition opens today.
Now in its 19th year, the CME Group University Trading Challenge allows teams of undergraduate and graduate students the opportunity to experience the excitement, energy and decision-making required of real-time futures trading in a number of CME Group's markets across multiple asset classes on a simulated, professional trading platform provided by CQG. Educational content and market commentary are also provided to all participants. Throughout the four week-long challenge, participating students will receive live market updates through Dow Jones newsfeeds and The Hightower Report.
"The many uncertainties in today's global economies are driving increased interest in and demand for hedging and risk management strategies," said Anita Liskey, Global Head of Brand Marketing and Communications at CME Group. "We encourage all university students who want to learn about derivatives markets and test their trading skills to participate in this unique hands-on educational experience."
University teams can participate on a student-led team or in cooperation with a faculty advisor. Advisors will have early registration access to register their teams beginning today at 9:00am CT. Registration for the general student population opens Wednesday, September 7 at 9:00am CT, and closes on Thursday, September 29 at 5:00pm CT. The live competition begins on Sunday, October 2 at 5:00pm CT and concludes on Friday, October 28 at 4:00pm CT.
Participants can register by following this link, and are encouraged to brush up on their market knowledge through the wide range of resources available through the trading challenge portal.
Last year, a total of 386 teams comprising more than 1,500 students from 24 countries competed, with the winning team coming from Colombia's University of Bogota Jorge Tadeo Lozano.
CME Group is committed to educating the next generation of finance professionals on the significance of its global derivatives markets and risk management. In addition to interactive events like the University Trading Challenge, CME Group also partners with other industry organizations to offer educational tools, such as Futures Fundamentals, a one-stop educational resource that explains the role of futures markets in everyday life. The goal of the site is to make financial education an engaging experience for anyone, regardless of how well versed they are in the world of finance.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.
View original content:
SOURCE CME Group | https://www.kxii.com/prnewswire/2022/08/22/cme-group-opens-registration-its-19th-annual-global-university-trading-challenge-2022/ | 2022-08-22T14:51:11Z |
Students Using Imagine Math Show Higher Scores and Proficiency Levels
SCOTTSDALE, Ariz., July 12, 2022 /PRNewswire/ -- Imagine Learning, the largest provider of digital curriculum solutions in the U.S., serving 15 million students in more than half the school districts nationwide, today announced the results of two new studies revealing that elementary and middle school students who used Imagine Math demonstrated significant academic gains on standardized assessments. The studies took place in schools across Texas, Florida, North Carolina, and South Carolina during the 2020-21 school year.
"As we continue to collaborate with districts, the results of these studies reveal what the future of learning can look like when the power of digital learning is harnessed to support educators," said Jeff Pendleton, SVP and General Manager of Supplemental and Intervention for Imagine Learning. "Students are making great strides through the use of our adaptive, personalized learning solutions and we're delighted to see Imagine Math accelerating learning and igniting breakthroughs."
- During the 2020-21 academic year, a public school district in Texas implemented Imagine Math with students in Grades 1-9. Imagine Learning obtained and analyzed Renaissance Star Math® test scores from more than 16,000 Imagine Math students and from a comparison group of students who were matched on their Fall 2020 Renaissance Star Math scaled score, race/ethnicity, and gender. Findings from the study show that after one year using Imagine Math, students demonstrated significantly greater gains on the Renaissance Star Math assessment than their nonparticipating peers. Additionally, the percentage of Imagine Math students reaching Proficient on the Renaissance Star Math assessment was greater than that of the matched non-user group.
- During the 2020-21 academic year, a national network of charter schools implemented Imagine Math with 3,048 students in Florida, North Carolina, and South Carolina. Imagine Learning analyzed Fall 2020 to Spring 2021 NWEA MAP Growth Math data among those Imagine Math students compared to a statistically matched group of 3,068 program non-users who were demographically and academically similar. Overall, findings from the study showed that the students who used Imagine Math demonstrated a significantly greater growth rate from Fall 2020 to Spring 2021 than non-users.
Imagine Math combines a rich curriculum with fun, adaptive digital experiences to help students become confident math learners. Ideal as a supplement to standards-based PreK—Geometry core instruction, its two age-appropriate learning environments are designed for student engagement. In grades PreK-2, Imagine Math is designed to inspire a lifelong love of mathematics and is fully available in both English and Spanish. The program immerses early learners in an engaging storybook context that seamlessly teaches young students to see mathematics in their everyday world. In Grades 3 and above, students are invited to a meaningful exploration of mathematical understanding. Rigorous, standards-rich content adapts to the unique needs of each learner to develop essential foundations and conceptual understanding they need to achieve grade-level mastery. Unique to Imagine Math, point-of-need access to live instruction by certified, bilingual math educators is available to make deep learning beyond the bell a reality. More information is available at imaginelearning.com/imagine-math.
Imagine Learning is a PreK–12 digital learning solutions company that ignites learning breakthroughs by designing forward-thinking solutions at the intersection of people, curricula, and technology to drive student growth. Imagine Learning serves more than 15 million students and partners with more than half the school districts nationwide. Imagine Learning's flagship products include Imagine Edgenuity®, online courseware and virtual school services solutions; supplemental and intervention solutions for literacy, language, mathematics, robotics, and coding; and high-quality, digital-first core curriculum, including Illustrative Mathematics®, EL Education®, and Odell Education®—all on the Imagine Learning Classroom—and Twig Science®. Read more about Imagine Learning's digital solutions at imaginelearning.com.
View original content to download multimedia:
SOURCE Imagine Learning LLC | https://www.kxii.com/prnewswire/2022/07/12/two-new-studies-reveal-significant-gains-student-performance-with-imagine-math/ | 2022-07-12T17:18:47Z |
- SoftBank Corp. becomes second global mobile network operator to take equity stake in 1NCE
- SoftBank Corp. will exclusively sell 1NCE in 19 markets across APAC, including Australia, Japan, Malaysia, Singapore
- 1NCE will open offices in Singapore and Japan to expand its lifetime IoT connectivity and software services to APAC
COLOGNE, Germany, June 8, 2022 /PRNewswire/ -- SoftBank Corp. has secured an equity stake in the company and signed an exclusive distribution deal covering the Asia-Pacific (APAC) region. SoftBank Corp., a leading Japanese communication and information technology service provider, will sell 1NCE IoT services exclusively in 19 APAC markets.
1NCE will open sales offices and technical operations in Singapore and Tokyo to expand its service capability to Australia, Bangladesh, Cambodia, China, India, Indonesia, Japan, Malaysia, Myanmar, Nepal, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam.
"1NCE is the only company that can deliver true cross-border, future-proof IoT connectivity without uncertainty – a perfect extension of SoftBank Corp.'s existing IoT portfolio," said Daichi Nozaki, Vice President, Head of Global Business Division, Enterprise Business Unit at SoftBank Corp. "We've closely followed 1NCE's strong U.S. launch earlier this year and expect the same explosive growth in the underserved APAC region."
Full Press release: https://1nce.com/en/news/
About SoftBank Corp.
Guided by the SoftBank Group's corporate philosophy, "Information Revolution – Happiness for everyone," SoftBank Corp. (TOKYO: 9434) provides telecommunications services and combines them with advanced technologies to develop and operate new businesses in Japan and globally.
About 1NCE
1NCE is the only provider of connectivity and software for IoT at a global flat rate – offering fast, secure, and reliable cellular connectivity and software services in more than 110 countries worldwide.
Media Contact
Dennis Knake
E-Mail: dennis.knake@1NCE.com
+49 151/62777643
Brad Chase
E-Mail: brad.chase@1NCE.com
View original content:
SOURCE 1NCE | https://www.mysuncoast.com/prnewswire/2022/06/08/1nce-signs-exclusive-deal-with-softbank-corp-drive-iot-expansion-asia-pacific/ | 2022-06-08T09:03:47Z |
NEW YORK, June 10, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Dentsply securities between June 9, 2021 and May 9, 2022, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/xray.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
The Complaint alleges that throughout the Class Period, Defendants touted its "go-tomarket strategy" and "more sophisticated and strategic incentive plans" as drivers of the Company's success. Dentsply also assured investors that it complied with Generally Accepted Accounting Principles ("GAAP") and maintained adequate internal controls over financial reporting, yet the Company announced revenues and earnings that were inflated by the improper recognition of revenue. As a result of these misrepresentations, Dentsply stock traded at artificially inflated prices throughout the Class Period.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/xray or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Dentsply you have until August 1, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com
View original content to download multimedia:
SOURCE Bronstein, Gewirtz & Grossman, LLC | https://www.kxii.com/prnewswire/2022/06/10/bronstein-gewirtz-amp-grossman-llc-notifies-dentsply-sirona-inc-xray-investors-with-losses-exceeding-1-million-class-action-encourages-investors-contact-firm/ | 2022-06-10T14:20:42Z |
Panera Bread relocates and all-new options open for residents
JACKSONVILLE, Fla., Aug. 9, 2022 /PRNewswire/ -- Ferber Company (Ferber), a privately held real estate development and investment company headquartered in Ponte Vedra Beach, FL announces its acquisition of a 1.54 acre parcel located in the heart of the Oakleaf Town Center to house a brand new free standing Panera Bread.
The current Panera in Oakleaf has been in operation for 10 years in an end cap location. The new freestanding cafe will feature a double drive through, rapid pick up option, and improved parking for the restaurant. "Covid accelerated the need for drive through options," said Tom Mundy, Executive Vice President at Ferber Company. "This is a growth market and while the strong majority of restaurants were already moving to drive through, Covid confirmed that customers feel much more comfortable using the drive through option." The new location is already under construction and Panera hopes to be open in the Spring of 2023. The Ferber Company acquired the parcel in June and they are working with Prosser, Inc, Cuhachi Peterson, Ladson Construction and Coastal Plain Construction on the new build.
In St. Johns County, the mixed use Durbin Creek Crossing development off of Race Track Road, already in progress, will see the addition of some familiar and new options for shoppers. Aldi Supermarket and Burger King are already open. Scheduled to open in late summer are First Coast Credit Union, ABC Liquors, and Peppers. Also in late summer, the first apartment units are scheduled to launch from DHI Communities (a DR Horton Company). The fourth quarter of 2022 will see a new 7-Eleven and Scrubbles Car Wash opening. Both TD Bank and Elliano's Coffee have begun construction as well. The company also just announced an agreement for a Starbucks and Taco Bell to round out the development.
About Ferber Company: Ferber Company is a privately held real estate development and investment company headquartered in Ponte Vedra Beach, FL. with offices in St. Petersburg and Singer Island, and Basking Ridge, NJ. Celebrating 115 years in business in 2022, the company has just launched its new website. For more information, visit www.ferbercompany.com.
View original content to download multimedia:
SOURCE The Ferber Company | https://www.mysuncoast.com/prnewswire/2022/08/09/ferber-company-adding-popular-businesses-st-johns-duval-county/ | 2022-08-09T18:14:53Z |
Celebrating ambitious pioneers tackling our biggest challenges
COLUMBUS, Ohio , May 23, 2022 /PRNewswire/ -- Ernst & Young LLP (EY US) announced that Mickey Shimp, President of Mix Talent was named an Entrepreneur Of The Year® 2022 East Central Award finalist. Entrepreneur Of The Year is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies who think big to succeed.
Shimp was selected by a panel of independent judges according to the following criteria – entrepreneurial spirit, purpose, growth and impact – among other core contributions and attributes. When asked about his proudest accomplishment as an entrepreneur, he said, "My proudest accomplishment so far has been helping to build Mix Talent with his incredible team who lives our core values every day to help companies make a positive impact on the lives of patients."
Mix Talent is a talent acquisition and consulting organization built to support the near-term goals and long-term success of pharma, biotech, digital therapeutics/medtech, and gene therapy organizations. Founded in 2018, Mix Talent has grown from six to 110 teammates and for the past two years has averaged more than 38% growth year over year. Their unique mix of knowledge, technology, and instinct have helped their clients go beyond just hiring headcount to truly creating dynamic organizations.
"I am so honored to be selected as a finalist for this incredible recognition," said Shimp. "I'm especially proud of our growth and this recognition for Mix Talent, because as the last two years have taught us, it's that with the right people and the right values you can fight through anything."
The regional finalists will be recognized, and winners will be announced at the East Central awards celebration on June 16, 2022 at Stage AE in Pittsburgh, PA. The regional winners will then be considered by the National independent judging panel for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation's most prestigious gatherings of high-growth, market-leading companies. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the EY World Entrepreneur Of The Year™ Award in June 2023.
For over 35 years, EY US has celebrated the unstoppable entrepreneurs who are building a more equitable, sustainable and prosperous world for all. The Entrepreneur Of The Year program has recognized more than 10,000 US executives since its inception in 1986. Entrepreneur Of The Year Award winners have exclusive, ongoing access to the experience, insight and wisdom of fellow alumni and other members of the entrepreneurial community in over 60 countries — all supported by vast EY resources.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are presented by PNC Bank. In East Central, sponsors also include Valuation Research Corporation, Morgan Lewis & Bockius LLP and Frost Brown Todd LLC.
About Entrepreneur Of The Year®
Entrepreneur Of The Year is the world's most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind.
It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National overall winners go on to compete for the EY World Entrepreneur Of The Year™ title. ey.com/us/eoy
About EY Private
As Advisors to the ambitious™, EY Private professionals possess the experience and passion to support private businesses and their owners in unlocking the full potential of their ambitions. EY Private teams offer distinct insights born from the long EY history of working with business owners and entrepreneurs. These teams support the full spectrum of private enterprises including private capital managers and investors and the portfolio businesses they fund, business owners, family businesses, family offices and entrepreneurs. Visit ey.com/us/private
About EY
EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets.
Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate.
Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.
Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US.
View original content to download multimedia:
SOURCE Mix Talent | https://www.wibw.com/prnewswire/2022/05/23/ey-announces-mickey-shimp-mix-talent-an-entrepreneur-year-2022-east-central-award-finalist/ | 2022-05-23T20:35:14Z |
Report revamps Environmental, Social and Governance (ESG) Framework, highlights efforts to reduce emissions on ship and at port
MIAMI, May 13, 2022 /PRNewswire/ -- Today Royal Caribbean Group (NYSE: RCL) released its 14th annual sustainability report, providing a comprehensive update on the company's Environmental, Social and Governance (ESG) framework and activities across its three wholly owned brands: Royal Caribbean International, Celebrity Cruises and Silversea Cruises.
New for 2021, Royal Caribbean Group revamped its ESG framework to better reflect the company's contributions to a more sustainable cruise industry. The ESG framework focuses on five distinct ways to deliver great vacation experiences responsibly: Champion communities and the environment; provide unforgettable cruise experiences; foster human rights and be an employer of choice; advance net zero innovation; and govern responsibly.
"All of us at Royal Caribbean Group are focused on delivering the best vacations possible and doing so responsibly," said Jason Liberty, CEO, Royal Caribbean Group. "This report reflects our commitment to continuous innovation and building a sustainable cruise industry while growing our business for good."
The release of the 2021 Seastainability Report follows the recent announcement that Royal Caribbean Group has committed to another five-year partnership with World Wildlife Fund (WWF). A flagship partner, WWF will help the company continue to establish sustainable business practices in areas including emissions, sustainable tourism and more.
This year's ESG report highlights the company's unrelenting efforts to decarbonization, especially through the company's Destination Net Zero strategy, which aims to establish Science-Based Targets (SBT) and achieve net zero emissions by 2050.
Destination Net Zero, along with other ESG initiatives, will ensure Royal Caribbean Group develops ambitious and measurable goals for continued carbon emissions reduction, sustainable business development and growth, sustainable tourism, and waste management. Destination Net Zero encapsulates Royal Caribbean Group's focus on serving as a catalyst for innovation in the industry, with developments that include:
- Introducing a fuel-cell hybrid design that allows for zero emission in port.
- Future-proofing the company's ship-building portfolio through fuel flexibility and innovation that ensure each new ship class is 20% more energy efficient than its predecessor.
- Developing waste management technologies that can convert waste to energy. Currently 100% of the fleet is equipped to be landfill-free.
- Being ready, through shore power, to connect to local power grids as soon as it becomes available.
This year's report was shaped by RCG's 2021 materiality assessment and references the Global Reporting Initiative's (GRI) 2020 core reporting standards. The report is also aligned, to the extent possible, with the Sustainable Accounting Standards Board (SASB) standards.
To view Royal Caribbean Group's 2021 sustainability report and learn more about the company's efforts, visit: www.royalcaribbeangroup.com/sustainability.
About Royal Caribbean Group
Royal Caribbean Group (NYSE: RCL) is one of the leading cruise companies in the world with a global fleet of 63 ships traveling to approximately 1,000 destinations around the world. Royal Caribbean Group is the owner and operator of three award winning cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises and it is also a 50% owner of a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. Together, the brands have an additional 11 ships on order as of March 31, 2022. Learn more at www.royalcaribbeangroup.com or www.rclinvestor.com.
Forward-Looking Statements
Certain statements in this press release constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, the company's expectations, estimates, forecasts and projections regarding environmental, social and governance (ESG) initiatives and the company's ability to achieve its ESG goals. Forward-looking statements reflect management's current expectations and are subject to risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Factors that could affect our results include, among others, those discussed under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q, as well as our other filings with the SEC, copies of which may be obtained by visiting our Investor Relations website at www.rclinvestor.com or the SEC's website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
View original content to download multimedia:
SOURCE Royal Caribbean Group | https://www.wibw.com/prnewswire/2022/05/13/royal-caribbean-group-unveils-2021-seastainability-report/ | 2022-05-13T19:48:39Z |
POKROVSK, Ukraine (AP) — The Russian rocket strikes came early in the morning in the eastern Ukrainian town of Pokrovsk on Wednesday, shaking buildings, jolting people out of bed and sending chunks of concrete and jagged pieces of metal flying through the air.
One of the two rockets left a crater at least three meters deep, remnants of the projectile still smoldering as nearby residents picked through the debris of their homes, trying to salvage whatever they could.
A row of low terraced houses nearby suffered significant damage, with roofing tiles blown off, door frames ripped from the walls and pieces of brick, concrete and asphalt scattered on the ground.
Four civilians were wounded, said Pavlo Kyrylenko, head of the Donetsk military administration. At least one of them suffered a head wound and was ferried to the local hospital by ambulance, blood seeping through the bandages and trickling down the side of his neck.
The strikes in Pokrovsk were among several over the past two days that have hit towns and villages as Russia pressed forward in its offensive in the Donbas, Ukraine’s eastern industrial heartland.
“There’s no place left to live in, everything is smashed,” said Viktoria Kurbonova, a mother-of-two who lived in one of the terraced houses. The windows had been blown out by an earlier strike about a month ago, and they had replaced them with plastic sheeting. That, she said, probably saved their lives as at least there was no glass flying around.
She had been asleep when the strike hit, just meters from her house.
“There was a really big flash and a lot of dust,” Kurbonova said, standing outside her home still in her pajamas, her legs and arms blackened by soot. Her 4-year-old son wandered around, clutching a toy train, while her 2-year-old daughter smiled in a stroller nearby.
“I was reaching for my child and I couldn’t find him in the dust,” she said. The boy had been sleeping in the same room as her, while her daughter had been in the next room with Kurbonova’s mother. They were all shaken, but none were hurt.
Kyrylenko said Russian strikes killed 12 civilians the previous day in the Donetsk region, and wounded another 10. Another strike on the city of Kramatorsk, northeast of Pokrovsk, hit a multi-story building under construction, damaging it and blowing out windows in nearby buildings but causing no casualties.
“Russians continue hitting the cities that are away from the front line,”Kyrylenko said on his Telegram channel. “They would like to kill as many civilians as possible and cause panic. That is why the only good choice is evacuation. Evacuation saves lives.”
The governor of the neighboring Luhansk region, Serhiy Haidai, said at least six civilians had been killed and eight wounded over the past 24 hours in shelling in the town of Sieverodonetsk, at the heart of the Russian offensive in eastern Ukraine.
Russian forces have been attempting to encircle Sieverodonetsk and cut off Ukrainian forces there. Haidai accused the Russians of deliberately targeting shelters where civilians were hiding.
Moscow-backed separatists have fought Ukrainian forces in the Donbas for eight years and hold large swaths of territory. Sievierodonetsk and neighboring cities are the only part of the Donbas’ Luhansk region still under Ukrainian government control.
___
Follow the AP’s coverage of the war at https://apnews.com/hub/russia-ukraine | https://cw33.com/news/international/ap-international/russian-rockets-hit-eastern-ukrainian-town-of-pokrovsk/ | 2022-05-26T01:55:39Z |
RCPD officers respond to separate incidents costing victims $1K+ apiece
MANHATTAN, Kan. (WIBW) - Officers in Riley Co. responded to two separate incidents costing the victims more than $1,000 apiece.
The Riley Co. Police Dept. Activity Report indicates that around 2:30 p.m. on Friday, Sept. 2, officers were called to the 300 block of N 9th St. with reports of criminal damage to property.
When officials arrived, they said a 52-year-old man reported that his skate ramp had been damaged by a 38-year-old male suspect which cost him about $1,200.
A short distance away, around 9:45 a.m., on Saturday, Sept. 3, officers were called to the 1100 block of Moro St. in Aggieville with reports of theft.
When officials arrived, they said a 21-year-old man reported his red Apple iPhone 13 was stolen while he was at Tubby’s Bar costing him about $1,100.
If anyone has information about the crimes they should contact RCPD at 785-537-2112 or the Manhattan Riley Co. Crime Stoppers at 785-539-7777.
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/09/06/rcpd-officers-respond-separate-incidents-costing-victims-1k-apiece/ | 2022-09-06T16:52:42Z |
Leading Legal Technology Services Organization Has Nearly Tripled in Size Since January 2022
WASHINGTON, Aug. 15, 2022 /PRNewswire/ -- Redgrave Data, a full-service ALSP created to solve the most complicated and sophisticated data challenges, today announced it has seen enormous growth over the last six months, with a substantial increase in client business in the U.S. as well as new business prospects overseas since its launch at the start of 2022. The company has also added a number of highly accomplished legal and data science professionals to its team, and disclosed plans to establish a significant presence in Germany to serve current and future global clients by the close of 2022.
With highly customized and innovative services and solutions centered at the intersection of the law, technology, and science, Redgrave Data reimagines how data is analyzed and used to provide defensible technology strategies, insight, and solutions to clients facing challenges related to electronically stored information. The Redgrave Data team is co-founded and led by Mollie Nichols, who is joined by other co-founders Scott Culbertson, Dave Lewis, Mark Noel, and Lindsey Worth.
Redgrave Data's North American expansion has been propelled by several new anchor clients, which include some of the world's largest tech companies that increasingly require thorough and timely outcomes to data challenges associated with legal matters. Corporations faced with near impossible eDiscovery deadlines and millions of documents turn to Redgrave Data to fix technology and process issues, and to deploy sophisticated analytics and custom machine learning models.
"Since Redgrave Data launched this past January, the company has grown almost 200% as a result of an impressive crop of household name brands that turned to us for our expertise in the legal and technology fields," said Mollie Nichols, CEO of Redgrave Data. "Our growth is attributed to a sizable amount of work with tech giants. Redgrave Data's bespoke solutions development for clients is on track to outpace our original projections when we launched, and we are absolutely thrilled."
Redgrave Data Co-founder and Chief Scientific Officer Dr. Dave Lewis has been named an inaugural member of the AI Ethics Advisory Board (AIEB) organized by the Institute for Experiential AI at Northeastern University. AIEB provides corporations with client-tailored AI ethics boards and expert independent guidance on responsible AI deployment. Their on-demand multidisciplinary teams avoid the need for enterprises to find, assess, and compensate an in-house AI ethics board while dealing with the ever-changing societal and regulatory landscape around artificial intelligence.
Lewis, who has over three decades of experience in artificial intelligence and statistics, supports Redgrave Data clients in implementing and defending processes that address complex information management issues in litigation, corporate investigations, and regulatory oversight. "I'm honored to join the Institute's distinguished scholars and thinkers and congratulate professors Ricardo Baeza-Yates and Cansu Canca on organizing this novel endeavor," said Lewis. "My involvement is a part of Redgrave Data providing its clientele with the latest thinking and guidance on ethically and responsibly deploying AI to achieve business outcomes, while protecting privacy and security."
For more information about Northeastern University's initiative, visit http://ms.spr.ly/6048jGIno.
Tara Emory, Redgrave Data's senior vice president of strategic operations and consulting, has been ranked for the last four years by Chambers USA nationwide Litigation Support Guide, rising through the Band rankings. In 2022, Tara emerged in Band 1 for USA Litigation Support - eDiscovery, one of only two people to do so.1 "What sets [Tara] apart is her ability to really listen to what the client needs and bring it to fruition," said Nichols. "She has a deep understanding of the challenges clients face not only from a technological perspective, but also from a legal perspective. That's a rare and valuable combination."
Redgrave Strategic Data Solutions, LLC (Redgrave Data) provides innovative and defensible technology strategies, insights, services, and solutions to clients who face electronically stored information challenges. The firm's expertise in the intersection of technology and the law, including its hands-on approach to client data, allow it to address the toughest challenges in litigation, investigations, information governance, data privacy, and other regulatory matters. Affiliated with Redgrave LLP, the leading law firm specializing in information law, Redgrave Data is operated by an executive team comprised of industry luminaries in data and information governance, privacy, analytics, litigation, and eDiscovery. To learn more about the company, please visit https://www.redgravedata.com/
1 https://chambers.com/legal-rankings/ediscovery-usa-nationwide-58:2817:12788:1
View original content to download multimedia:
SOURCE Redgrave Data | https://www.mysuncoast.com/prnewswire/2022/08/15/redgrave-data-announces-exceptional-market-momentum-with-new-professional-team-members-achievements-planned-european-expansion/ | 2022-08-15T20:31:02Z |
In Partnership with Snowflake, Turnkey Solutions Provider Enables Advisors Excel to Combine Disparate Data Systems, Automate Workflows, and Create Practice Efficiencies to Position Advisors for Unlimited Growth
EXTON, Pa. and TOPEKA, Kan., June 22, 2022 /PRNewswire/ -- iPipeline® announces that Advisors Excel, a Topeka-based financial marketing organization, will leverage iPipeline's services to obtain real-time metrics for analyzing product and operational performance, generate competitive benchmarking and create market penetration opportunities. Financial advisors within the Advisors Excel network will also be able to leverage these insights for automating workflows to increase practice efficiencies.
iPipeline integrates its InsureSight Data Factory, which is powered by data cloud company Snowflake, with Advisors Excel's customer relationship management (CRM) system. This takes previously siloed data from across the organization's systems and unites it so that it can be shared across business lines. The end result enables Advisors Excel to analyze life insurance/annuity cases, quotes, and e-Application data – all in an easier and faster process -- to access the streamlined data. This solution will enable Advisors Excel to generate scorecards for each advisor, providing them with their overall ranking compared to peers across key metrics, including cycle time, placement ratio, paid cases, and paid premiums.
To learn more about how iPipeline can help you leverage analytics and create efficiencies to capitalize on business opportunities, click here to see how we helped Advisors Excel increase their premium by $1.2 million in 12 months.
"Many distribution firms are working with disparate data systems that have created roadblocks for continued growth. We offer the ability to look at new ways to view data and in ways that intelligence tools and pivot tables simply cannot do," said David Libesman, Vice President of Data Analytics at iPipeline. "By unifying their data streams through our InsureSight solution, Advisors Excel can now leverage core insights to scale its business, make staffing projections, and provide financial advisors with the opportunity to maintain a competitive advantage in the marketplaces they serve. We are extremely proud to play a key role in helping Advisors Excel become a data-driven company."
Developed by iPipeline's data analytics and data science team, the Case Analytics service in InsureSight leverages data from iPipeline's Agency Management System, which is comprised of more than 300 BGAs (brokerage general agents), 70 carriers, 800,000 annual application submissions, $8 billion in annuity deposits, and $4 billion in life insurance premiums across the industry.
"We have worked with iPipeline consistently for more than a decade and have grown together as our businesses continue to evolve," said Jim Bowman, President of Life at Advisors Excel. "iPipeline is truly a leader within the life insurance and annuities data space. We view iPipeline as a strategic partner for us over the long haul. As new solutions become available through their ecosystem, we are excited to expand this existing relationship and the services we currently leverage to meet our strategic vision."
In partnership with data cloud company Snowflake, iPipeline takes the siloed information from Advisors Excel and organizes it into one centralized location. This enhances and streamlines regulatory oversight and compliance while providing financial advisors with a broad enterprise view across all channels.
"Big Data is not just a trendy marketing term; it's become a necessity to empower our business leaders with different ways to view data from various perspectives," said Ryan Fickel, Chief Technology Officer of Advisors Excel. "We can't do that if data is isolated from one system to another. iPipeline has provided us with the tools and access to consolidate multiple datasets, producing insights that can affect our bottom line—such as performance and trends."
To learn more about iPipeline's InsureSight solution, please visit https://www.ipipeline.com/products/insuresight, or get in touch with a sales representative via our Contact Us page: https://www.ipipeline.com/contact-us/.
About iPipeline
iPipeline is building the end-to-end digitized ecosystem for the life insurance and wealth management industries, which will enable millions of uninsured or under-insured Americans to secure their financial futures as part of a holistic financial planning experience. The firm is working to optimize all application and processing workflows—from quote to commission—and consolidating them within one of the most expansive straight-through processing platforms, significantly reducing paper, saving time, and increasing premiums and placements for insurance agents. iPipeline is also committed to offering premier subscription-based tools to help financial institutions and advisors automate and digitize financial transactions, comply with regulations, and seamlessly incorporate life insurance and annuities into client accounts.
The iPipeline digital ecosystem incorporates one of the industry's largest data sets to enable advisors and agents to optimize their businesses. Since its establishment in 1995, iPipeline has facilitated 1.5 billion quote responses, $32 billion in savings on printing and mailing costs, the collection of 55 billion premiums, and the protection of 25 million lives. iPipeline operates as a unit of Roper Technologies (NYSE: ROP), a constituent of the S&P 500® and Fortune 500® indices. For more information, please visit https://www.ipipeline.com/.
About Advisors Excel
Advisors Excel, founded in 2005, has redefined the role a marketing organization can play in supporting independent financial advisors. Their growth has been unparalleled in the industry and is achieved by working with a smaller group of select advisors. With a focus on making good advisors great business owners, Advisors Excel has revolutionized how financial professionals build and operate their businesses.
In 2021, the 500 advisors working with Advisors Excel did over $8.9 billion in annuity, Medicare, and life insurance production. Their affiliated Registered Investment Advisory Firm, AE Wealth Management, currently manages over $18.8 billion and has been named one of the fastest-growing RIAs in the country.
Media Contacts:
Laura Simpson
JConnelly for iPipeline
973-713-8834
ipipelinepr@jconnelly.com
Tracey Stratton
Public Relations Manager, Advisors Excel
tracey.stratton@advisorsexcel.com
View original content to download multimedia:
SOURCE iPipeline | https://www.kxii.com/prnewswire/2022/06/22/ipipeline-provides-advisors-excel-with-unified-path-toward-accessing-core-data-analytics-financial-services/ | 2022-06-22T18:51:33Z |
LOS ANGELES, June 27, 2022 /PRNewswire/ -- Balmoral Funds, LLC ("Balmoral") announced today that it has successfully completed its previously announced acquisition of Trecora Resources ("Trecora") at a price of $9.81 per share, net to each seller, in cash, without interest and subject to any required tax withholdings.
With the completion of the acquisition, Trecora's stock will cease trading on the New York Stock Exchange and Trecora will no longer be listed on any public market.
Blank Rome LLP served as legal advisor to Balmoral, and Piper Sandler served as financial advisor to Balmoral. Guggenheim Securities, LLC served as exclusive financial advisor to Trecora, and Morgan, Lewis & Bockius LLP served as legal advisor to Trecora.
Balmoral is a Los Angeles, CA based private equity fund that was founded in 2005. Balmoral's objective is to be the financial partner of choice for entrepreneurial, emotionally intelligent and successful C-suite executives and operating advisors creating transformative, revitalizing change in the businesses they co-invest in together. Balmoral has approximately $1.5 billion of assets under management. Balmoral typically invests in companies that have revenues between $30 to $500 million and require equity investments of $10 to $100 million, with the capability of investing an additional $100 million or more in particularly compelling opportunities.
Trecora owns and operates a specialty petrochemicals facility specializing in high purity hydrocarbons and other petrochemical manufacturing and a specialty wax facility, both located in Texas, and provides custom processing services at both facilities.
This press release contains "forward-looking statements" relating to the acquisition of Trecora by Balmoral. In some cases, forward-looking statements may be identified by terminology such as "believe," "may," "will," "should", "predict", "goal", "strategy", "potentially," "estimate," "continue," "anticipate," "intend," "could," "would," "project," "plan," "expect," "seek" and similar expressions and variations thereof. These words are intended to identify forward-looking statements. Balmoral and Trecora have based these forward-looking statements on current expectations and projections about future events and trends that they believe may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs of Balmoral and Trecora. Forward-looking statements are subject to significant known and unknown risks and uncertainties that may cause actual results, performance or achievements in future periods to differ materially from those assumed, projected or contemplated in the forward-looking statements, including, but not limited to, the following factors: the potential effects of the acquisition on Trecora, the participation of third parties in the consummation of the transaction and the combined company, the risk that stockholder litigation in connection with the transaction may result in significant costs of defense, indemnification and liability; and other risks and uncertainties, including those set forth in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Trecora's Annual Report on Form 10-K for the year ended December 31, 2021 and Quarterly Report on Form 10-Q for the quarter ended May 5, 2022, which are on file with the Securities and Exchange Commission (the "SEC") and available on the SEC's website at www.sec.gov. The information contained in this document is provided only as of the date hereof, and no party undertakes any obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.
CONTACT: Jeremy Hellman, jhellman@equityny.com
View original content to download multimedia:
SOURCE Trecora Resources | https://www.mysuncoast.com/prnewswire/2022/06/27/balmoral-funds-llc-completes-acquisition-trecora-resources/ | 2022-06-27T14:39:24Z |
A look at what’s happening around the majors today:
___
OPENING DAY
Chicago Cubs veteran Kyle Hendricks is set to deliver the first pitch of the season against Corbin Burnes and Milwaukee at Wrigley Field just past 2:20 p.m. EDT, the first of seven games still on the calendar amid rainy forecasts across the country.
Gerrit Cole and the Yankees had been set to start at home against the rival Boston Red Sox, but New York announced Wednesday that the game was postponed to Friday with inclement weather in the forecast all day Thursday. Same for the Minnesota Twins and their opener against visiting Seattle.
Still plenty on the docket, though.
The World Series champion Atlanta Braves plan to raise a banner before hosting Cincinnati, and they’ll do it without fan favorite Freddie Freeman, who signed with the Dodgers last month. Los Angeles is among 16 teams that won’t open until Friday.
The Mets and Nationals are still a go in Washington — they just pushed back the scheduled start three hours to 7:05 p.m. EDT because rain is expected in the afternoon. Second-year righty Tylor Megill gets the surprise assignment for New York, with Jacob deGrom injured and fellow Cy Young Award winner Max Scherzer targeting Friday off a hamstring issue.
WELCOME TO THE SHOW
Plenty new around the majors this year, starting with the branding in Cleveland. The Guardians make their regular-season debut in Kansas City with ace Shane Bieber on the mound against Zack Greinke.
Cleveland will get the first, surely, of many looks at Bobby Witt Jr., baseball’s top prospect who forced his way into the Royals’ opening day lineup. A shortstop in the minors, Witt will play third base to start his big league career.
He’s one of several touted prospects told they’ll begin the season in the majors, including Seattle outfielder Julio Rodríguez, Detroit slugger Spencer Torkelson, Philadelphia shortstop Bryson Stott and Tampa Bay outfielder Josh Lowe. Cincinnati right-hander Hunter Greene — who was up to 104 mph at Triple-A last year — will start a game over the weekend.
DH DUTY
Shohei Ohtani begins his AL MVP defense by pitching and hitting for the Angels against Houston — and he’ll be the only hurler asked to do both. A new rule allows the Los Angeles Angels star (and other pitchers, if they’re ever the designated hitter) to still bat after they’ve left the mound.
The DH was added to the National League this winter, creating 15 job opportunities for sluggers who aren’t exactly built to defend. Nelson Cruz signed a one-year deal with the Nationals and seems ready for another big season at 41 years old — he hit a grand slam in his final spring at-bat.
The new rule also cleared a spot for the Cardinals to bring back 42-year-old Albert Pujols for a farewell tour. St. Louis hosts the Pirates, with Adam Wainwright pitching to Yadier Molina for what could be the final time as those two players also ponder retirement after 2022.
NEW PLACE
Freeman’s replacement, Matt Olson, plays his first regular-season game with his hometown Braves after being acquired in a trade from Oakland. Kenley Jansen is Atlanta’s new closer.
The Cubs say Japanese star Seiya Suzuki has seemed remarkably comfortable in his first U.S. season. Chicago fans get to greet the 27-year-old outfielder, who slugged 38 homers last season in Japan’s Central League.
Starling Marte (Mets), Luke Voit (Padres), Mark Melancon (Diamondbacks), Andrew McCutchen (Brewers) and Andrelton Simmons (Cubs) are among other familiar faces set to make debuts after switching clubs.
DON’T SKIP ME
Buck Showalter, Bob Melvin and Oliver Marmol are among the managers with new teams this year.
The well-traveled Showalter leads the Mets at Nationals Park. Melvin left Oakland and now guides the San Diego Padres, who open at Arizona. Marmol manages his first regular-season game when the St. Louis Cardinals host Pittsburgh.
NOW HEAR THIS
For the first time, umpires will be given microphones to provide explanations following replay reviews this season. The change should eliminate some mystery — and maybe even some frustration — for fans who previously had to wait until after games to find out exactly what the crew was discussing with replay headquarters.
___
More AP MLB: https://apnews.com/hub/MLB and https://twitter.com/AP_Sports | https://cw33.com/sports/ap-sports/leading-off-opening-day-guardians-debut-ohtani-and-braves-2/ | 2022-04-08T00:01:06Z |
Nutrafol brings award winning, science-backed approach to hair health to the scalp microbiome, introducing education, clinical research and testing to the category
NEW YORK, June 8, 2022 /PRNewswire/ -- Today Nutrafol, the leading company reshaping the category of hair health, announced its newest product line and innovation in hair biology: Scalp Microbiome Support. After years of research on the scalp barrier and the impact of internal and environmental triggers on the scalp microbiome, Nutrafol is at the industry forefront with this patent pending, physician-formulated suite of products designed to balance the scalp microbiome and complement the internal foundation established with Nutrafol's award-winning nutraceuticals for optimal hair growth. Nutrafol's Scalp Microbiome Support continues to reflect the brand's individualized, whole-body approach and consists of a Build-Up Blocker exfoliating mask, Root Purifier shampoo and Stress Reliever scalp essence to create an optimal ecosystem for a healthy scalp barrier – an essential part of overall hair health.
Our bodies are complex ecosystems composed of diverse microbes that help us survive. From training the immune system to assisting the body absorb key nutrients, a balanced microbiome is essential for optimal health. Similarly to the gut microbiome within the body, the scalp microbiome shields hair follicles and the scalp from infection, toxins, irritation, hair damage and more. This results in a stronger scalp barrier and healthier hair quality. In contrast, a disrupted and unbalanced scalp microbiome can lead to dryness, irritation, damaged hair, oil buildup and even stunt hair growth.
For years, Nutrafol's dedicated team of scientists have analyzed the impact of the scalp microbiome on cultivating the optimal ecosystem for healthy hair, developing formulas rooted in science to bring skin care-level support back to the scalp. Nutrafol's new Scalp Microbiome suite – Build-Up Blocker, Root Purifier and Stress Reliever – are vegan, sulfate and paraben free, and contain advanced, natural ingredients that nourish and preserve the scalp microbiome for healthy hair. The Scalp Microbiome line has received the Microbiome Friendly Seal, a certification reserved for products that follow specific clinical testing to ensure each product protects and promotes good diversity of microbes.
"The scalp microbiome is not just another trendy health topic being talked about on social media – it is an important element to overall hair health that should be cared for just as much as people care about their skin routines," said Giorgos Tsetis, CEO and co-founder of Nutrafol. "Nutrafol has spent an extensive amount of time studying and understanding the impact that a balanced scalp microbiome has on our hair, and has created innovative formulas aimed at maintaining the optimal ecosystem for healthy hair, as a complement to our hair growth nutraceuticals. We're excited to announce the launch of Scalp Microbiome Support, a revolutionary suite of products that will bring and keep scalp health at the forefront of the hair health industry conversation."
Nutrafol's Scalp Microbiome Support is made up of three essential products for scalp health, based on consumer's needs for their unique hair journey:
- Build-Up Blocker – An exfoliating mask, used 1-2 times per week, that removes excess oil buildup using natural key ingredients, gentle acids, sebum balancing amino acids and plant detoxifiers. 100% of users had a clinically effective reduction in sebum immediately.
- Root Purifier – A daily, nourishing and cleansing shampoo containing clinically proven ingredients such as a natural alternative to sulfates, a biosurfactant, prebiotics and vegan protein, that balances PH levels and creates the ideal environment for a healthy scalp and thriving hair. 100% of users had a clinical effective reduction in sebum immediately.
- Stress Reliever – A scalp microbiome essence, used daily, made with soothing botanicals, collagen boosters, and pre & postbiotics to calm the scalp, that visibly reduces redness and improves a dry flaky, sensitive scalp. 97% of users felt their scalp was soothed after incorporating it into their weekly routine for 4 weeks.
"Generally speaking, scalps are often underwashed and lathered with harsh chemicals that strip scalp microbiomes – exposing the scalp to damaging factors like pollution, toxins, dirt and more," said Dr. Chesahna Kindred, MD, board-certified dermatologist. "Existing scalp care is often focused on improving specific scalp issues. Nutrafol's Scalp Microbiome Support focuses on how balancing the scalp microbiome directly impacts the overall look and feel of hair, creating a foundation for healthy hair, allowing hair to grow to its fullest potential. Physicians have been waiting for a revolutionary portfolio of products like Scalp Microbiome to enter the market that will educate patients on the importance of a healthy scalp and meet all of the unique and individualized needs that our patients have when it comes to caring for their scalp microbiomes."
Nutrafol's Scalp Microbiome line follows the recent launch of Growth Activator, the patent-pending, first-of-its-kind hair serum that uses the power of plant-derived exosomes from Ashwagandha seeds to boost cellular renewal on the scalp for thicker-looking hair. Nutrafol's Scalp Microbiome Support is available for individual purchase, based on consumer needs, as well as in travel and full size bottles.
For more information, please visit www.nutrafol.com.
As the #1 Dermatologist-recommended hair growth supplement brand, Nutrafol is setting a new scientific standard for wellness through an individualized, whole body approach. With a new caliber of effective, clinically-backed, premium products, Nutrafol addresses the internal root causes as the foundation of hair growth with additional hair health support at the scalp. Nutrafol's extensive team of doctors and researchers are constantly investing in scientific research and developments at the forefront of genetics, biotechnology, and anti-aging medicine to remain on the cutting-edge of hair health innovation. Nutrafol is backed by more than 3,000+ physicians, clinics and stylists across the U.S. for its trusted, reliable results, and has received numerous prestigious accolades.
For press inquiries, please contact Nutrafol@launchsquad.com.
View original content to download multimedia:
SOURCE NUTRAFOL | https://www.kxii.com/prnewswire/2022/06/08/nutrafol-diversifies-suite-products-with-revolutionary-scalp-system-balancing-scalp-microbiome/ | 2022-06-08T13:41:48Z |
Colorado Amber Alert cancelled, mom, 2 small kids found safe
Published: May. 28, 2022 at 8:10 PM EDT|Updated: 9 minutes ago
DENVER (Gray News) - An Amber Alert in Colorado has been cancelled after police say two small children and their mother who were believed to have been taken by force were found safe.
Police were looking for 1-year-old Naveana Marrufo and 2-month-old Ramon Marrufo, in addition to their mother, Francheska Tafoya, 24.
Police said the three were taken by Julian Marrufo-Gutierrez, 28.
No further details have been released.
Copyright 2022 Gray Media Group, Inc. All rights reserved. | https://www.mysuncoast.com/2022/05/29/amber-alert-issued-colorado-after-mom-2-small-kids-taken-by-force/ | 2022-05-29T00:40:11Z |
Gov. Brian Kemp stands with officials whose teams are part of the state's Crime Suppression Unit. The governor updated citizens on the unit's accomplishments this week.
ATLANTA – Gov. Brian Kemp provided updated figures regarding the Multi-Agency Crime Suppression Unit's success since it was first established in April of 2021:
▪ 27,821 vehicle stops
▪ 655 DUI's
▪ 510 reckless driving incidents
▪ 18,888 citations
▪ 682 pursuits
▪ 526 wanted persons apprehended
▪ 148 stolen guns recovered
▪ 259 recovered guns
▪ 243 drug arrests
▪ 1,493 impounded vehicles
▪ 375 stolen vehicles recovered, amounting to $8,108,600
▪ 27 murder suspects apprehended
▪ 48 out of state arrests
Responding to a rise in violent crime and criminal street racing activity, Kemp directed the Georgia Department of Public Safety to put together a Crime Suppression Unit with local and state law enforcement officials. The detail is coordinated by the Georgia Department of Public Safety and now includes the Georgia State Patrol, the Motor Carrier Compliance Division, the Georgia Bureau of Investigation, the Department of Natural Resources, the Department of Community Supervision, the Atlanta Police Department, and the Fulton County Sheriff’s Office. The detail conducted its first wave on April 9, 2021.
The Crime Suppression Unit also has conducted operations in other cities – like Columbus and Macon. The Department of Public Safety has more information on those operations.
Kemp has pledged his support of the Crime Suppression Unit as long as it is needed to protect Georgians, and he and First Lady Marty Kemp praised the following public safety teams for carrying out this critically important work:
Envision beach living? Stacker collected data from a 2021 WalletHub study comparing U.S. beach towns by affordability, weather, safety, economy, education, health, and quality of life. Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/news/governor-praises-work-of-state-crime-suppression-unit/article_7743488a-ef12-11ec-912a-5f5444d4efe7.html | 2022-06-18T16:27:41Z |
Scott Rye Leads Conversation on "Missing Link" in Cybersecurity
AUSTIN, Texas, June 7, 2022 /PRNewswire/ -- During an interview in Austin at the leading global data center conference, CyberSecure IPS founder and CEO Scott Rye shared his thoughts on protecting against the increasing problem of bad actors targeting and threatening critical infrastructures. The interview also revealed the company's ground-breaking monitoring solution; a next-generation step relative to legacy platforms familiar to the Data Center World audience.
As a result of CyberSecure IPS' leadership in cyber-physical security, Rye spoke to Alan Howard, Principal Analyst at Omdia's Cloud & Data Center, further reinforcing the company's first-time exhibit for the commercial sector of the data center community.
"Having the opportunity to share information about our unique data protection systems with one of the most well-known and respected experts in the field was a definite highlight of the conference," Rye said.
During the interview, Rye revealed what he believes to be the biggest threat to data center security: physical vulnerability. He explained that the "missing link" in cybersecurity is the monitoring of critical physical infrastructure.
While system hacking through software can cripple systems, Rye explained, even more damage can be caused simply by cutting the connection to the data center. Damage to infrastructure is even more dangerous than a digital hack because it needs to be repaired physically; it causes an outage during which no communication can take place. "When you stop someone from communicating, they are vulnerable," Rye said.
CyberSecurity IPS focuses precisely on protecting critical infrastructure. After originating its software work exclusively with the Department of Defense and other 3-letter government organizations requiring the utmost in security standards, CyberSecure IPS expanded into the commercial sector where similar security gaps exist within enterprise data centers, especially "hyper data centers."
As commercial data centers grow, inherent networks require higher speeds that necessitate higher levels of encryption. Encryption, however, slows down bandwidth significantly; Rye explained that CyberSecure IPS' hardware monitoring technology offers the same level of protection by 'watching' data traffic without interfering with it.
The company's enterprise solution processes a comprehensive range of sensor data to monitor the entire cyber-physical environment. This provides insight into security and protection through a holistic, real-time dashboard that's easy to use.
As a veteran, Rye said, creating military-grade security for commercial use is a vital mission in an increasingly dangerous world.
A global leader in the cybersecurity space, CyberSecure IPS constantly innovates its suite of patented software and hardware solutions which integrate to bring the physical realm under constant surveillance and provide holistic protection. The most advanced national governments and biggest data centers worldwide look to CyberSecure IPS to protect their critical infrastructure. Learn more at cybersecureips.com.
Contact: Scott Rye, sales@cybersecureips.com
View original content to download multimedia:
SOURCE CyberSecure IPS | https://www.mysuncoast.com/prnewswire/2022/06/07/biggest-threat-facing-data-centers-revealed-during-interview-data-center-world-by-cybersecure-ceo/ | 2022-06-07T17:46:43Z |
Most Great Barrier Reef coral studied this year was bleached
CANBERRA, Australia (AP) — More than 90% of Great Barrier Reef coral surveyed this year was bleached in the fourth such mass event in seven years in the world’s largest coral reef ecosystem, Australian government scientists said.
Bleaching is caused by global warming, but this is the reef’s first bleaching event during a La Niña weather pattern, which is associated with cooler Pacific Ocean temperatures, the Great Barrier Reef Marine Authority said in its annual report released late Tuesday that found 91% of the areas surveyed were affected.
Bleaching in 2016, 2017 and 2020 damaged two-thirds of the coral in the famed reef off Australia’s eastern coast.
Coral bleaches as a heat stress response, and scientists hope most of the coral will recover from the current event, said David Wachenfeld, chief scientist at the authority, which manages the reef ecosystem.
“The early indications are that the mortality won’t be very high,” Wachenfeld said on Wednesday.
“We are hoping that we will see most of the coral that is bleached recover and we will end up with an event rather more like 2020 when, yes, there was mass bleaching, but there was low mortality,” Wachenfeld added.
The bleaching events in 2016 and 2017 led to “quite high levels of coral mortality,” Wachenfeld said.
Simon Bradshaw, a researcher at the Climate Council, an Australia-based group that tracks climate change, said the report demonstrated the reef’s survival depended on steep global emission cuts within the decade.
“This is heartbreaking. This is deeply troubling,” Bradshaw said. “It shows that our Barrier Reef really is in very serious trouble indeed.”
Last December, the first month of the Southern Hemisphere summer, was the hottest December the reef had experienced since 1900. A “marine heatwave” had set in by late February, the report said.
A United Nations delegation visited the reef in March to assess whether the reef’s World Heritage listing should be downgraded due to the ravages of climate change.
In July last year, Australia garnered enough international support to defer an attempt by UNESCO, the United Nations’ cultural organization, to downgrade the reef’s World Heritage status to “in danger” because of damage caused by climate change.
But the question will be back on the World Heritage Committee’s agenda at its annual meeting next month.
The Great Barrier Reef accounts for around 10% of the world’s coral reef ecosystems and was named because of the extensive hazards it posed to 18th century seafarers. The network of more than 2,500 reefs covers 348,000 square kilometers (134,000 square miles).
Coral is made up of tiny animals called polyps that are fed by microscopic algae that live inside the reefs and are sensitive to changes in water temperatures.
The algae provide the reefs with their kaleidoscope of colors and produce sugars through photosynthesis that provide the coral with most of its nutrients.
Rising ocean temperatures turn the chemicals that the algae produce into toxins. The coral turns white as it effectively spits the poisonous algae out.
Heat stress beyond a few weeks can lead the coral to die of starvation.
The latest bleaching is an unwelcome reminder of the differences in climate change policy among Australian politicians.
The conservative government seeking reelection on May 21 has less ambitious emission reduction targets than the center-left opposition is promising.
Prime Minister Scott Morrison’s Liberal Party aims to reduce Australia’s emissions by 26% to 28% below 2005 levels by 2030.
The opposition Labor Party has promised to reduce emissions by 43% by the end of the decade.
Morrison was widely criticized at the U.N. climate conference last November for failing to set a more ambitious target.
The environmental group Greenpeace Australia Pacific said in a statement the extent of the latest bleaching was “another damning indictment of the Morrison government which has failed to protect the reef and exacerbated the problem through its support of fossil fuels.”
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/05/11/most-great-barrier-reef-coral-studied-this-year-was-bleached/ | 2022-05-11T13:58:10Z |
CEDARHURST, N.Y., June 1, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Lilium N.V. f/k/a Qell Acquisition Corp. (NasdaqGS: LILM, LILMW, QELL, QELLU, QELLW),, if they purchased the Company's securities between March 30, 2021 and March 14, 2022, inclusive (the "Class Period"). Shareholders have until June 17, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-lilm/https://kclasslaw.com/cases/securities/nyse-hmlp/, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com
View original content to download multimedia:
SOURCE Kuznicki Law PLLC | https://www.kxii.com/prnewswire/2022/06/02/filing-deadline-kuznicki-law-pllc-announces-class-action-behalf-shareholders-lilium-nv-fka-qell-acquisition-corp-lilm/ | 2022-06-02T03:45:26Z |
SHANGHAI and HONG KONG, May 18, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, announces that the uses of XPOVIO®(selinexor) for Multiple Myeloma (MM) patients with first relapse or multiple relapses were incorporated into the Guidelines for the Diagnosis and Management of Multiple Myeloma in China (2022 revision). This is the first time that selinexor has been included in the guidelines.
The Guidelines for the Diagnosis and Management of Multiple Myeloma in China (2022 revision) was jointly developed and revised by the Chinese Hematology Association of the Chinese Medical Doctor Association (CMDA) and the Chinese Society of Hematology of the Chinese Medical Association (CMA), and was published in the Chinese Journal of Internal Medicine in May 2022.
The 2022 Guidelines for MM incorporated four selinexor combination therapy regimens comprised of selinexor and other biological and/or chemotherapy agents. Recommendations for the treatment of relapsed/refractory MM (R/R MM) are based on the multiple sources of medical evidence including patients' response to prior treatment. As one of the most recognized guidelines in China, the guidelines are widely adopted among Chinese oncologists in their clinical practice.
Prof. Jin Lu, at Peking University People's Hospital, commented, "MM is a malignancy that arises from plasma cells in the bone marrow, commonly occurring in middle-aged and elderly populations. As a result of an aging population, the incidence of MM has been rising sharply in China in recent years. Despite the medical advances in MM in the past two decades, R/R MM still remains a major clinical challenge faced by clinicians in day-to-day practices. Selinexor, the world's first oral inhibitor of the nuclear export protein, was jointly recommended by the CMDA and CMA in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China (2022 revision), which indicates strong recognition of selinexor's therapeutic utility in Myeloma. Meanwhile, we hope that other on-going studies will generate additional data supporting even wider clinical adoption of selinexor."
Dr. Jay Mei, Antengene's Founder, Chairman and CEO said, "Antengene is pleased to fulfill our mission of treating cancer patients with relapsed/refractory disease by bringing selinexor to the market in China and other Asia Pacific geographies. Inclusion in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China (2022 revision) is important because it highlights the robust clinical evidence that supports the use of selinexor in patients with R/R MM from first relapse through the full spectrum of disease progression. We believe that the combination of strong clinical data and inclusion into the guidelines for MM will make it easier for practitioners to incorporate selinexor into patient care and pave the way for patients with R/R MM to benefit from this novel therapy."
Dr. Kevin Lynch, Antengene's Chief Medical Officer added, "Antengene is especially pleased for the use of selinexor to be recommended from the first relapse or multiple relapses. We understand that cancer care is complex and that having effective treatment options for the first relapse that offers the potential for durable disease control is especially important to patients and their families. We look forward to bringing this important therapy to patients in China and other Asia Pacific geographies."
Practice Guidelines for the treatment of relapsed myeloma
About Multiple Myeloma (MM)
MM is caused by the dysregulated proliferation of plasma cells. It is the second most common hematologic malignancy in many countries. Despite availability of a number of treatments for relapsed patients, MM is prone to relapse and most patients still succumb to their disease. MM is the second most common hematological malignancy in China, with an estimated about 15,000 to 20,000 new MM patients and 10,300 deaths per year.[1]
About XPOVIO® (selinexor)
Selinexor is the first and only oral XPO1 inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed/refractory multiple myeloma (R/R MM) and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). By blocking the nuclear export protein XPO1, selinexor can promote the intranuclear accumulation and activation of tumor suppressor proteins and growth regulating proteins, and down-regulate the levels of multiple oncogenic proteins. Due to its novel mechanism of action, selinexor is being evaluated for use in multiple combination regimens to improve treatment efficacy.
Antengene secured approval of selinexor in China in December 2021 for R/R MM and plans to launch the product in the second quarter of 2022. Antengene has also secured approval for selinexor in South Korea for use in R/R MM and R/R DLBCL in July 2021, in Singapore for use in R/R MM and R/R DLBCL and in Australia for use in R/R MM in March 2022. Antengene is conducting 10 clinical studies in mainland China (3 are being jointly conducted by Antengene and Karyopharm Therapeutics Inc. [Nasdaq:KPTI]) for relapsed/refractory hematological malignancies and advanced solid tumors.
About Antengene
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs.
Forward-looking statements
The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, see the section titled "Risk Factors" in our periodic reports filed with the Hong Kong Stock Exchange and the other risks and uncertainties described in the Company's Annual Report for year-end December 31, 2021, and subsequent filings with the Hong Kong Stock Exchange.
For more information, please contact:
Investor Contacts:
Donald Lung
E-mail: Donald.Lung@antengene.com
Mobile: +86 18420672158
PR Contacts:
Peter Qian
E-mail: Peter.Qian@antengene.com
Mobile: +86 13062747000
View original content to download multimedia:
SOURCE Antengene Corporation Limited | https://www.wibw.com/prnewswire/2022/05/18/antengene-announces-xpovio-treatment-regimens-included-first-time-guidelines-diagnosis-management-multiple-myeloma-china/ | 2022-05-18T07:53:33Z |
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Attention 17 Education & Technology Group Inc. ("17EdTech") (NASDAQ: YQ) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded 17EdTech securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with 17EdTech's December 2020 initial public offering.
If you suffered a loss on your investment in 17EdTech, contact us about potential recovery by using the link below. There is no cost or obligation to you.
ABOUT THE ACTION: The class action against 17EdTech includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) 17EdTech's K-12 Academic AST Services would end less than a year after the Company's initial public offering; (2) as part of its ongoing regulatory efforts, Chinese authorities would imminently curtail and/or end 17EdTech's core business; and (3) as a result, defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: September 19, 2022
Aggrieved 17EdTech investors only have until September 19, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:
SOURCE The Law Offices of Vincent Wong | https://www.mysuncoast.com/prnewswire/2022/09/12/class-action-alert-law-offices-vincent-wong-remind-17edtech-investors-lead-plaintiff-deadline-september-19-2022/ | 2022-09-12T10:27:36Z |
Lil Durk is sporting a bandage over his eye and taking some time out after a pyrotechnic device went off in front of him during Lollapalooza.
Video circulating on social media shows the rapper on stage at the Chicago music festival when the special effect explodes in front of him, causing him to back up and wipe his face with his shirt.
On Sunday, Lil Durk posted a photo of himself in what appeared to be a medical room, wearing a mask over his mouth and nose and a bandage on his eye.
"Due to the incident that happened at Lollapalooza in Chicago on stage, I'ma take a break & focus on my health," the caption on his Instagram post read. "I finished my performance yesterday for my fans. Appreciate y'all."
Lil Durk is a native of Chicago. The massive multiday music festival is held there annually in historic Grant Park.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/entertainment/lil-durk-is-taking-a-break-after-a-lollapalooza-pyrotechnics-explosion/article_79184d7d-534a-5c55-a26e-d80bbec1f407.html | 2022-08-01T17:11:11Z |
Company achieves 37% reduction of fugitive methane emissions in 2021
LOS ANGELES, June 16, 2022 /PRNewswire/ -- Southern California Gas Co. (SoCalGas) has submitted its annual fugitive emissions report to the California Public Utilities Commission (CPUC). The report shows that SoCalGas has significantly exceeded the state's 2025 goal for reducing fugitive methane emissions. SoCalGas reported that in 2021 it reduced fugitive methane emissions by 37% – passing the state's goal of a 20% reduction by 2025 and nearing the state's goal of a 40% reduction by 2030.
The company's success comes from significant innovation in new detection technologies. SoCalGas was the first utility in the nation to implement aerial methane mapping using helicopter-mounted LiDAR technology to detect leaks. The company also has begun using drones – including first-of-its-kind hydrogen-powered drone technology – to map and detect methane.
"It is a testament to our dedicated workforce that we have not only exceeded 2025 reduction goals, but also are quickly approaching 2030 goals as we continue to build the cleanest, safest and most innovative energy company in America," said Jimmie Cho, SoCalGas Chief Operating Officer.
Percentage calculations are based upon a 2015 emissions baseline. Utilities' progress toward state goals are tracked and reported via CPUC-mandated annual reports.
SoCalGas has made meaningful strides to reduce methane emissions since 2015, in addition to investments in leak detection technology.
Accomplishments include:
- Accelerated leak repairs relating to our aerial methane mapping program reduced methane emissions equivalent to avoiding 1,031 metric tons of carbon dioxide equivalent emitted and incrementally increased the ability of detecting and repairing leaks faster
- SoCalGas accelerated its leak survey cycles from every three years to every year for certain types of pipe, leading to more prompt leak repairs further reducing methane emissions
- A 94% reduction in gas venting during maintenance or repairs when compared to 2015, which is equivalent to avoiding 39,432 metric tons of carbon dioxide equivalent emitted
- A 92% reduction in emissions from SoCalGas storage facilities since 2015 due to upgrades in compressor and venting equipment
Last year, SoCalGas announced its aspiration to achieve net zero greenhouse gas emissions in its operations and the energy it delivers by 2045 and earlier this year released its ASPIRE 2045 Sustainability Strategy to help reach that goal.
For more information about SoCalGas' sustainability efforts, please visit https://www.socalgas.com/sustainability.
About SoCalGas
Headquartered in Los Angeles, SoCalGas® is the largest gas distribution utility in the United States. SoCalGas delivers affordable, reliable, and increasingly renewable gas service to 21.8 million consumers across 24,000 square miles of Central and Southern California. Gas delivered through the company's pipelines will continue to play a key role in California's clean energy transition—providing electric grid reliability and supporting wind and solar energy deployment.
SoCalGas' mission is to build the cleanest, safest and most innovative energy company in America. In support of that mission, SoCalGas aspires to achieve net-zero greenhouse gas emissions in its operations and delivery of energy by 2045 and to replacing 20 percent of its traditional natural gas supply to core customers with renewable natural gas (RNG) by 2030. Renewable natural gas is made from waste created by dairy farms, landfills, and wastewater treatment plants. SoCalGas is also committed to investing in its gas delivery infrastructure while keeping bills affordable for customers. SoCalGas is a subsidiary of Sempra (NYSE: SRE), an energy services holding company based in San Diego.
For more information visit socalgas.com/newsroom or connect with SoCalGas on Twitter (@SoCalGas), Instagram (@SoCalGas) and Facebook.
View original content to download multimedia:
SOURCE Southern California Gas Company | https://www.wibw.com/prnewswire/2022/06/16/socalgas-surpasses-californias-2025-methane-emissions-reduction-goals-nears-2030-goal/ | 2022-06-16T22:00:49Z |
- NT-I7 plus pembrolizumab showed anti-tumor activity in heavily pretreated patients for whom checkpoint inhibitors are usually ineffective
- NT-I7 and atezolizumab showed preliminary favorable safety and anticancer activity in relapsed/refractory high-risk skin cancer patients
ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, presented new data from two on-going clinical studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, 3-7 June 2022. The data, presented in poster discussion and poster display sessions, combine its lead asset NT-I7 (efineptakin alfa), a long-acting human IL-7, with check-point inhibitors (CPI) pembrolizumab and atezolizumab, and showed that anti-cancer and safety results associated with NT-I7 were consistent with previously communicated results.
In the phase 2a study NIT-11o, NT-I7 combined with pembrolizumab showed preliminary anticancer activity and a manageable toxicity profile in heavily pretreated patients with immunologically cold microsatellite stable tumors (MSS), colorectal cancers (CRC), and pancreatic ductal adenocarcinoma cancers (PDAC) not previously treated with CPIs, as well as in CPI-treated patients with triple negative breast cancers (TNBC), non-small cell lung cancers (NSCLC), and small-cell lung cancers (SCLC). CPIs are usually ineffective in patients with immunologically cold tumors, such as MSS-CRC or PDAC, and in patients progressing despite prior PD-1/PD-L1 inhibition. ORR for the MSS-CRC cohort was 11.1% with 40.7% DCR; and the PDAC cohort had an ORR of 7.7% with 34.6% DCR (per iRECIST). Two patients out of 26 in the PDAC cohort showed significant target lesion reduction (- 100% and -72% respectively). In all cohorts, including CPI-treated and CPI-naïve subjects, NT-I7 plus pembrolizumab led to an increase in change of mean absolute lymphocyte count from baseline.
In the phase 1b/2a study NIT-106, the combination of NT-I7 with atezolizumab showed favorable safety and anticancer activity in CPI-relapsed/refractory high-risk skin cancer patients. The recommended phase 2 dose (RP2D) was determined so that phase 2a dose expansion is now enrolling. The combination increased by 30-fold the stem-cell memory T cells (Tscm), which may be associated to better anti-tumor activity.
Dr. Se Hwan Yang, Ph.D., President and Chief Executive Officer of NeoImmuneTech said: "We are pleased to gather additional evidence of the efficacy and safety of NT-I7 in combination with check-point inhibitors. Encouraging preliminary results from study NIT-110 led us to expand patient recruitment in the MSS-CRC and PDAC cohorts in order to enhance statistical significance. While study NIT-110 is still on-going, we look forward to more mature data by Q4 2022 that could confirm the benefit of combining our T cell amplifier NT-I7 with a checkpoint inhibitor (CPI) in patients with immune-cold microsatellite stable colorectal cancer or pancreatic cancer and in those who progressed on previous CPI treatment."
As part of the ASCO 2022 poster program, a Trial-in-Progress poster was also presented on the design of Phase 1b study NIT-112, indicating progress of NT-I7 plus CAR-T development.
The links to the posters are as follows:
About NT-I7 (efineptakin alfa) (rhIL-7-hyFc)
NT-I7 (efineptakin alfa) is the only clinical-stage long-acting human IL-7, and is being developed in oncologic and immunologic indications, where T cell amplification and increased functionality may provide clinical benefit. IL-7 is a fundamental cytokine for naïve and memory T cell development and for sustaining immune response to chronic antigens (as in cancer) or foreign antigens (as in infectious diseases). NT-I7 exhibits favorable PK/PD and safety profiles, making it an ideal combination partner. NT-I7 is being studied in multiple clinical trials in solid tumors and as vaccine adjuvant. Studies are being planned for testing in hematologic malignancies, additional solid tumors and other immunology-focused indications.
About NeoImmuneTech, Inc.
NeoImmuneTech, Inc. (NIT) is a clinical-stage T cell-focused biopharmaceutical company, dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases. NIT is led by the scientific founder and inventor of NT-I7 (efineptakin alfa) and has a strong executive team with rich industry experience. NIT is expanding rapidly in personnel and operations, as well as partnering with industry and academic leaders to investigate NT-I7 as monotherapy and in combination with various immunotherapeutics. For more information, please visit www.neoimmunetech.com.
Forward-looking Statements
The statements contained herein may contain certain forward-looking statements relating to NeoImmuneTech, Inc. (the "Company") that are based on its beliefs and expectations about the future. These forward-looking statements are based on a number of assumptions about the future, some of which are beyond the Company's control and are not a guarantee of future performance or developments. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect events that occur or circumstances that arise after the date of these documents. Accordingly, you should not place reliance on any forward-looking information or statements contained herein.
Some of the data contained in these documents were obtained from various external sources, and the Company has not independently verified such data. Accordingly, the Company makes no representations as to the accuracy or completeness of the data, and such data involves risks and uncertainties, and is subject to change based on various factors.
View original content:
SOURCE The NeoImmuneTech, Inc | https://www.kxii.com/prnewswire/2022/06/06/neoimmunetechs-lead-asset-nt-i7-efineptakin-alfa-shows-preliminary-anticancer-activity-combination-with-check-point-inhibitors/ | 2022-06-06T11:22:16Z |
Raiders GM embraces draft pressure despite no high pick
By JOSH DUBOW
AP Pro Football Writer
New Las Vegas Raiders general manager Dave Ziegler knows his tenure will be judged heavily on how well he handles the draft. Ziegler says he embraces that pressure, but it will take at least another year for his drafting acumen to be fairly judged. The Raiders traded away their top two picks in this year’s draft for All-Pro receiver Davante Adams and won’t pick until 86th overall this year. Las Vegas’ biggest needs are on the offensive line and in the secondary. | https://localnews8.com/sports/ap-national-sports/2022/04/22/raiders-gm-embraces-draft-pressure-despite-no-high-pick/ | 2022-04-22T23:27:06Z |
Gunman in Montenegro kills 10 then shot dead by passerby
CETINJE, Montenegro (AP) — A man went on a shooting rampage in the streets of this western Montenegro city Friday, killing 10 people, including two children, before being shot dead by a passerby, officials said.
Montenegrin police chief Zoran Brdjanin said in a video statement shared with media that attacker was a 34-year-old man he identified only by his initials, V.B.
Brdjanin said the man used a hunting rifle to first shoot to death two children ages 8 and 11 and their mother, who lived as tenants in the attacker’s house in Cetinje’s Medovina neighborhood.
The shooter then walked into the street and randomly shot 13 more people, seven of them fatally, the chief said.
“At the moment, it is unclear what provoked V.B. to commit this atrocious act,” Brdjanin said.
Andrijana Nastic, the prosecutor coordinating the crime scene investigation, told journalists that the gunman was killed by a passerby and that a police officer was among the wounded. She said nine of those killed died at the scene and two died at a hospital where they were taken for surgery.
Cetinje, the seat of Montenegro’s former royal government, is 36 kilometers (22 miles) west of Podogrica, the current capital of the small Balkan nation.
Prime Minister Dritan Abazovic wrote on his Telegram channel that the incident was “an unprecedented tragedy” and urged the nation “to be, in their thoughts, with the families of the innocent victims, their relatives, friends and all the people of Cetinje.”
President Milo Djukanovic said on Twitter that he was “deeply moved by the news of the terrible tragedy” in Cetinje, calling for “solidarity” with the families who lost loved-ones in the incident.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/08/12/gunman-montenegro-kills-10-then-shot-dead-by-passerby/ | 2022-08-12T22:03:57Z |
NEW YORK, June 9, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings ("Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings" or the "Company") (NYSE: BKKT) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Bakkt securities between March 31, 2021 and November 19, 2021, both dates inclusive; and/or (b) Bakkt Class A common stock pursuant and/or traceable to documents issued in connection with the business combination between the Company and Bakkt Holdings, LLC completed on or about October 15, 2021. Follow the link below to get more information and be contacted by a member of our team:
BKKT investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company had defective financial controls; (ii) as a result, there were errors in the Company's financial statements related to the misclassification of certain shares issued prior to the business combination between the Company and Bakkt Holdings, LLC; (iii) accordingly, the Company would need to restate certain of its financial statements; (iv) the Company downplayed the true scope and severity of these issues; (v) the Company overstated its remediation of its defective financial controls; and (vi) as a result, the documents issued in connection with the business combination and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
WHAT'S NEXT? If you suffered a loss in Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings during the relevant time frame, you have until June 20, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP | https://www.kxii.com/prnewswire/2022/06/09/bkkt-lawsuit-alert-levi-amp-korsinsky-notifies-bakkt-holdings-inc-fka-vpc-impact-acquisition-holdings-investors-class-action-lawsuit-upcoming-deadline/ | 2022-06-09T10:55:14Z |
BEIJING, July 6, 2022 /PRNewswire/ -- International Solar Building Design Competition 2022, hosted by International Solar Building Design Competition Organizing Committee -- themed with Sunshine & Station in the Scenery, is located in the Giant Panda Habitat Nature Reserve in Guanbagou Basin Nature Mini-Reserve, Pingwu County, Sichuan Province. The competition takes research station as the subject and explores new methods and ideas for ecological conservation with renewable resources. The project is going to build a research station to provide working and living places to visitors, researchers and students. The first prize will be put into construction, and the winning team will participate in the deepening of the project together with the expert team.
Participants will compete for 1 first prize (with a bonus of RMB 100000), 3 second prizes, 6 third prizes, 20 recognition awards, and 30 honorable mention prizes with a total bonus of RMB 320000. Participants must register before 15 August and submit their entries before 30 September. No registration fees.
The competition is hosted by the International Solar Energy Society, the Central Research Institute of China Construction Technology Group, and China Architecture Design & Research Group, with China National Engineering Research Center for Human Settlements as the organizer and Delta Group as the title sponsor.
The competition, themed with hot topics in renewable resources' application in architecture, promotes the application of clean energy such as solar energy in architecture and daily life. It has been held for eleven years since 2005 and has received 1873 valid entries from 9345 teams. We have participants from 232 Chinese universities, 25 foreign universities, and over 120 construction-related enterprises. The project focuses on the implementation of the competition results, with a total of five competition projects completed and put into use so far. All members are looking forward to working with participants to spread the idea of green, low-carbon, energy-saving and sustainable development.
Scan the QR code on the poster for registration. For more information, please visit the official website: www.isbdc.cn
View original content to download multimedia:
SOURCE International Solar Building Design Competition Organizing Committee | https://www.wibw.com/prnewswire/2022/07/07/international-solar-building-design-competition-2022-kicks-off/ | 2022-07-07T01:44:31Z |
Pro bull rider Ouncie Mitchell killed in Salt Lake City
Published: Sep. 13, 2022 at 2:51 PM EDT|Updated: 1 hour ago
SALT LAKE CITY (AP) — A pro bull rider was killed in Utah overnight Monday in what Salt Lake City police are calling a domestic violence homicide.
Police say in a news release that Demetrius Omar Lateef Allen was found shot outside an apartment complex in Salt Lake City after he got into an argument with a woman he had been dating.
Allen died at a hospital. PBR commissioner Sean Gleason says Allen went by the name Ouncie Mitchell as a pro bull rider.
Police arrested LaShawn Denise Bagley, a 21-year-old woman, on suspicion of murder. It’s unknown if Bagley had an attorney.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/09/13/pro-bull-rider-ouncie-mitchell-killed-salt-lake-city/ | 2022-09-13T19:51:50Z |
Age Group 36 to 50 Most Likely to Be Diagnosed with Post-COVID Conditions; Females More Likely Than Males to Receive Such Diagnoses
Thirty-One Percent Had No Identified Preexisting Chronic Comorbidities
NEW YORK, May 18, 2022 /PRNewswire/ -- The majority (75.8 percent) of patients diagnosed with a post-COVID condition had never been hospitalized for COVID-19, according to a new study from FAIR Health. Among patients who presented with a post-COVID diagnosis, 81.6 percent of females had not had a COVID-19 hospitalization compared to 67.5 percent of males.
The study was among the first to use the official ICD-10 diagnostic code (U09.9) for post-COVID conditions that became effective October 1, 2021. Analyzing private claims data from 78,252 patients diagnosed with the U09.9 code from October 1, 2021, to January 31, 2022, the study was released today as a white paper entitled Patients Diagnosed with Post-COVID Conditions: An Analysis of Private Healthcare Claims Using the Official ICD-10 Diagnostic Code.
Also known by such terms as long COVID and post-acute sequelae of COVID-19, post-COVID conditions comprise a wide range of health problems that may occur four weeks or more after infection with the virus that causes COVID-19. In the new FAIR Health study, the population of patients diagnosed with post-COVID conditions is analyzed by COVID-19 hospitalizations, age, gender, number of days from initial COVID-19 diagnosis to last post-COVID diagnosis during the study period, preexisting chronic comorbidities, co-occurring diagnoses and risk scores. Among the key findings:
- The age group 36 to 50 was the most likely to be diagnosed with U09.9 post-COVID conditions; 34.6 percent of patients with that diagnosis were in that age group.
- Females were more likely than males to be diagnosed with U09.9 post-COVID conditions. Females made up 59.8 percent of the population of patients with that diagnosis, while males made up 40.2 percent. By comparison, within the cohort of people diagnosed with COVID-19 in the FAIR Health repository, 53.8 percent of patients were female and 46.2 percent were male.
- Of patients who presented with a U09.9 post-COVID condition, 30.7 percent had no identified preexisting chronic comorbidities.
- The three diagnoses most commonly co-occurring on the same claim line with the U09.9 post-COVID diagnosis in patients across all ages and genders were abnormalities of breathing (23.2 percent of patients with post-COVID conditions), cough (18.9 percent) and malaise and fatigue (16.7 percent).
- In patients with a U09.9 post-COVID diagnosis, certain co-occurring diagnoses were more common in some age groups than across all age groups: for example, multisystem inflammatory syndrome in patients aged 0 to 12; abnormalities of heartbeat in the age group 13 to 22; generalized anxiety disorder in patients aged 23 to 35; and hypertensive diseases in the age group 65 and older.
- "Other and unspecified myopathies" (diseases that affect the muscles that control voluntary movement) occurred in patients in the post-COVID population 11.1 times more often than in the same population prior to COVID-19. Pulmonary embolism occurred 2.6 times more often. "Other disorders of brain," including post-viral fatigue syndrome and certain forms of encephalopathy, occurred two times more often.
- On average, in all age groups, patients with a U09.9 post-COVID condition had higher Department of Health & Human Services-Hierarchical Condition Category (HHS-HCC) risk scores after their diagnosis of COVID-19 than before. HHS-HCC risk scores identify which patients are likely to consume more healthcare resources and potentially incur more healthcare-related costs in the long run.
FAIR Health President Robin Gelburd stated: "Post-COVID conditions have become an issue of growing national concern. FAIR Health is pleased to shed light on this issue using the official ICD-10 diagnostic code for such conditions that became effective last fall. We hope these findings prove helpful for all individuals diagnosed with post-COVID conditions, as well as for providers, payors, policy makers and researchers."
This is the second FAIR Health study on post-COVID conditions; the first was released in June 2021, before the ICD-10 code for such conditions became effective. Other FAIR Health studies on the COVID-19 pandemic have examined projected US costs for COVID-19 patients requiring inpatient stays, the impact of the pandemic on hospitals and health systems, the impact on healthcare professionals, key characteristics of COVID-19 patients, the impact on the dental industry, risk factors for COVID-19 mortality, the impact on pediatric mental health and treatment and hospitalization costs.
For the new white paper, click here.
Follow us on Twitter @FAIRHealth
About FAIR Health
FAIR Health is a national, independent nonprofit organization that qualifies as a public charity under section 501(c)(3) of the federal tax code. It is dedicated to bringing transparency to healthcare costs and health insurance information through data products, consumer resources and health systems research support. FAIR Health possesses the nation's largest collection of private healthcare claims data, which includes over 36 billion claim records and is growing at a rate of over 2 billion claim records a year. FAIR Health licenses its privately billed data and data products—including benchmark modules, data visualizations, custom analytics and market indices—to commercial insurers and self-insurers, employers, providers, hospitals and healthcare systems, government agencies, researchers and others. Certified by the Centers for Medicare & Medicaid Services (CMS) as a national Qualified Entity, FAIR Health also receives data representing the experience of all individuals enrolled in traditional Medicare Parts A, B and D; FAIR Health includes among the private claims data in its database, data on Medicare Advantage enrollees. FAIR Health can produce insightful analytic reports and data products based on combined Medicare and commercial claims data for government, providers, payors and other authorized users. FAIR Health's systems for processing and storing protected health information have earned HITRUST CSF certification and achieved AICPA SOC 2 compliance by meeting the rigorous data security requirements of these standards. As a testament to the reliability and objectivity of FAIR Health data, the data have been incorporated in statutes and regulations around the country and designated as the official, neutral data source for a variety of state health programs, including workers' compensation and personal injury protection (PIP) programs. FAIR Health data serve as an official reference point in support of certain state balance billing laws that protect consumers against bills for surprise out-of-network and emergency services. FAIR Health also uses its database to power a free consumer website available in English and Spanish, which enables consumers to estimate and plan for their healthcare expenditures and offers a rich educational platform on health insurance. An English/Spanish mobile app offers the same educational platform in a concise format and links to the cost estimation tools. The website has been honored by the White House Summit on Smart Disclosure, the Agency for Healthcare Research and Quality (AHRQ), URAC, the eHealthcare Leadership Awards, appPicker, Employee Benefit News and Kiplinger's Personal Finance. FAIR Health also is named a top resource for patients in Dr. Marty Makary's book The Price We Pay: What Broke American Health Care—and How to Fix It and Dr. Elisabeth Rosenthal's book An American Sickness: How Healthcare Became Big Business and How You Can Take It Back. For more information on FAIR Health, visit fairhealth.org.
Contact:
Rachel Kent
Senior Director of Marketing
FAIR Health
646-396-0795
rkent@fairhealth.org
View original content to download multimedia:
SOURCE FAIR Health | https://www.kxii.com/prnewswire/2022/05/18/new-fair-health-study-reports-76-percent-patients-diagnosed-with-post-covid-conditions-had-never-been-hospitalized-covid-19/ | 2022-05-18T18:19:35Z |
SHANGHAI, June 24, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China, announced that it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1).
Since the Company is already before a Hearings Panel for its failure to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2),pursuant to Listing Rule 5810(d)(2), rather than submit a compliance plan for Staff's review, the Company is to address the matter before the Hearings Panel.
About Molecular Data, Inc.
Molecular Data Inc. is a technology-driven platform in China's chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company's e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including the potential impact of COVID-19 on our business within and outside of China. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results.
View original content:
SOURCE Molecular Data Inc. | https://www.wibw.com/prnewswire/2022/06/24/molecular-data-inc-receives-nasdaq-notification/ | 2022-06-24T21:27:30Z |
FAIRFAX, Va., June 1, 2022 /PRNewswire/ -- Knowesis Inc. (Knowesis) was awarded prime positioning for the Defense Health Agency's OMNIBUS IV contract. The potential $10 billion contract vehicle for services supporting military medical research and development programs will be supported by a cohort of companies from the commercial, academic, and nonprofit sectors.
The OMNIBUS IV Indefinite Delivery Indefinite Quantity (IDIQ) multiple-award contract provides awardees the opportunity to compete for task orders in the areas of Research and Development, Research and Development Support Services, Regulatory Processes, and Translational Science Support Services.
"We are proud to be among the list of contractors to win this opportunity," John Broughton, Knowesis Director of Business Development, said of the announcement. "Our expertise in medical and scientific research, along with proficiencies in program evaluation, translational science, data analytics, program management and more, makes us the perfect partner to support the Defense Health Agency's Military Research and Development needs on the OMNIBUS IV contract."
According to SAM.gov, the contract's base ordering period will conclude on June 19, 2027, and a five-year option period would extend work performance through June 19, 2032.
Knowesis is a Center for Veterans Enterprise (CVE) certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and a certified Woman-Owned Small Business (WOSB), providing a full range of professional consulting services to federal and state government agencies to include Scientific and Medical Research, Computational Sciences, Information Management, Technology and Security, Operations and Management, Policy and Program Evaluation, and Strategic Communications. We currently support multiple entities within the Department of Defense, Veterans Affairs, Homeland Security, and the National Institutes of Health.
Knowesis maintains offices in Fairfax, Virginia, with staff at locations across the United States. More information about the company can be found at https://www.knowesis-inc.com/ as well as on Facebook, Twitter, and LinkedIn.
View original content to download multimedia:
SOURCE Knowesis Inc. | https://www.kxii.com/prnewswire/2022/06/01/knowesis-awarded-prime-role-defense-health-agencys-10b-omnibus-iv-military-medical-rampd-services-contract/ | 2022-06-01T15:25:52Z |
Collaboration aims to drive adoption for Quantum-Safe Cryptography before it's too late
WATERLOO, Canada, May 25, 2022 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today announced it will provide support for quantum-resistant secure boot signatures for NXP® Semiconductors' (NASDAQ: NXPI) crypto-agile S32G vehicle networking processors in a demonstration to illustrate how to mitigate the risk of potential quantum computing attacks on in-vehicle software.
The new integration will allow software to be digitally signed using the National Institute of Standards and Technology's (NIST) recently endorsed CRYSTALS Dilithium digital signature scheme that will be quantum resistant, providing peace of mind to those relying on – and delivering – long lifecycle assets such as systems in critical infrastructure, industrial controls, aerospace and military electronics, telecommunications, transportation infrastructure, and connected cars. The collaboration is set to guard against an increasingly risky future when quantum computers will be able to easily break traditional code signing schemes.
For more information, register to attend the one hour "Post-Quantum Cyber Attacks, how to Prepare and Prevent" webinar on June 9, 2022 at 11:00 a.m. ET.
While quantum computing promises to deliver huge leaps forward in processing power, it also has the potential to render today's public key cryptography useless. In recent months, NATO, the White House and NIST have all taken steps to prepare for a 'Y2Q' scenario in which quantum computers become weaponized by threat actors and many widely used security methods become useless against next-generation attacks.
The BlackBerry® Certicom® Code Signing and Key Management Server leverages the NXP S32G chip's secure boot flow to achieve fast and agile quantum protection. Using quantum-resistant signature schemes such as Dilithium for low-level device firmware, over-the-air software updates and software bills of material (SBOMs) mitigates the risk of potential quantum computing attacks on critical software updates, addressing a major security concern for a number of industries.
"As quantum computers continue to advance in development, it's increasingly important to work to secure today's systems against these future threats," said Joppe Bos, Senior Principal Cryptographer at NXP Semiconductors. "Collaborating with BlackBerry strengthens our solution to address the critical need to harden code signing and software update infrastructure against future cryptosystem vulnerabilities."
"In the lead up to Y2K, US business spent upwards of $100 billion to avoid calamity and the issue was simply a matter of adding two digits to the date field. Y2Q, when quantum attacks become possible, is on another level, posing a significant threat to industries selling or operating long-lived assets with updatable software," said Jim Alfred, VP, BlackBerry Technology Solutions. "NXP shares our vision of mitigating the risk of quantum computing concerns and, thanks to their support for hash-based signatures, together we can provide cybersecurity teams with the tools they need now to prevent their existing security measures from becoming obsolete."
To learn more about the Code Signing and Key Management Server and why BlackBerry Certicom technology is widely deployed in smartphone chips, smart meters, car telematics, and IoT devices, please visit www.certicom.com.
About BlackBerry
BlackBerry (NYSE: BB; TSX: BB) provides intelligent security software and services to enterprises and governments around the world. The company secures more than 500M endpoints including over 195M vehicles. Based in Waterloo, Ontario, the company leverages AI and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy solutions, and is a leader in the areas of endpoint security, endpoint management, encryption, and embedded systems. BlackBerry's vision is clear - to secure a connected future you can trust.
BlackBerry. Intelligent Security. Everywhere.
For more information, visit BlackBerry.com and follow @BlackBerry.
NXP and the NXP logo are trademarks of NXP B.V. All other product or service names are the property of their respective owners. All rights reserved. © 2022 NXP B.V.
Trademarks, including but not limited to BLACKBERRY and EMBLEM Design are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.
Media Contact:
BlackBerry Media Relations
+1 (519) 597-7273
mediarelations@BlackBerry.com
View original content to download multimedia:
SOURCE BlackBerry Limited | https://www.mysuncoast.com/prnewswire/2022/05/25/blackberry-nxp-join-forces-help-companies-prepare-prevent-y2q-post-quantum-cyber-attacks/ | 2022-05-25T13:06:26Z |
BOSTON, July 26, 2022 /PRNewswire/ -- Goulston & Storrs, an Am Law 200 firm, has received a top ranking in Private Wealth Law in Massachusetts in the 2022 edition of Chambers USA High Net Worth (HNW) Guide. Five Goulston & Storrs directors – Mark Balk, Mark Christopher, Andrew Rothstein, Marshall Senterfitt, and Mark Swirbalus – also ranked among the top attorneys in the directory.
Goulston & Storrs was one of only four firms to receive a Band 2 ranking in Private Wealth Law. Highly-regarded for handling trust and estate planning and administration for domestic and international clients, Goulston & Storrs' private client team "also has a particular expertise in contentious probate and fiduciary matters" and is known for "top quality work that is thoughtful and contextual."
In the Private Wealth Disputes category, Mark Swirbalus, co-chair of Goulston & Storrs' Litigation group, and Marshall Senterfitt received top rankings. According to Chambers, Swirbalus is an "outstanding" trust and estates litigator who is "smart, reasonable and practical, but zealous in representation for clients." Senterfitt "totally instills confidence" and is "thoughtful and careful and as good a probate and general civil litigator as you will find."
In the Private Wealth Law category, Mark Christopher was ranked with Chambers noting that he "advocates with heart and energy" in trust and estate administration and fiduciary litigation matters. Andrew Rothstein, who co-chairs the firm's Private Client & Trust Group, also ranked for his "tax efficient wealth planning for families." Rothstein is "good at explaining things and following through so the client is sure what they want to do." Finally, Mark Balk was recognized with Chambers highlighting that his "excellent reputation as a thoughtful advisor to high net worth families is well deserved."
The Chambers USA HNW Guide to the world's leading private wealth advisors is culled from thousands of in-depth interviews with clients to assess the reputations and expertise of business lawyers worldwide. Rankings are based on technical legal ability, client service, depth of team, commercial vision and business understanding, diligence, and value for money.
About Goulston & Storrs
Collaboration is not just a pillar of our strategy; it is the key to our competitive advantage and approach to clients, community, and each other. At Goulston & Storrs, we practice law with excellence and integrity. We are a place where mutual respect and collaboration drive open discussion, transparency, creativity and optimal results for our clients. We are committed to being a diverse and inclusive workplace where sophisticated business is conducted with genuine camaraderie. To learn more about us, visit www.goulstonstorrs.com.
View original content to download multimedia:
SOURCE Goulston & Storrs PC | https://www.kxii.com/prnewswire/2022/07/26/goulston-amp-storrs-receives-top-ranking-private-wealth-law-by-chambers-usa-high-net-worth-guide-2022-five-attorneys-ranked-leaders/ | 2022-07-26T15:11:14Z |
BHUBANESWAR, India, Sept. 8, 2022 /PRNewswire/ -- Kalinga Institute of Social Sciences (KISS), Bhubaneswar has won the prestigious UNESCO King Sejong Literacy Prize 2022 for its outstanding literacy programme based on the recommendations of an international jury.
The UNESCO King Sejong Literacy Prize is sponsored by the Government of the Republic of Korea and recognizes contributions to mother language-based literacy development. KISS has received the award in the category of 'Mother Tongue Based Multilingual Education programme'. The award carries an endowment of US$ 20,000, a medal and a diploma. KISS is a constituent of the KIIT Group of Institutions.
The award was presented at a global award ceremony organised by UNESCO in Côte d'Ivoire on 8 and 9 September 2022 to celebrate International Literacy Day.
The programme aims to tackle the challenges of poor retention of indigenous students in elementary schools due to classroom language barriers and teachers' incapacity to deal with multilingual and multicultural classrooms effectively.
Every year, the UNESCO International Literacy Prizes focus on a specific theme. This year, the spotlight was on Transforming Literacy Learning Spaces. KISS is the fifth institute from India and the first from Odisha to receive this international prize. It is also the third among the non-profit NGOs and first indigenous based organisation to be conferred with this award.
KISS, the largest institute for the indigenous students in the world, is credited with the adoption of innovative pedagogies as learning tools and bringing about a perceptible change in the socio-economic lives of the indigenous population through education. This recognition also brings the state of Odisha to prominence on the world map for its efforts at changing the education ecosystem. Moreover, it is also a big day of celebration for indigenous communities as it is truly an award for them.
KISS is a not-for-profit organisation headquartered in Bhubaneswar, Odisha, India. It was established in 1992-93 by well-known educationist Dr Achyuta Samanta to empower the indigenous population through education. It is a fully free residential educational institution that provides holistic education, comprehensive skilling and sports empowerment.
The educational initiative at KISS comprises a school, a college and a university founded with the objective of providing food, education and empowerment to indigenous children.
"I thank UNESCO for recognizing our efforts and social innovations in the field of education, literacy and indigenous empowerment. In my childhood, I struggled to get proper education and now I put all my life and soul to provide holistic education to millions at margins," Dr. Samanta said in his message.
KISS has transformed the lives of 70,000 indigenous children (30,000 children pursuing education and 40,000 alumni) directly and about 700,000 lives in the indigenous communities indirectly. Its higher education wing, KISS Deemed-to-be University is the world's first university exclusively for indigenous students. KISS has in its course of evolution and function collaborated with various UN agencies and organs for the implementation of several initiatives related to education and empowerment. KISS has been in special consultative status with ECOSOC since 2015 and is affiliated with UNDPI.
Since its inception, KISS has been respecting the diversity of indigenous languages and dialects. It has consistently focused on imparting classroom teaching in the mother tongue at elementary levels before transitioning to a common language. This one-of-its-kind pioneering efforts of KISS took a concrete shape in the form of 'Mother Tongue-Based Multilingual Education' in 2013.
KISS, which adopted the Multilingual Education Programme through innovation sandbox, has set an example for other educational institutions and governments to impart classroom teaching in indigenous languages. It aims to tackle the challenges of poor retention of indigenous students in elementary schools due to classroom language barriers and teachers' incapacity to deal with multilingual and multicultural classrooms effectively. The programme is in a hybrid format with face-to-face and distance learning modules using low-tech solutions such as television, radio, and text messaging.
Media Contact:
Dr. Shradhanjali Nayak
director.pr@kiit.ac.in
+91 674 2725636
Photo: https://mma.prnewswire.com/media/1894670/KISS_Foundation.jpg
Photo: https://mma.prnewswire.com/media/1894669/Achyuta_Samanta_with_students.jpg
Logo: https://mma.prnewswire.com/media/1507512/KISS_Logo.jpg
View original content to download multimedia:
SOURCE KISS | https://www.wibw.com/prnewswire/2022/09/08/kiss-wins-prestigious-unesco-literacy-prize-2022-mother-tongue-based-learning/ | 2022-09-08T15:41:03Z |
STOCKHOLM, Aug. 19, 2022 /PRNewswire/ --
The clinical development of fostrox remains the focus
April - June
Financial summary for the quarter
- Net turnover amounted to SEK 0.5 (0.9) million.
- The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -21.5 (-17.1) million. Basic and diluted earnings per share amounted to SEK -0.42 (-0.31) and SEK -0.42 (-0.31) respectively.
- Cash flow from operating activities amounted to SEK -17.6 (-21.9) million.
- Cash and cash equivalents at the end of the period amounted to SEK 162.8 (247.8) million.
Significant events during the quarter
- At Medivir's AGM on May 5, Uli Hacksell, Lennart Hansson, Bengt Westermark and Yilmaz Mahshid were re-elected and Anette Lindqvist was newly elected as board members in the company. Uli Hacksell was re-elected as chairman of the board. An van Es Johansson had declined re-election.
January - June
Financial summary for the period
- Net turnover amounted to SEK 1.0 (10.8) million.
- The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -52.9
(-24.3) million. Basic and diluted earnings per share amounted to SEK -1.00 (-0.51) and SEK -1.00 (-0.51) respectively. - Cash flow from operating activities amounted to SEK -57.5 (-23.3) million.
- Cash and cash equivalents at the end of the period amounted to SEK 162.8 (247.8) million.
Significant events after the period
- Fostroxacitabinebralpamide - the name given to MIV-818 by the World Health Organization (WHO) - received formal approval as a pharmaceutical name in the USA by the United States Adopted Names (USAN) Council.
Conference call for investors, analysts and the media
The Interim Report January - June 2022 will be presented by Medivir's CEO, Jens Lindberg.
Time: Friday, August 19, 2022, at 14.00 (CET).
Phone numbers for participants from:
Sweden + 46 8 566 426 93
Europe +44 33 3300 9031
US +1 646 722 4902
The presentation will be available on Medivir's website after completion of the conference.
CEO's message
Our steadfast determination is one of the most important factors enabling Medivir to deliver continued good results, both with fostrox and in the business development of our other assets.
The past quarter was above all characterized by the work to drive the clinical development of our cutting-edge project fostroxacitabine bralpamide (fostrox), for the treatment of hepatocellular carcinoma (HCC). Fostrox has the potential to become the first liver-targeted and orally administered drug that can help patients with various cancers of the liver. Its unique mechanism of action in liver cancer enables attractive combination treatments with other drug alternatives for HCC.
In our currently ongoing phase 1b/2a combination study, fostrox is given in two different combinations, either with Lenvima®, a tyrosine kinase inhibitor, or with Keytruda®, an anti-PD-1 checkpoint inhibitor. The study is conducted at clinical trial centers in the UK, Spain and South Korea.
During the second quarter, we have continued to focus on activating additional trial centers and on recruiting patients to the two arms in the study. We have now initiated 3 centers in the UK, 5 centers in Spain and 5 centers in South Korea. In addition, we intend to increase the number of investigators and centers primarily in South Korea. We are also working to open centers in additional countries. At the same time, we have intensified Medivir's presence at the activated trial centers to ensure that investigators and other staff have a continued focus on our study.
Increased competition from other studies in our patient population and changes in second-line treatment, where we saw patients could receive Tecentriq® + Avastin® treatment also in second-line, have led to slower recruitment than planned in Europe in the second quarter. We are therefore in the process of broadening and simplifying the inclusion criteria, among other things by opening up to third-line patients if they do not have an overly advanced liver disease.
These measures, which include broadened inclusion criteria, an increased number of trial centers and investigators as well as an increased presence of our employees at the centers, create the conditions for the recruitment rate to increase during the second half of 2022.
I would also like to mention that the name fostroxacitabine bralpamide that we received from the WHO has now also received formal approval as a drug name in the USA by the USAN Council. Furthermore, our work to open an Investigational New Drug (IND) in the USA in 2023 is progressing according to plan.
The continued focus for our business development lies on our two clinical projects for partnerships, remetinostat and MIV-711. Both projects come with very robust data packages. The data packages for these two projects have been strengthened during 2021-2022 and we continue our dialogue with external parties with the ambition of finding the best possible solution for each substance.
During the quarter, we have seen continued positive development of IGM Bioscience's clinical development work with birinapant. In the phase I clinical trial in solid tumors with birinapant in combination with IGM's own DR5 agonist antibody IGM-8444, patient inclusion in the third dose escalation cohort has been completed. No dose-limiting toxicity or clinically significant hepatotoxicity has been observed to date. The patient recruitment for the fourth dose-escalation cohort of the study has been initiated. The agreement with IGM can potentially provide milestone payments up to a total of approximately USD 350 million as well as tiered royalties up to "mid-teens".
Finally, in 2017, Medivir's MBLI program, aimed at addressing the threat of resistant bacteria, was out-licensed to AMR Centre in England. AMR, today INFEX Therapeutics, has in 2022 presented additional preclinical data and communicated its intention to initiate a phase 1 program in 2022/23. Several countries have developed innovative financial solutions for new antibiotics, which has increased the commercial opportunities for this type of pharmaceutical. Medivir is entitled to a share of potential future revenue.
I would also like to extend a warm welcome to Anette Lindqvist, who was elected as a new member of Medivir's board at the annual general meeting on May 5. I also want to thank An van Es Johansson, who declined re-election, for her efforts as a board member.
We are working with great enthusiasm to achieve the goal that our cutting-edge project fostrox can become an effective drug against liver cancer which would make a real difference for patients and for healthcare and thus also for our shareholders. We see that the measures we have taken in the clinical program have begun to yield results and look forward with confidence to the second half of the year and to keeping you informed about Medivir's continued development.
Jens Lindberg
Chief Executive Officer
For further information, please contact:
Magnus Christensen, CFO
Phone: +46 (0)8 5468 3100
E-mail: magnus.christensen@medivir.com
This report has not been subject to auditors' review.
The information was submitted for publication at 08.30 CET on August 19, 2022.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Medivir | https://www.wibw.com/prnewswire/2022/08/19/medivir-ab-interim-report-january-june-2022/ | 2022-08-19T08:30:14Z |
MADRID, June 13, 2022 /PRNewswire/ -- Yadea (01585:HK), the world's leading electric two-wheeler brand, is gearing up for a high-profile launch event in Madrid this month to make a splash in the Spanish market. The company will showcase its brand and products at Madrid City Hall on June 21 under the theme #YADEATakestheCity.
"We are excited to be entering the Spanish market. We hope that with our Spanish debut, more people will embrace our Electrify Your Life philosophy and live more sustainably," said Aska Zeng, CEO of Yadea Europe. "We want to bring new mobility ideas to the table in those markets most committed to decarbonization and future mobility solutions."
Headlining the product showcase is the high-end YADEA Vfly series along with the Y1S commercial delivery scooter that was unveiled in Milan last year. Other Yadea products will also be on show covering categories such as electric motorcycles, bicycles, and kick scooters. The event will also provide a platform for Yadea's striking designs. The company has already received some international recognition, picking up the 2020 Red Dot Award for its C1 model in Germany as well as an IDEA Award in the US.
Designed for performance, Yadea products deliver on beauty, power, and comfort while incorporating the most up-to-date industry trends. Graphene 3.0 battery technology is a particular highlight, drawing high praise from Nobel Laureate in physics and "Father of Graphene" Professor Andre Geim. It combines long life, fast charging, and extreme temperature resistance with a huge operational range.
Jointly created with Studio F.A. Porsche, Yadea's VFLY series are intelligent high-end products. The Meteor Falcon N scooter's smart AI voice assistant allows riders to handle calls, music, radio, and even route planning on the go.
Yadea will also showcase its fast-charging technology during the event. The company's automotive-grade solutions meet both European and Chinese standards and can work directly with existing electric car piles, removing the need for new installations. They support AC charging with OBC power of up to 2kw for full charging in under 3.5 hours. DC fast-charging up to 30kw can charge a lithium battery to 80% at 25 degrees Celsius in just 10 minutes.
Yadea has made great strides in expanding its business into overseas markets in 2021, including the brand's global launch with the "Electrify Your Life" slogan, and became the official partner for the 2021 XLETIX Challenge Berlin. Present in over 90 countries globally, Yadea notably launched in Italy in November with a high-profile launch event at EICMA 2021.
Yadea aims to empower people around the world so they can move away from traditional gas-powered vehicles and swap them for green energy alternatives. In collaboration with Spanish partners, Yadea will continue to develop more green mobility solutions and co-create a better future for European customers. With its next stop in Madrid, the firm aims to establish itself as a world-class global brand.
Please stay tuned for the event on June 21.
About Yadea
Yadea is a global leader in developing and manufacturing electric two-wheel vehicles including electric motorcycles, electric mopeds, electric bicycles and electric kick scooters. To date, Yadea has sold products to 60 million users in over 80 countries, and has a network of 40,000+ retailers worldwide. With a mission to help people "Electrify Your Life", Yadea continues to invest in R&D, production and global expansion to build a shared and sustainable future for humankind.
For more information, visit our:
Official Website: https://www.yadea.com/
Facebook: https://www.facebook.com/Yadea.Official
Instagram: https://www.instagram.com/YADEA.GLOBAL/
Twitter: https://twitter.com/YadeaGlobal
View original content to download multimedia:
SOURCE Yadea | https://www.wibw.com/prnewswire/2022/06/13/yadea-eyes-spanish-market-with-madrid-launch-event/ | 2022-06-13T11:16:46Z |
Sponsored by Major Brands Such as Macy's, Stila Cosmetics, and Avelo Air, The Inaugural Idaho Fashion Week Promises to Deliver a Big-City Fashion Show Feel in Boise, Idaho.
BOISE, Idaho, June 10, 2022 /PRNewswire/ -- Idaho Fashion Week is a brand-new production that will take place over two days this month, focusing on bringing fashion industry leaders from around the country to Boise, Idaho. Idaho Fashion Week 2022 will be unlike any previously produced fashion show in Boise, due to the caliber of designers, models, media, and influencers that will be in attendance and on the production team. In addition to runway shows, the June 18-19 event will also feature workshops and panels led by fashion industry big-hitters such as Kentaro Kameyama, winner of Project Runway season 16, celebrated makeup artist Carlos Gonzalez, and model Monique Victoria, who competed on the popular show America's Next Top Model. The shows on Saturday June 18th will be held at 8pm (doors will open at 7pm) at the Jackson Jet Center, with workshops and master classes taking place on Sunday June 19th from 12-6pm at the Grove Hotel in downtown Boise.
The event is dedicated to bringing stars from the fashion industry to Boise so as to connect Idaho to the greater fashion community, and also to help diversify the world of fashion. This means casting models of all sizes, genders, and races, as well as working only with designers and sponsors who are similarly dedicated to positively influencing the world of fashion to be more inclusive. Featured designers will include Kentaro Kameyama, Mister Triple X, Jose Gonzalez, Rooney Mae Couture (a local Boise designer), as well as Macy's, who is also a title sponsor of the event.
Idaho Fashion Week will be partnering with the nonprofit organization Dress For Success, who work to provide underserved women with clothing needed for job interviews, as well as leadership training and career counseling. Idaho Fashion Week has committed to donating a portion of all ticket sales to Dress For Success, in addition to donating artwork to them, for them to auction off at their major fundraising events later in the year.
Idaho Fashion Week is the first event of its kind to come to Boise. Led by Executive Producer Amanda Rouse, the Idaho Fashion Week production team members have previously produced New York Fashion Week, Los Angeles Fashion Week, Miami Swim Week, and other major runway shows throughout the globe.
June 18th, 2022, 8pm: The Shows - The Idaho Fashion Week runway shows will take place at the Jackson Jet Center, at 3815 Rickenbacker St, Boise. Doors will open at 7pm, and the shows will begin at 8pm.
June 19th, 2022, 12-6pm: The Experience - Held at the Grove Hotel in downtown Boise, The Experience will consist of three sessions, including two master classes and one panel discussion. The topics will cover:
- Editorial Makeup Application, taught by internationally published makeup artist Carlos Gonzalez
- Inside Fashion: Expert Panel, hosted by model Monique Victoria, designer Kentaro Kameyama, and fashion photographers Adrian Tapia and Arun Nevader
- The Art of Design: From Concept to Runway, hosted by Kentaro Kameyama, featured designer and winner of Project Runway season 16
Tickets for Idaho Fashion Week: The Shows begin at $65 (ensuring a 4th row seat), and run up to $250 for front-row seating.
Tickets for the workshops on June 19th are $25 per class. Tickets can be purchased on the Idaho Fashion Week website, www.idahofashionweek.com.
Media Contact
Rachel Willingham
willingham.rach@gmail.com
425.270.9265
View original content:
SOURCE Idaho Fashion Week | https://www.mysuncoast.com/prnewswire/2022/06/10/first-ever-idaho-fashion-week-comes-boise-bringing-star-designers-models-production-team/ | 2022-06-10T20:44:31Z |
COPENHAGEN, Denmark (AP) — Norway on Wednesday joined fellow Scandinavian countries in offering a second booster shot of COVID-19 vaccine to some of its population, to be available from July 1 to people aged 75 and over, because of a rise in infections.
“There is a need to vaccinate our most vulnerable citizens,” Health Minister Ingvild Kjerkol said, adding that vaccination remains “the cornerstone of the government’s preparedness.”
Nursing home residents and people over 80 should be first in line, Kjerkol said, adding that the summer holidays could be “demanding” for some municipalities — which in Norway are responsible for handling vaccinations.
“I would therefore like to emphasize that the pace of vaccination must be adapted to the municipalities’ capacity,” she said.
Denmark has offered a second booster shot to nursing home residents and people aged 50 and over, while Sweden recommended a third booster shot for people with an increased risk of becoming seriously ill and anyone aged 65 and over.
___
Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic | https://cw33.com/health/ap-health/norway-joins-neighbors-offers-extra-booster-shot-to-elderly/ | 2022-06-29T17:37:54Z |
- In his new capacity, Sulaiman Al Ali will lead both YahClick, Yahsat's data solutions arm, and Thuraya, its mobility business
- Al Ali's expanded portfolio reflects Yahsat's commitment to maximizing its combined strength, driving synergies across the company and creating additional value for its customers and partners
ABU DHABI, UAE, July 1, 2022 /PRNewswire/ -- Al Yah Satellite Communications Company PJSC ("Yahsat") listed on the Abu Dhabi Securities Exchange ("ADX") under (SYMBOL: YAHSAT) (ISIN: AEA007501017), the UAE's flagship satellite solutions provider, today announced the appointment of Sulaiman Al Ali as the Chief Commercial Officer (CCO) of Yahsat and will be effective as of July 1, 2022.
Sulaiman Al Ali will assume the role following the departure of Farhad Khan who served as CCO of Yahsat for the past six years. Khan has been a key proponent of the expansion of the Group's YahClick business in existing and new markets.
Al Ali has been with the Yahsat Group since 2014, initially serving as a Director within the Yahsat Government Solutions area, prior to assuming the role of Deputy Chief Executive Officer of Thuraya in 2019 and subsequently its Chief Executive Officer (CEO) in 2021. As CEO of Thuraya, Al Ali has been instrumental in driving operational excellence and delivering new and innovative solutions to customers in a post-pandemic environment, as well as establishing a platform for strong future growth.
Al Ali's appointment aligns with Yahsat's commitment to maximizing the combined strength of its wide bench of technologies, services and capabilities to deliver greater value and innovation to its customers across the globe.
Commenting on the announcement, Ali Al Hashemi, Group CEO of Yahsat said: "I am delighted to announce the appointment of Sulaiman Al Ali as Chief Commercial Officer of Yahsat. Sulaiman's new position and expanded portfolio is reflective of his outstanding contributions across the Group and will enable us to expand and advance our customer solutions by effectively leveraging the distinct and complementary qualities offered by our fixed and mobility business and technology platforms. On behalf of myself and the leadership team, I take this opportunity to thank Farhad for his unstinting service and delivery to Yahsat and YahClick and wish him every success as he embarks upon his future endeavours."
Sulaiman Al Ali, CCO of Yahsat, added: "I am deeply honoured to have been appointed as the Chief Commercial Officer for Yahsat. I am committed to combining the collective strengths of our business to amplify the value we can deliver to our customers and partners. Yahsat is ideally placed to address the complex issues facing our customers by offering them a highly-equipped one-stop shop where they are able to fulfil their various satellite communications needs. We look forward to harnessing the innovative spirit that runs across Yahsat's commercial business to provide an unparalleled level of service to our customers."
About Al Yah Satellite Communications Company PJSC
Al Yah Satellite Communications Company PJSC (Yahsat) is a public company listed on the Abu Dhabi Securities Exchange (ADX) and a subsidiary of Mubadala Investment Company PJSC, offering multi-mission satellite services in more than 150 countries across Europe, the Middle East, Africa, South America, Asia and Australasia.
For more information, visit: www.yahsat.com; Follow us on Twitter: @YahsatOfficial
Photo - https://mma.prnewswire.com/media/1851527/Yahsat_Chief_Commercial_Officer.jpg
Logo - https://mma.prnewswire.com/media/1851528/Yahsat_Logo.jpg
View original content:
SOURCE Al Yah Satellite Communications Company PJSC | https://www.mysuncoast.com/prnewswire/2022/07/01/yahsat-announces-appointment-sulaiman-al-ali-chief-commercial-officer-yahsat-drive-next-phase-yahclick-thuraya-growth/ | 2022-07-01T05:31:14Z |
Wild finish: Orioles rally to beat Red Sox 2-1 in 10th
By DAVID GINSBURG
Associated Press
BALTIMORE (AP) — Jorge Mateo scored the winning run in the 10th inning on a throwing error by pitcher Hirokazu Sawamura, capping a comeback that carried the Baltimore Orioles past the Boston Red Sox 2-1. Baltimore had runners on first and second with no outs when Robinson Chirinos dropped a bunt in front of the mound. Sawamura (0-1) scooped up the ball and threw it well over the head of third baseman Rafael Devers, allowing Mateo to score easily. Held without a hit until the sixth inning and trailing 1-0 in the eighth, the Orioles rallied to end a five-game skid. | https://localnews8.com/sports/ap-national-sports/2022/04/30/wild-finish-orioles-rally-to-beat-red-sox-2-1-in-10th/ | 2022-05-01T04:53:14Z |
The Rhino T8 Offers a truly Scalable, Global solution for Enterprise to Securely Support Specialized Applications in Healthcare, Retail, Hospitality, Food Service, Transportation and Logistics.
MIAMI, June 14, 2022 /PRNewswire/ -- Social Mobile, a mobility solutions provider specializing in Android Enterprise deployments, announced that the Rhino T8 is now certified for use on the T-Mobile and AT&T networks. The Rhino T8 is a Google Mobile Services (GMS) certified, 8" tablet with LTE connectivity support for most countries in the world, allowing organizations to deploy and manage a single solution in all geographies.
A leading provider of Android Enterprise solutions, Social Mobile offers custom mobile solutions intended to solve specific challenges for organizations. Starting with evaluating an organization's existing challenges, Social Mobile develops a comprehensive, scalable, and secure solution that encompasses custom software, custom hardware, custom APIs and a single viewpoint to manage an entire fleet of devices from a centralized location. Additionally, Social Mobile offers a complete mobility as a service solution where devices can be purchased (CAPEX) or leased (OPEX) and packaged with optional data plans, deployment, RMA management, help desk and other services, all included in one monthly cost.
As a GMS-certified device, Social Mobile has committed to supporting a three-year lifespan for the T8, making it a suitable option for use in a wide range of industries. The T8 has become a widely recognized option for enterprise due to security, cost, long term availability, extended support, and optional customizations.
"The Rhino T8 is an extremely powerful and versatile Android-powered tablet capable of supporting all types of custom applications, without the bloatware that is typically pre-loaded in consumer-grade offerings," said Tyler Forst, President of Social Mobile. "Now certified with two major US telcos, the Rhino T8 is a no brainer for organizations searching for a cost-effective, scalable and readily available solution that can be trusted to support business-critical operations across industries and continents."
Founded in 2011, Social Mobile is a Google Mobile Services (GMS) partner, leveraging the Android operating system to design, engineer, and manufacture turnkey, mobility-as-a-service deployments that enable enterprise organizations to utilize smart solutions to support an array of business-critical operations. An OEM, managed service provider, and consultancy, Social Mobile is uniquely positioned to serve as a domestic design partner to US clients, controlling all aspects of the development supply-chain, and ensuring the utmost in security and availability. To learn more about other Social Mobile products and solutions, visit: https://socialmobile.com.
Media Relations Contact:
Michael Benedetto
Springboard
michael.benedetto@springboardpr.com
View original content:
SOURCE Social Mobile | https://www.mysuncoast.com/prnewswire/2022/06/14/social-mobiles-rhino-t8-tablet-now-certified-use-t-mobile-atampt-networks/ | 2022-06-14T13:40:48Z |
NEW YORK and SAN DIEGO, July 18, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP, a preeminent national consumer rights law firm, announces that it is investigating claims on behalf of Elephant Insurance Services, LLC ("Elephant Insurance") customers.
On or around April 25, 2022, Elephant Insurance detected an apparent cyberattack attack on its internal network (the "Data Breach"). An investigation revealed that between March 26, 2022 and April 01, 2022, an unauthorized party gained access to Elephant Insurance's internal network and to certain individuals' information.
On or around May 25, 2022, Elephant Insurance began notifying consumers of the Data Breach. Information acquired includes names or other personal identifier in combination with driver's license numbers or non-driver identification card numbers.
If you received a NOTICE OF DATA BREACH from Elephant Insurance and you reside in the United States, if you wish to discuss this investigation, or if you have any questions regarding your rights and interests in this matter, please contact Wolf Haldenstein immediately by telephone at (800) 575-0735, via e-mail at byrd@whafh.com, or visit our website at www.whafh.com
CLICK HERE TO FILL OUT CONTACT FORM
Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of consumer rights litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas and offices in New York and San Diego. Courts have repeatedly recognized the reputation and expertise of this firm and have appointed it to major positions in complex litigation.
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Gregory Stone, Director of Case and Financial Analysis
Rachele R. Byrd, Esq.
Email: gstone@whafh.com or byrd@whafh.com
Tel: (800) 575-0735 or (619) 239-4599
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
View original content to download multimedia:
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP | https://www.mysuncoast.com/prnewswire/2022/07/18/wolf-haldenstein-adler-freeman-amp-herz-llp-elephant-insurance-services-llc-data-breach-investigation-alert/ | 2022-07-18T13:16:15Z |
NEW YORK, July 9, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CareDx, Inc. (NASDAQ: CDNA) between February 24, 2021 and May 5, 2022, both dates inclusive (the "Class Period"), of the important July 22, 2022 lead plaintiff deadline.
SO WHAT: If you purchased CareDx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the CareDx class action, go to https://rosenlegal.com/submit-form/?case_id=2700 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the RemoTraC service; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company's testing services revenue reported throughout the Class Period artificially inflated; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the CareDx class action, go to https://rosenlegal.com/submit-form/?case_id=2700 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A. | https://www.mysuncoast.com/prnewswire/2022/07/09/rosen-top-ranked-investor-counsel-encourages-caredx-inc-investors-with-losses-over-100k-secure-counsel-before-important-july-22-deadline-securities-class-action-cdna/ | 2022-07-10T10:46:34Z |
NEW YORK, June 13, 2022 /PRNewswire/ -- 5WPR, one of the largest independently owned PR firms in the U.S., announces today the expansion of the sustainable consumer goods practice team of experts.
The sustainability team works across numerous consumer sectors, including food, beverage, home, beauty, and lifestyle practice areas as consumer demand for more sustainable offerings continues to rise. With this heightened focus, the team leverages key opportunities to build brand awareness and highlight the actions taken by these brands to create a healthier environment.
"Every day we are inspired by our expanding roster of clients, who offer sustainable practices and packaging, to do better for both people and planet," said 5WPR CEO, Dara A. Busch. "The brands we work with are at the forefront of driving the mission of sustainability within their industries. In response to their growing efforts and the influx of sustainability-forward programs, we're thrilled to be expanding our team and services for this growing area within our agency."
5WPR's 2022 Consumer Culture Report found that 70% of respondents take it upon themselves to research if a company ethically and sustainably sources and produces, prior to purchasing.
5WPR excels in the category, launching innovative, purpose-driven brands to the U.S. market that focus on planet-minded and ethically-conscious clients year-round.
5W Public Relations helps consumer products and brands build strong, authentic relationships with customers. PR services offered to consumer good clients include messaging and positioning, media relations, influencer relations, product launches, new market expansion campaigns, executive visibility programs, fundraising announcements, content creation, sponsorships/partnerships, digital media campaigns, thought leadership and speaking opportunities.
About 5WPR
5W Public Relations is a full-service PR agency in NYC known for cutting-edge programs that engage with businesses, issues and ideas. With more than 275 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications and Reputation Management), Public Affairs, Crisis Communications and Digital Marketing (Social Media, Influencer, Paid Media, SEO). 5W was named to Inc. Magazine's Best Workplaces 2022 list, awarded 2020 PR Agency of The Year, and brings leading businesses a resourceful, bold and results-driven approach to communication.
Media Contact
Dara A. Busch
dbusch@5wpr.com / 212-999-5585
View original content to download multimedia:
SOURCE 5W Public Relations | https://www.wibw.com/prnewswire/2022/06/13/5wpr-expands-sustainable-consumer-goods-practice-team-experts/ | 2022-06-13T14:12:32Z |
TSX and OTCQX: MPVD
TORONTO and NEW YORK, July 18, 2022 /PRNewswire/ - Mountain Province Diamonds Inc. ("Mountain Province", the "Company") (TSX: MPVD) (OTC: MPVD) is pleased to provide interim drilling results for the Hearne Northwest Extension at Gahcho Kué Mine. The Hearne kimberlite is one of four kimberlites being mined at Gahcho Kué, presently ranked at 5th in the world with an annual diamond production of approximately six million carats. Mountain Province is a 49% shareholder at Gahcho Kué with joint venture partner De Beers Canada as operators. With the success of the recently completed drilling program, further drilling of the Northwest Extension will be implemented with the goal to define the volume and depth extent of the kimberlite.
Drilling Highlights for the Hearne Northwest Extension Program
- Kimberlite intersected in over 60% of 14 drill holes completed to date
- Mineralized intersects range from 24.3 to 114.5 meters
- Longest intersect of 114.5 meters contains hypabyssal and tuffisitic kimberlite
- Lithologies are visually similar to the main Hearne kimberlite
Mark Wall, the Company's President and Chief Executive Officer, commented:
"Hearne has been a consistent surprise since mining started at Gahcho Kué. Hearne was originally defined with separate north and south lobes, which we redefined in 2018 after drilling out additional kimberlite ore that connected the two lobes. In-pit mining has now discovered more kimberlite extending to the northwest and to depth and so far, the results fully support the opportunity to consider the underground extraction of diamonds at Gahcho Kué in the future. We look forward to further delineating the Hearne northwest extension with the goal of increasing the Gahcho Kué mine life."
The Hearne Northwest Extension was exposed in a bench face in late 2021 during routine mining operations. Geophysical surveys were conducted over the exposed kimberlite, on the ramp over the bench face exposure, and outside of the pit to the west-northwest. Based on in-pit geophysics, drilling focused to the west northwest where similar electromagnetic and gravity signatures were similar to those in the pit. The original exposure of kimberlite in the Hearne pit is provided in the first image. The kimberlite is outlined in yellow, with broken country rock above the kimberlite outlined in green. The horizontal distance across the kimberlite exposure is roughly 25 meters.
Since January 2022, 14 drillholes (4,284 meters) have defined the Hearne Northwest Extension. The results indicate that the extension trends more northerly than was suggested by the geophysics. The geophysics identified a northwest-trending structure, but two drillholes completed across the structure did not intersect kimberlite. Plan views of the Hearne Northwest Extension relative to the open pit, ground geophysics and recent drilling are seen in the second set of images.
The blue box on the left image is expanded on the right image. Three-digit numbers on the right image mark drillholes completed to date on the Northwest Extension. The dashed line indicates the approximate start of the Northwest Extension. The shape of the extension is approximate and based on modeling of the limited drilling to date.
Nine of the 14 drillholes have intersected hypabyssal kimberlite ('HK') and tuffisitic kimberlite ('TK') with intersects ranging from 23.02 to 114.53 meters. Drillhole MPV-22-595C is still underway in kimberlite with an intersect of 48 meters as at the time of this release. Both the HK and TK rock types are visually consistent with the known internal units at Hearne. The true thickness and depth extent of the Northwest Extension are unknown based on the limited drilling results. A summary of drilling that presently defines the Hearne Northwest Extension is provided below.
Logging, petrographic and mineral chemistry studies are underway to properly define the HK and TK contacts in the extension and their relationship to the main Hearne kimberlite. Following on results of these detailed studies, further drilling will be implemented with the goal to define the volume and depth extent of the Northwest Extension.
Mountain Province Diamonds is a 49% participant with De Beers Canada in the Gahcho Kué diamond mine located in Canada's Northwest Territories. The Gahcho Kué Joint Venture property consists of several kimberlites that are actively being mined, developed, and explored for future development. The Company also controls 106,202 hectares of highly prospective mineral claims and leases that surround the Gahcho Kué Joint Venture property that include an indicated mineral resource for the Kelvin kimberlite and inferred mineral resources for the Faraday kimberlites.
For further information on Mountain Province Diamonds and to receive news releases by email, visit the Company's website at www.mountainprovince.com.
The disclosure in this news release of scientific and technical information regarding Mountain Province's mineral properties has been reviewed and approved by Matthew MacPhail, P.Eng., MBA, and Tom E. McCandless, Ph.D., P.Geo., both employees of Mountain Province Diamonds and Qualified Persons as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects.
This news release contains certain "forward-looking statements" and "forward-looking information" under applicable Canadian and United States securities laws concerning the business, operations and financial performance and condition of Mountain Province Diamonds Inc. Forward-looking statements and forward-looking information include, but are not limited to, statements with respect to operational hazards, including possible disruption due to pandemic such as COVID-19, its impact on travel, self-isolation protocols and business and operations, estimated production and mine life of the project of Mountain Province; the realization of mineral reserve estimates; the timing and amount of estimated future production; costs of production; the future price of diamonds; the estimation of mineral reserves and resources; the ability to manage debt; capital expenditures; the ability to obtain permits for operations; liquidity; tax rates; and currency exchange rate fluctuations. Except for statements of historical fact relating to Mountain Province, certain information contained herein constitutes forward-looking statements. Forward-looking statements are frequently characterized by words such as "anticipates," "may," "can," "plans," "believes," "estimates," "expects," "projects," "targets," "intends," "likely," "will," "should," "to be", "potential" and other similar words, or statements that certain events or conditions "may", "should" or "will" occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are based on a number of assumptions and subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Many of these assumptions are based on factors and events that are not within the control of Mountain Province and there is no assurance they will prove to be correct.
Factors that could cause actual results to vary materially from results anticipated by such forward-looking statements include the development of operation hazards which could arise in relation to COVID-19, including, but not limited to protocols which may be adopted to reduce the spread of COVID-19 and any impact of such protocols on Mountain Province's business and operations, variations in ore grade or recovery rates, changes in market conditions, changes in project parameters, mine sequencing; production rates; cash flow; risks relating to the availability and timeliness of permitting and governmental approvals; supply of, and demand for, diamonds; fluctuating commodity prices and currency exchange rates, the possibility of project cost overruns or unanticipated costs and expenses, labour disputes and other risks of the mining industry, failure of plant, equipment or processes to operate as anticipated.
These factors are discussed in greater detail in Mountain Province's most recent Annual Information Form and in the most recent MD&A filed on SEDAR, which also provide additional general assumptions in connection with these statements. Mountain Province cautions that the foregoing list of important factors is not exhaustive. Investors and others who base themselves on forward-looking statements should carefully consider the above factors as well as the uncertainties they represent and the risk they entail. Mountain Province believes that the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.
Although Mountain Province has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Mountain Province undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. Statements concerning mineral reserve and resource estimates may also be deemed to constitute forward-looking statements to the extent they involve estimates of the mineralization that will be encountered as the property is developed.
Further, Mountain Province may make changes to its business plans that could affect its results. The principal assets of Mountain Province are administered pursuant to a joint venture under which Mountain Province is not the operator. Mountain Province is exposed to actions taken or omissions made by the operator within its prerogative and/or determinations made by the joint venture under its terms. Such actions or omissions may impact the future performance of Mountain Province. Under its current note and revolving credit facilities Mountain Province is subject to certain limitations on its ability to pay dividends on common stock. The declaration of dividends is at the discretion of Mountain Province's Board of Directors, subject to the limitations under the Company's debt facilities, and will depend on Mountain Province's financial results, cash requirements, future prospects, and other factors deemed relevant by the Board
View original content to download multimedia:
SOURCE Mountain Province Diamonds Inc. | https://www.mysuncoast.com/prnewswire/2022/07/18/mountain-province-diamonds-provides-drilling-highlights-hearne-northwest-extension-gahcho-ku/ | 2022-07-18T23:44:12Z |
CARMEL, Ind., Aug. 18, 2022 /PRNewswire/ -- Orchard Software and CDR Laboratories have partnered to rapidly implement monkeypox testing. According to the Centers for Disease Control and Prevention, the number of Monkeypox (Orthopoxvirus) cases are on the rise. To mitigate the virus' spread, laboratories must quickly identify the virus and communicate results so that timely treatment and contact tracing can take place.
Miami-based CDR Laboratories is a CLIA and CAP life science laboratory that specializes in molecular diagnostics with a focus on speed of results reporting to enable faster patient care. CDR Labs also provides chemistry, toxicology, and hematology testing. Its collaboration with Orchard enables rapid reporting and response to monkeypox virus test results.
"CDR Labs is proud to respond to the public health emergency to provide a safe, accurate test for identification of Monkeypox," said Sarah M.J. Helber, PhD, HCLD (ABB), Chief Laboratory Officer for CDR Labs. "Our goal is to provide efficient collection and rapid turnaround times for all our patients to curb the spread of this disease. As the first laboratory to collaborate with Orchard on implementing monkeypox testing, I was pleased with how rapidly Orchard was able to configure our LIS to process and report monkeypox results."
"We are excited to partner with CDR Laboratories to facilitate rapid reporting of Monkeypox virus results to help address this public health emergency," said Billie Whitehurst, CEO of Orchard Software. "Our innovative solution provides laboratories with ordering and reporting tools that allow them to play an active part in addressing infectious disease threats."
Orchard Software Corporation is a leader in the laboratory information system industry and offers a variety of solutions. Orchard serves more than 2,000 laboratories across the country, helping them improve efficiency, reduce errors, and enhance integration. Orchard's cloud-based solutions are installed in physician groups and clinics, hospitals, independent reference labs, student health centers, veterinary labs, public health organizations, universities, and retail facilities. For more information regarding Orchard Software Corporation, visit www.orchardsoft.com.
Media Contact:
Steve Hurwitz, Vice President of Marketing
(800) 856-1948 | shurwitz@orchardsoft.com
View original content to download multimedia:
SOURCE Orchard Software Corporation | https://www.wibw.com/prnewswire/2022/08/18/orchard-software-announces-monkeypox-testing-cdr-labs/ | 2022-08-18T12:37:26Z |
ANAHEIM, Calif. (AP) — In a season that has turned into a titanic struggle for the Los Angeles Angels, they suffered another pain-staking defeat Thursday.
The Halos tied a major league record with seven solo home runs, including two by Shohei Ohtani, but still lost to the Oakland Athletics 8-7 in a crazy matinee affair at Angel Stadium.
The Angels are the first team in the majors to hit seven solo homers and score no other runs in a game. They’re also the sixth team to hit seven homers and lose, according to STATS.
“I guess they always say solo home runs don’t beat you, but you feel like if you hit seven, you might. It didn’t work out for us,” Angels interim manager Phil Nevin said.
Los Angeles was 24-13 and tied with Houston for the AL West lead after beating Oakland on May 15. Since then, the Angels have gone 20-48 and are a season-low 17 games under .500 at 44-61.
The tailspin has included a 14-game losing streak, the firing of Joe Maddon on June 7, blowing a four-run, eighth-inning lead at Philadelphia on June 5 and a wild, bench-clearing brawl against the Seattle Mariners on June 26.
Ramon Laureano homered and drove in four runs, and Seth Brown had a two-run shot during a six-run third inning for AL-worst Oakland. Sean Murphy also drove in two runs for the Athletics, who took the final two games of the series and have won six of their last nine.
“Today was a little bit of a different baseball game than I have probably been a part of. It is a very interesting boxscore,” Oakland manager Mark Kotsay said. “I’m happy that our eight held up, and we were able to get a win.
“The goal is to win the game and score more runs. Solo home runs at the end of the day are nice, but they don’t necessarily always help you win games.”
Paul Blackburn (7-6) picked up his first win since June 16 despite surrendering four home runs on six hits.
“It was one of those days where any ball hitting the air seemed like it went out,” said Blackburn, who went five innings and struck out three. “I’ve never seen anything like that, but I’ll take a series win any day.”
Ohtani left Wednesday night’s game due to a left forearm cramp, but he bounced back with three hits and two RBIs. It was his 11th multihomer game in the majors and fifth this season.
Mickey Moniak — acquired from Philadelphia on Tuesday as part of the Noah Syndergaard trade — homered to right with one out in the ninth to get the Angels within a run. Max Stassi drew a walk but Taylor Ward struck out and A.J. Puk got Ohtani to fly out to short on the first pitch for his third save.
Kurt Suzuki, Taylor Ward, Jo Adell and Jared Walsh also went deep for the Angels, who went 2-5 on their homestand. The seven homers also tied an overall franchise record.
“It’s obviously a positive thing. I would have liked to get the win, but you know, offensively we’ve been needing to pick it up a little bit. So it was a positive sign,” said Ward, referring to the Angels batting .199 as a team in July.
The Los Angeles Dodgers were the last team to hit seven solo home runs on June 24, 2018, against the New York Mets.
Los Angeles led 2-0 after two innings on shots by Ohtani and Suzuki before Oakland broke it open in the third against Halos starter Janson Junk (1-1).
The Athletics sent 11 to the plate in the inning and scored six runs. Laureano tied it at 2 on a one-out double with the bases loaded before Murphy’s double into the left-center gap gave them the lead. Brown then chased Junk by driving a first-pitch curveball into the elevated seats in right-center to make it 6-2.
Junk threw five scoreless innings in his last start July 27 at Kansas City. The right-hander didn’t have the same success this time, with six runs allowed on five hits and two strikeouts.
“I think everybody started to focus on what they wanted to do in their zone. He was throwing a lot of breaking balls and this team threw a lot of breaking balls this series,” Brown said. “It was everyone kind of locking into they pitch they wanted.”
Laureano extended Oakland’s lead to 8-3 in the fourth when he connected on an elevated sinker by Touki Toussaint for a two-run homer to center.
Walsh went deep in the sixth and Ohtani in the seventh to make it 8-6.
ONE BY ONE
Solo shots by Ward and Adell in the third and fourth innings made it only the second time in franchise history the Angels have homered in each of the first four innings. The last time it happened was Aug. 19, 2017, in Baltimore when Mike Trout went deep in the first and third and Luis Valbuena did it in the second and fourth.
It is the third time it has occurred in the majors this season. The Los Angeles Dodgers did it May 24 at Washington and the Minnesota Twins on April 10 against Seattle.
TRAINER’S ROOM
Angels: Trout (left ribcage inflammation) began rotational exercises Wednesday. There is no update on when he will resume swinging a bat. … P Griffin Canning (low back stress reaction) has not started throwing and has been ruled out from pitching this season.
UP NEXT
Athletics: Have a rare Friday off before hosting San Francisco in a two-game weekend series. RHP Adam Oller (1-4, 7.68 ERA) pitches Saturday’s Bay Bridge Series opener.
Angels: Hit the road for seven games. LHP Patrick Sandoval (3-7, 3.61 ERA) gets the call Friday night in Seattle.
___
More AP MLB: https://apnews.com/hub/MLB and https://twitter.com/AP_Sports | https://cw33.com/sports/ap-sports/angels-tie-mlb-record-with-7-solo-hrs-but-lose-to-athletics/ | 2022-08-05T13:19:27Z |
LONDON, June 9, 2022 /PRNewswire/ -- Executive Search Firm, Forsyth Barnes, announced that everyone in the company would be receiving a 10% raise across their offices in London, Nottingham, and New York. The decision was made in response to rising energy and fuel prices to minimize the impact of the cost of living increases.
"We are incredibly proud to have developed a family of talented, hard-working, and loyal individuals. We are a people-first business who will always, always look after our own," said Managing Partner Scott Parsons.
Forsyth Barnes' second Managing Partner, Roheel Ahmad thanked the team for their hard work and resilience over the past six years, stating, "Your ambition to work alongside us and grow this business into a lasting legacy that is bigger than any of us is infectious and inspiring, and this is just one of the ways we give thanks to you all."
Speaking with some employees, it's clear how significant this gesture is. "I had relocated to our London office at the end of 2021, and the cost of living had already increased. This is such an unexpected surprise, adding to all of the other incentives, rewards, and raises over the years. I'm so excited and proud to work for such a people-centric business," notes one employee.
The business profits funding this raise are wholly organic, as Forsyth Barnes has never received external funding. "We are built entirely off the back of our own success," said Parsons. He continues, "The main driver for us as business owners is to ensure everyone within our team will work their best selves and leave the office each day their best selves too."
ABOUT FORSYTH BARNES
Forsyth Barnes are specialists in Mid-Senior to Executive Level recruitment on a permanent and interim basis. They operate across eTail, Fintech, and Sports & Entertainment industries, globally.
View original content:
SOURCE Forsyth Barnes | https://www.mysuncoast.com/prnewswire/2022/06/09/talent-partner-forsyth-barnes-announces-10-company-wide-pay-rise-aid-cost-living-crisis/ | 2022-06-09T15:47:21Z |
Improving rigor and transparency measures should lead to improvements in reproducibility across the scientific literature, but assessing measures of transparency tends to be very difficult if performed manually by reviewers.
TORONTO and PHILADELPHIA, July 27, 2022 /PRNewswire/ -- JMIR Publications recently published "Establishing Institutional Scores With the Rigor and Transparency Index: Large-scale Analysis of Scientific Reporting Quality" in the Journal of Medical Internet Research (JMIR), which reported that improving rigor and transparency measures should lead to improvements in reproducibility across the scientific literature, but assessing measures of transparency tends to be very difficult if performed manually by reviewers.
The overall aim of this study is to establish a scientific reporting quality metric that can be used across institutions and countries, as well as to highlight the need for high-quality reporting to ensure replicability within biomedicine, making use of manuscripts from the Reproducibility Project: Cancer Biology.
The authors address an enhancement of the previously introduced Rigor and Transparency Index (RTI), which attempts to automatically assess the rigor and transparency of journals, institutions, and countries using manuscripts scored on criteria found in reproducibility guidelines (eg, NIH, MDAR, ARRIVE).
Using work by the Reproducibility Project: Cancer Biology, the authors could determine that replication studies scored significantly higher than the original papers which, according to the project, all required additional information from authors to begin replication efforts.
Unfortunately, RTI measures for journals, institutions, and countries all currently score lower than the replication study average. If they take the RTI of these replication studies as a target for future manuscripts, more work will be needed to ensure the average manuscript contains sufficient information for replication attempts.
Dr. Anita Bandrowski from the University of California San Diego said, "Research reproducibility is necessary for scientific progress. However, over the last decade, numerous reports on research irreproducibility have shed light on a lingering problem, one that is proving to be both troublesome and costly."
In an effort to encourage reproducibility, numerous scientific organizations and journals have adopted the Transparency and Openness Promotion guidelines, which focus on establishing best practices at the level of individual journals.
Along a similar vein, the publisher-driven Materials Design, Analysis, and Reporting framework is a multidisciplinary research framework designed to improve reporting transparency across life science research at the level of individual manuscripts.
This framework provides a consistent, minimum reporting checklist whose criteria were used, in part, to create the first RTI, a journal quality metric focusing on research methodologies and reporting transparency.
Specifically, the authors here introduce the latest version of the RTI, which represents the mean SciScore over a subset of papers, and demonstrate how it can be used to assess reporting transparency within research institutions.
While we cannot simply describe all papers scoring a "2" as not replicable and all papers scoring an "8" as replicable, as numerous fields and their subsequent best practices exist, we can state that higher scores are associated with more methodological detail and as such are likely easier to use to attempt a replication.
DOI - https://doi.org/10.2196/37324
Full-text - https://www.jmir.org/2022/6/e37324
Free Altmetric Report - https://jmir.altmetric.com/details/130343509
JMIR Publications is a leading, born-digital, open access publisher of 30+ academic journals and other innovative scientific communication products that focus on the intersection of health and technology. Its flagship journal, the Journal of Medical Internet Research, is the leading digital health journal globally in content breadth and visibility, and it is the largest journal in the medical informatics field.
To learn more about JMIR Publications, please visit https://www.JMIRPublications.com or connect with us via:
YouTube - https://www.youtube.com/c/JMIRPublications
Facebook - https://www.facebook.com/JMedInternetRes
Twitter - https://twitter.com/jmirpub
LinkedIn - https://www.linkedin.com/company/jmir-publications
Instagram - https://www.instagram.com/jmirpub/
Head Office - 130 Queens Quay East, Unit 1100 Toronto, ON, M5A 0P6 Canada
If you are interested in learning more about promotional opportunities please contact us at Communications@JMIR.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited. JMIR Publications is a registered trademark of JMIR Publications.
SciScore is a scientific content checker / validation tool that verifies common rigor criteria (NIH, MDAR, ARRIVE) and research resources (antibodies, cell lines, organisms). These guidelines can be checked by editorial, but the process is tedious and takes a lot of effort from a skilled professional, so checklists are enforced only in the best-resourced journals. SciScore uses text mining techniques to do the job in minutes, providing a report to the editors, reviewers or authors about criteria that have and have not been addressed. Furthermore, it provides a numerical score, which allows editors to assess the percentage of criteria met or not met at a glance.
Contact Researchers: Anita Bandrowski | anita@scicrunch.com
Contact Media/Publishers: Martijn Roelandse | martijn@martijnroelandse.dev
This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com.
View original content:
SOURCE JMIR Publications | https://www.mysuncoast.com/prnewswire/2022/07/27/journal-medical-internet-research-rigor-transparency-index-large-scale-analysis-scientific-reporting-quality/ | 2022-07-27T16:50:35Z |
- FB2001 (Bofutrelvir) is a Coronavirus Mpro inhibitor, which exhibited potent anti-SARS-CoV-2 activity in vitro and in vivo
- Phase 1 results show FB2001 to be generally safe and well tolerated. No significant difference was observed between Chinese and American populations. Single-agent antiviral concentrations have been reached in the blood plasma and lung tissues without the need for pharmacokinetic enhancer, thus potentially minimizing the risk of drug interactions
- It significantly reduces coronavirus viral load in the lungs and brain of a murine model, the latter which may have clinical implications for the sequelae of the central nervous system of COVID-19. FB2001 is the first anti-COVID-19 drug to report antiviral activity in the brain
- The BRIGHT (Bofutrelvir in Global Hospitalized Patients) study, a Phase 2/3 trial that explores the utility of FB2001 in reducing the time to recovery in patients hospitalized due to COVID-19 has begun
ATLANTA, Aug. 8, 2022 /PRNewswire/ -- Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candidate, FB2001 – a small molecule inhibitor of coronavirus main protease (Mpro) – in healthy adult volunteers.
The data, presented today at the poster session of the 11th International Conference on Emerging Infectious Diseases (ICEID), showed FB2001 to be safe and well tolerated among trial participants. Adverse events reported during the trial were mostly mild-to-moderate in severity, with no significant differences observed between participants in the Chinese and American study centers.
"We are pleased by the positive results from FB2001's phase 1 trial. It is a significant milestone for us and the healthcare community", said Dr CJ Wang, Chief Executive Officer of Frontier Biotechnologies. "This promising result will spur us on to strive for success in later-stage trials. We believe that the work done at Frontier Biotech can elevate our efforts in the fight against COVID-19 in China and abroad."
A total of 120 participants (80 Whites in the US and 40 Chinese in China) received intravenous infusions of FB2001 at either single doses from 5 mg to 400 mg, or multiple doses of 30 mg to 400 mg daily for 5 days. The key findings from the study are as follows:
- FB2001 was safe and well tolerated up to 400 mg per day
- Without using a pharmacokinetic enhancer, FB2001 exhibited plasma and lung drug concentration above the in vitro antiviral EC50 value.
- No significant difference was observed between Chinese and American populations.
The results from the Phase 1 trial build on preclinical in vivo data of FB2001, where the drug was observed to reduce viral loads in both the lung and brain tissues of mice. Pharmacokinetic data obtained from preclinical studies showed significantly higher concentration of FB2001 in the lung compared to plasma. "FB2001 has demonstrated in vivo antiviral activity in the lung and brain tissue of SARS-CoV-2 mouse model without the need for pharmacokinetic boosting. Therefore, it holds great promise as a treatment for acute COVID-19 as well as long-COVID, both of which will be evaluated in further follow-up studies", said Dr Jay Lalezari, MD, Medical Director of Quest Clinical Research in San Francisco.
The current intravenous formulation of FB2001 is ideal for hospitalized patients with its rapid onset of action and is suited for patients with dysphagia or other problems with swallowing. Working with clinical research organizations, regional regulatory agencies, and local clinical centers, Frontier Biotechnologies has started a pivotal Phase 2/3 study (BRIGHT trial) to enroll about 1,200 hospitalized patients in hundreds of clinical centers worldwide. "The phase 1 data were really promising", said Dr Michael Hu, Chief Medical Officer of Frontier Biotechnologies, "and we are confident to carry out the pivotal trial to explore the utility of the drug in reducing the time to recovery in hospitalized patients due to COVID-19."
Frontier Biotechnologies is also developing a pulmonary formulation of FB2001 that could be used in out-patient setting for the treatment of mild Covid-19, as well as for post exposure prophylaxis. When inhaled directly into the respiratory tract and lungs, the tissue concentration of FB2001 is much higher than that in plasma; hence, the onset of action and viral clearance could potentially be faster than that of oral therapy.
About Frontier Biotechnologies
Founded in 2013, Frontier Biotechnologies Inc. ("Frontier Biotech") is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health.
View original content to download multimedia:
SOURCE Frontier Biotechnologies | https://www.kxii.com/prnewswire/2022/08/08/frontier-biotechnologies-announces-positive-phase-1-results-its-first-coronavirus-main-protease-mpro-small-molecule-inhibitor-laying-foundation-treatment-acute-long-covid/ | 2022-08-08T17:09:58Z |
VIRGINIA BEACH, Va., May 12, 2022 /PRNewswire/ -- Choice Financial Group (Choice) announced today that it has acquired Pennsylvania-based Fonner Insurance Associates (Fonner).
Fonner, located in Abington, PA, is a full-service property and casualty agency that serves individuals and businesses in the greater Philadelphia area. Fonner is led by For 30 years, the Fonner family has been dedicated to providing their clients with insurance solutions. William (Bill) Fonner and Eric Fonner will continue managing the business as part of Choice. "We are thrilled that Bill and Eric will continue to lead their team in our first Pennsylvania office," said Richard Braun, President of Choice Financial Group.
"After reviewing our options in the marketplace, partnering with Choice was an easy decision given the resources made available to us and the growth potential of joining a rapidly expanding insurance platform. We are excited about our future together," said Bill Fonner. Eric Fonner echoed that sentiment, saying "The opportunity for us to accelerate the growth of our agency with minimal disruption was very attractive to us."
Fonner represents the sixth acquisition for Choice since partnering with Northlane Capital Partners in October 2021.
About Choice Financial Group: Choice Financial Group is a leading insurance agency with institutional capital support from Northlane Capital Partners, a middle-market private equity firm managing more than $1 billion of committed equity capital. Choice is expanding its market presence through targeted acquisitions. Choice is headquartered in Virginia Beach, Virginia, and has 18 offices in eight states.
For agency partnership opportunities, contact:
Bob Hilb, Head of M&A
804-564-9625
bob.hilb@choiceins.com
Richard Braun, President
757-416-5118
richard.braun@choiceins.com
For media inquiries, contact:
Mandy Berkowitz
mandy@theimagemarketinggroup.com
757-581-8116
View original content to download multimedia:
SOURCE Choice Financial Group | https://www.kxii.com/prnewswire/2022/05/12/choice-financial-group-enters-pennsylvania/ | 2022-05-12T14:49:23Z |
Grand jury reportedly probing Trump leadership PAC
WASHINGTON (AP) — A federal grand jury is reportedly seeking information about Donald Trump’s Save America leadership PAC as investigations into the former president continue to expand.
ABC News first reported Thursday that subpoenas issued in recent weeks have asked recipients about the political action committee’s formation, its fundraising activities and its spending.
The Department of Justice and a Trump spokesman did not immediately respond to requests for comment.
Trump is now the subject of numerous ongoing federal and state investigations, including several probing his role in the Jan. 6, 2021, attack on the U.S. Capitol building, his efforts to overturn the results of the 2020 election, and how thousands of government records, including documents with highly classified markings, ended up at his private Mar-a-Lago club.
Trump aggressively fundraised off the 2020 election, capitalizing on his supporters’ anger about and refusal to accept his loss. During its hearings, the House committee investigating the Jan. 6 attack said Trump’s fundraising machine had collected some $250 million from his campaigns to “Stop the Steal” and others in the aftermath of the election, mostly in small-dollar donations from Americans. One plea for cash went out 30 minutes before the Jan. 6 insurrection.
“Not only was there the big lie, there was the big ripoff,” Rep. Zoe Lofgren, D-Calif., said of the efforts.
No credible evidence has emerged to support Trump’s claims that the election was marred by mass fraud. Numerous state and local elections officials, including Trump’s own attorney general and judges he appointed, have also rejected such claims.
Trump’s PAC — which he has used to pay for his post-presidential rallies, other travel, legal bills and even the portraits of him and the former first lady that will one day hang in the Smithsonian’s National Portrait Gallery — has raised millions since its creation. It ended July with just under $100 million cash-on-hand, according to government filings.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/09/09/grand-jury-reportedly-probing-trump-leadership-pac/ | 2022-09-09T01:31:42Z |
CHARLESTON, S.C., Sept. 1, 2022 /PRNewswire/ -- Black Ink Technologies Corp., an integrated hardware and software company providing end-to-end zero trust immutable solutions for products and services, confirmed today that it has licensed its 20th filed patent. "Management and Tracking of Patient Encounters and Medical Information including Immutable Tokens, Digital Assets, and Smart Contracts."
A variety of studies over the last 2 decades have found that administrative expenses account for approximately 15% to 25% of total national health care expenditures, an amount that represents an estimated $600 billion to $1 trillion per year of the total national health expenditures of $3.8 trillion in 2019. Black Ink Tech subsidiary Paired Pharma Inc aims to "Put Care Back In Health Care" by utilizing blockchain, tokens, and NFTs to remove friction and provide immutable confirmed data to improve these admin processes, and reduce or eliminate fraud and patient encounter misclassification and thus ultimately save money which could result in lower health care costs to consumers. Ultimately, the platform makes the patient encounter experience easier and faster for both patient and health care professional allowing care, not paperwork, to become the priority.
Black Ink Tech has exclusively licensing 11 awarded patents this year alone related to NFTs, Blockchain, Smart Contracts, and Digital Assets. CEO Jeremy Blackburn stated "I am very excited about the coming month's developments and product releases as we have exclusive rights to multiple awarded patents that form the foundation of our platform that we will be able to grow from for decades to come. The first patents related to blockchain and smart contracts were filed in 2019, and awarded in 2020, with additional filings expected to continue for the foreseeable future. This positions Black Ink Tech to competitively implement its platform across multiple industries, proving truth and providing transparency that ultimately benefits the consumer and overall industries by maximizing asset and service value through necessary efficiency creation."
Founded in 2019, Black Ink Tech (BIT) provides transparency to every business and market segment by focusing on truth rather than trust in data information. With approximately 52 global team members on four continents, Black Ink Tech's development and market growth never sleep. Through BIT's multi-patented integrated blockchain software and hardware platform it produces end-to-end immutability which reduces or eliminates friction to increase efficiency, allows for full transparency, and maximizes product or service value. Initially starting in construction, BIT has expanded its product offering vastly and continues to expand to reach additional industries and markets.
To learn more about Black Ink Tech, please visit https://www.blackinktech.io
Tollen L, Keating E, Weil A. How administrative spending contributes to excess US health spending. Health Affairs blog. Published online February 2020. Accessed August 30, 2021. https://www.healthaffairs.org/do/10.1377/hblog20200218.375060/full/
Chernew M, Mintz H. Administrative Expenses in the US Health Care System - Why So High? JAMA Network article. Published online October 2021. Accessed August 20, 2021. https://jamanetwork.com/journals/jama/fullarticle/2785479#:~:text=A%20variety%20of%20studies%20over,of%20%243.8%20trillion%20in%202019.
View original content:
SOURCE Black Ink Tech | https://www.wibw.com/prnewswire/2022/09/02/putting-care-back-health-care-through-nfts-blockchain/ | 2022-09-02T01:55:05Z |
NEW YORK, Aug. 11, 2022 /PRNewswire/ -- SportsGrid, the nation's first and only 24-hour streaming network serving the massive sports wagering audience, announced the launch of the network on leading sports-first live TV streaming platform FuboTV (NYSE: FUBO) in the US & Canada. The SportsGrid Network viewer experience amplifies the emergence of new levels of fan engagement combined with the convergence between live sports programming and sports wagering.
SportsGrid is a live 24-hour sports wagering destination providing 18 hours of exclusive original programming hosted by a team of on-air personalities, sports and betting experts, and guest contributors. The network features real-time sports news, data, analytics, and statistics to engage sports audiences whenever and wherever with their connected devices. SportsGrid's reporting and analytic platform includes daily odds, lines, matchups, injury reports, statistics, news, and more across the NFL, NBA, MLB, NHL, college sports, golf, tennis, and soccer. The network's live programming originates from state-of-the-art television production facilities adjacent to Madison Square Garden in New York City and at the SG Studios & Production Hub located in Holmdel, New Jersey.
"We are extremely pleased to join FuboTV – the timing is perfect with the excitement with the upcoming NFL season and FIFA World Cup Soccer Championship." said Jason Sukhraj, GM Canada & Syndication. "The SportsGrid program lineup will serve the engaged fans with real-time actionable analytics before and during the live games as well."
SportsGrid, Inc. is the multimedia content and technology company providing digital innovative solutions for the convergence of sports content, gaming, and NextGen interactive video technology. The SportsGrid multimedia destinations include SportsGrid Streaming Video Network, SportsGrid Radio, SportsGrid.com, DailyRoto, and SportsGrid Studios. SportsGrid intelligence and data are provided by Sportradar featuring the seamless integration of their real time comprehensive data feeds and content solutions. For more information, please visit sportsgrid.com.
Media contact: Charles Theiss, charles@sportsgrid.com
View original content to download multimedia:
SOURCE SportsGrid | https://www.wibw.com/prnewswire/2022/08/11/sportsgrid-network-launches-fubotv/ | 2022-08-11T12:24:44Z |
- Creates a company with larger scale and significant free cash flow to unlock shareholder value
- Substantial combined gold reserve of 3.8 Moz and resource base of 18.3 Moz Measured & Indicated and 7.7 Moz Inferred1
- Strengthened mine-building, operating and financial capacity
- Streamlined corporate structure with direct realizable synergies
- No premium, all-share business combination
TORONTO and VANCOUVER, BC, July 25, 2022 /PRNewswire/ - GCM Mining Corp. (GCM) (TSX: GCM) (OTCQX: TPRFF) and Aris Gold Corporation (Aris Gold) (TSX: ARIS) (OTCQX: ALLXF) announce they have entered into a definitive agreement (the Arrangement Agreement) under which GCM will acquire all the outstanding Aris Gold shares not already held by GCM (the Transaction). The resulting entity will be named Aris Gold Corporation and will be led by Ian Telfer as Chair and Neil Woodyer as CEO and Director.
Ian Telfer, Aris Gold Chair, stated: "The combined group creates a top-in-class company with multiple tier one assets. After Aris Gold became operator of the Soto Norte joint venture, joining forces with GCM became a logical next step. Our increased scale will also broaden our future opportunities to continue building a +1 million ounce producer over the next few years."
Serafino Iacono, Executive Chair of GCM, stated: Each team has unique strengths with GCM being the Colombian leader for responsible, sustainable mining practices. Together with Aris Gold's Board and management, the combined group brings a track record of building sizable and successful mining companies; this transaction further diversifies the company's portfolio and reaffirms Colombia as an area of focus. While I am stepping down from a day-to-day executive role, I will remain a director and advisor on matters in Colombia as well as an enthusiastic securityholder."
Neil Woodyer, CEO of Aris Gold, stated: "We are building a gold mining business with scale, cash flow, a strong financial position with US$397 million of cash and US$260 million of additional committed funding, and a high-quality growth pipeline. Our teams are well known to each other, and together we will optimize the delivery of the growth projects to unlock shareholder value."
Under the terms of the Transaction, all the outstanding Aris Gold shares not held by GCM will be exchanged at a ratio of 0.5 of a common share of GCM for each common share of Aris Gold (the Exchange Ratio). The Exchange Ratio was determined at-market giving consideration to the 10-day and 20-day volume weighted average prices on the TSX for each of GCM and Aris Gold for the period ended July 22, 2022. Both the GCM and Aris Gold Boards of Directors (other than certain interested directors) have approved the terms of the Arrangement Agreement, and all of the directors and officers of both GCM and Aris Gold have entered into binding voting support agreements in favour of the Transaction, representing in aggregate 3.0% of GCM's issued shares and 9.0% of Aris Gold's issued shares.
- Creates the top-of-the-class company among junior producers and the largest gold company in Colombia, with diversification in Guyana and Canada.
- Experienced Board of Directors and management team with a track record of building value in the gold sector
- Brings together teams with unmatched experience in Colombia and extensive project development and mine building expertise
- Strong financial position to de-risk growth projects, with combined cash and committed funding of US$657 million2 and free cash flow generation from the Segovia Operations (US$84 million on a 12-month trailing basis to March 31, 2022)3
- Estimated G&A cost savings of US$10 million per year through the reduction of duplicative public company expenses and rationalizing other expenses
- No premium transaction that simplifies the ownership structure within a single company
- Substantial long-term re-rating potential, with share price upside from enhanced market visibility, trading liquidity, access to capital, and reduced cost of capital
The Board of Directors of the resulting entity will have nine members, with Ian Telfer as Chair and Daniela Cambone, David Garofalo, Mónica de Greiff, Serafino Iacono, Peter Marrone, Hernan Martinez, Attie Roux and Neil Woodyer as members.
Mónica de Greiff is new to the Aris Gold team and is a former Board Member of GCM, from 2018 to 2020, when she left to accept the position of Colombian Ambassador to Kenya. She has held positions in both the public and private sectors, including Minister of Justice for the Republic of Colombia and Vice Minister of Mines and Energy. Ms. de Greiff is a former member of the Board of Directors of the United Nations Global Compact, the world's largest corporate sustainability initiative.
The combined group will be led by Neil Woodyer as CEO and the corporate office will be based in Vancouver, Canada. Both Lombardo Paredes, CEO of GCM, and Mike Davies, CFO of GCM, will retire from their roles with GCM. Serafino Iacono will step back from an executive role but will continue as a member of the Board of Directors and an advisor on matters in Colombia.
The combined group will have a balanced mix of production, development, and exploration assets across the Americas with proven and probable mineral reserves of 3.8 million ounces of gold, measured and indicated mineral resources of 18.3 million ounces of gold, inclusive of mineral reserves, and inferred mineral resources of 7.7 million ounces of gold.4
- Segovia Operations (Antioquia, Colombia): a high-grade underground mining district that produced 206,389 ounces of gold in 2021. Operations at Segovia have been ongoing for over 150 years and there is a well-established history of mineral resource and reserve replacement. The Segovia Operations include the purchase of mined material from small-scale miners, which are described in the Segovia Technical Report[5] and represented about 16% of 2021's gold production, as part of an industry-leading Colombian program for the integration of informal small-scale miners into the supply chain, with added environmental, social and security benefits.
- Marmato Mine (Caldas, Colombia): a historic producing underground gold mine currently undergoing a modernization and expansion program, which includes the construction of a new decline, mine workings, 4,000 tpd carbon in pulp processing plant and dry stack tailings facilities. The Pre-Feasibility Study disclosed in the Marmato Technical Report estimates production of 175,000 ounces per year (oz/yr) from the optimized Upper Mine and the Lower Mine expansion project.5
- Toroparu Project (Cuyuni-Mazaruni, Guyana): an advanced stage open pit and underground gold project with estimated average gold production of 225,000 oz/yr over a 24-year mine life, as described in the Preliminary Economic Assessment (PEA) disclosed in the Toroparu Technical Report.6 Located approximately 50 kilometres southwest of the recently constructed Aurora gold mine, Toroparu is one of the largest undeveloped gold projects in the Americas and provides the combined company with a foothold in the emerging and highly prospective Central Guiana Shear Zone.5
- Soto Norte Project (Santander, Colombia): a large-scale feasibility-stage underground gold project undergoing permitting and licensing. In April 2022, Aris Gold became the operator of the Soto Note joint venture and is leading a new and reframed environmental permitting process. The Feasibility Study disclosed in the Soto Norte Technical Report estimates average gold production of 450,000 oz/yr over the steady state production years. Upon exercising its option to increase its joint venture ownership interest from 20% to 50%, the attributable gold production to Aris Gold would be 225,000 oz/yr.5
- Juby Project (Ontario, Canada): an advanced stage gold project with an open pit mineral resource located in the Abitibi greenstone belt.
While the combined company embarks on delivering its growth projects, the Board of Directors of the combined company is expected to initially adopt a no-dividend policy based on the strategic principle that internal cash flow generation is best deployed to advance high-return growth opportunities within the company.
On closing, GCM shareholders and Aris Gold shareholders (taking into consideration the 44.3% of Aris Gold currently held by GCM) are expected to own, on a diluted in-the-money basis, approximately 74% and 26% of the combined group, respectively.
The Arrangement Agreement includes customary transaction protection terms. GCM and Aris Gold have agreed to not solicit any alternative transactions and each party has the right to match any superior competing offer, with a reciprocal Transaction termination fee of US$6 million to be paid in certain circumstances.
The material conditions to completion of the Transaction include:
- Approval by Aris Gold's shareholders, with greater than 66 2/3% approval threshold and approval of disinterested minority shareholders.
- Approval by GCM's shareholders, with greater than 50% approval threshold.
- Receipt of all required governmental and regulatory approvals including TSX and Colombian anti-trust approvals.
- Other customary conditions.
It is anticipated that both the GCM and Aris Gold shareholder meetings will take place in mid September 2022, and completion of the Transaction is expected to occur promptly thereafter.
The Board of Directors of GCM determined it was advisable to establish a special committee of the independent directors of GCM (the GCM Special Committee), comprising Robert Metcalfe, De Lyle Bloomquist, Belinda Labatte and Jaime Perez Branger to, among other things, review and evaluate the merits of the proposed Transaction and to consider such materials and information needed, including an independent fairness opinion, and to make a recommendation to the Board of Directors of GCM in respect of the proposed Transaction.
The GCM Special Committee and the Board of Directors of GCM received a fairness opinion from its co-financial advisors, National Bank Financial Inc. (National Bank) and Stifel Nicolaus Canada (Stifel GMP) that, based upon and subject to the respective assumptions, limitations, qualifications of and other matters set forth in connection with the preparation of such opinion, the Transaction is fair, from a financial point of view, to GCM (the GCM Fairness Opinions).
Following the report and favourable recommendation of the GCM Special Committee, the Board of Directors of GCM (other than certain interested directors) approved the Transaction and determined to recommend approval of the Transaction to the GCM shareholders. In addition, all of the directors and officers of GCM have entered into binding voting support agreements with Aris Gold and GCM under which such individuals have agreed to support the Transaction and vote their GCM shares in favour of the Transaction.
A copy of the GCM Fairness Opinions, the factors considered by the GCM Special Committee and the Board of Directors of GCM and other relevant background information will be included in the management information circular and related documents that are expected to be delivered to the GCM shareholders in connection with a special meeting of GCM shareholders to be called to consider and approve the Transaction, filed with the applicable Canadian securities regulatory authorities and made available on GCM's SEDAR profile at www.sedar.com, and posted on GCM's website at http://www.gcm-mining.com/.
As of today, GCM beneficially owns 60,991,545 Aris Gold shares representing approximately 44.3% of the issued and outstanding Aris Gold shares. GCM is considered a "related party" of Aris Gold and the Transaction is a "business combination" of Aris Gold for the purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (MI 61-101). The Board of Directors of Aris Gold formed a special committee of independent directors comprising of Ian Telfer, Peter Marrone and Daniela Cambone (the Aris Special Committee) to, among other things, review and evaluate the merits of the proposed Transaction and to consider such materials and information needed including an independent fairness opinion and formal valuation, and to make a recommendation to the Board of Directors of Aris Gold in respect of the proposed Transaction.
BMO Nesbitt Burns Inc. (BMO Capital Markets) was retained by the Aris Special Committee to provide, under the supervision of the Aris Special Committee, an independent formal valuation prepared in accordance with MI 61-101 and independent fairness opinion. BMO Capital Markets provided its opinion (the BMO Fairness Opinion) to the Special Committee that, as of July 24, 2022, and subject to the assumptions, limitations and qualifications contained therein, the consideration to be received by the Aris Gold shareholders (other than GCM) pursuant to the proposed Transaction is fair from a financial point of view to the Aris Gold shareholders (other than GCM). BMO Capital Markets also prepared a formal valuation of the Aris Gold common shares (the Aris Gold Valuation) and the GCM common shares (the GCM Valuation), which are being issued as consideration, as required under MI 61-101. BMO Capital Markets concluded that, as of July 24, 2022, and subject to the assumptions, limitations, and qualifications included in the Aris Gold Valuation and GCM Valuation, respectively, that the value of the Aris Gold common shares on an en bloc basis7 was in the range of C$2.30 to C$3.10 per share and the value of the GCM common shares on a trading value basis was in the range of C$3.70 to C$5.75 per share.
Canaccord Genuity Corp. (Canaccord) was retained by the Aris Board of Directors and provided its opinion (the Canaccord Fairness Opinion) to the Aris Board of Directors that, as of July 24, 2022, and subject to the assumptions, limitations and qualifications contained therein, the consideration to be received by the Aris Gold shareholders (other than GCM) pursuant to the proposed Transaction is fair from a financial point of view to the Aris Gold shareholders (other than GCM).
Following the report and favourable recommendation of the Aris Special Committee, the Board of Directors of Aris Gold (other than certain interested directors) approved the Transaction and determined to recommend approval of the Transaction to the Aris Gold shareholders. In addition, all of the directors and officers of Aris Gold have entered into binding voting support agreements with GCM and Aris Gold under which such individuals have agreed to support the Transaction and vote their Aris Gold shares in favour of the Transaction.
A copy of the BMO Fairness Opinion, the Canaccord Fairness Opinion, the Aris Gold Valuation, the GCM Valuation, the factors considered by the Aris Special Committee and Board of Directors of Aris Gold and other relevant background information will be included in the management information circular and related documents that are expected to be delivered to the Aris Gold shareholders in connection with a special meeting of Aris Gold shareholders to be called to consider and approve the Transaction, filed with the applicable Canadian securities regulatory authorities and made available on Aris Gold's SEDAR profile at www.sedar.com, and posted on GCM's website www.arisgold.com.
National Bank Financial and Stifel GMP are acting as co-financial advisors to GCM and each has provided a fairness opinion to the GCM Special Committee and the Board of Directors of GCM.
Wildeboer Dellelce LLP, Proskauer Rose LLP and CLA Consultores S.A.S. are acting as Canadian, US and Colombian legal advisors to GCM, respectively, and the GCM Special Committee has retained Blake, Cassels & Graydon LLP as its independent counsel.
Canaccord is acting as financial advisor to Aris Gold and has provided a fairness opinion to the Board of Directors of Aris Gold. BMO Capital Markets was retained by the Special Committee and has provided a formal valuation and fairness opinion to the Aris Gold Special Committee.
Fasken Martineau DuMoulin LLP and Dentons are acting as Canadian and Colombian legal advisors to Aris Gold, respectively.
Ian Telfer, Serafino Iacono, and Neil Woodyer will host a conference call and webcast today, Monday, July 25, 2022 at 9am EDT/6am PDT.
No passcode is necessary to access the call or webcast.
Conference call
Toll-free US and Canada: 1-800-319-4610
International: +1 604-638-5340
Webcast – link here
A replay of the call will also be available by dialling the following numbers and using passcode 9244:
Toll-free US and Canada: 1-800-319-6413
International: +1 604-638-9010
Technical reports for Marmato, Soto Norte, and Juby have been filed with the Canadian securities regulatory authorities and are available for review on Aris Gold's website at www.arisgold.com and on the profile of Aris Gold Corporation on SEDAR at www.sedar.com. Technical reports for Segovia and Toroparu have been filed with the Canadian securities regulatory authorities and are available for review on GCM's website at www.gcm-mining.com and on the profile of GCM on SEDAR at www.sedar.com. These reports confirm that the qualified persons responsible for the preparation of the technical reports have verified the data disclosed, including drilling, sampling, assaying, and QAQC protocols and results, and are of the opinion that the sample recovery, preparation, analyses, and security protocols used for the mineral resource estimates are reliable for that purpose.
Scientific and technical information concerning Marmato is summarized, derived, or extracted from the Marmato Technical Report entitled "Revised NI 43-101 Technical Report Pre-Feasibility Study Marmato Project Colombia" dated September 18, 2020 with an effective date of March 17, 2020. The Marmato Technical Report was prepared by Ben Parsons, MSc, MAusIMM (CP), Eric J. Olin, MSc Metallurgy, MBA, SME-RM, MAusIMM, Fernando Rodrigues, BS Mining, MBA, MAusIMM, MMSAQP, Jeff Osborn, BEng Mining, MMSAQP, Joanna Poeck, BEng Mining, SME-RM, MMSAQP, Fredy Henriquez, MS Eng, SME, ISRM, Breese Burnley, P.E., Cristian A Pereira Farias, SME-RM, David Hoekstra, BS, PE, NCEES, SME-RM, David Bird, PG, SME-RM, Mark Allan Willow, MSc, CEM, SME-RM, and Tommaso Roberto Raponi, P.Eng, each of whom is independent of the Company within the meaning of NI 43-101 and is a "Qualified Person" as such term is defined in NI 43-101.
Scientific and technical information concerning Soto Norte is summarized, derived, or extracted from the Soto Norte Technical Report entitled "NI 43-101 Technical Report Feasibility Study of the Soto Norte Gold Project, Santander, Colombia", dated March 21, 2022 with an effective date of January 1, 2021. The Soto Norte Technical Report was prepared by Ben Parsons, MSc, MAusIMM (CP), Chris Bray, BEng, MAusIMM (CP), Dr John Willis PhD, BE (MET), MAusIMM (CP), and Dr Henri Sangam, Ph.D., P.Eng., each of whom is independent of the Company within the meaning of NI 43-101 and is a "Qualified Person" as such term is defined in NI 43-101. The report was also prepared by Robert Anderson, P.Eng., a Qualified Person who is considered non-independent of the Company.
Scientific and technical information concerning Segovia is summarized, derived, or extracted from the Segovia Technical Report entitled "NI 43-101 Technical Report, Prefeasibility Study, Segovia Project, Antioquia, Colombia" dated May 6, 2022 with an effective date of December 31, 2021. The Segovia Technical Report was prepared by Ben Parsons, MSc, MAusIMM (CP), Eric Olin, MSc, MBA, MAusIMM, SME-RM, Cristian A. Pereira Farias, SME-RM, David Bird, MSc, PG, SME-RM, Fredy Henriquez, MS Eng, SME, ISRM, Jeff Osborn, BEng Mining, MMSAQP, Fernando Rodrigues, BS Mining, MBA, MAusIMM, MMSAQP, Giovanny Ortiz, BS Geology, FAusIMM, Joshua Sames, PE, BEng Civil, Mark Allan Willow, MSc, CEM, SME-RM, and Jeff Parshley, P.G., each of whom is independent of the Company within the meaning of NI 43-101 and is a "Qualified Person" as such term is defined in NI 43-101.
Scientific and technical information concerning Toroparu is summarized, derived, or extracted from the Toroparu Technical Report entitled "Revised NI 43-101 Technical Report and Preliminary Economic Assessment for the Toroparu Gold Project, Upper Puruni River Region of Western Guyana" dated February 4, 2022 with an effective date of December 1, 2021. The Toroparu Technical Report was prepared by Glen Kuntz, P. Geo., Brian Wissent, P.Eng, Daniel Yang, P.Eng, Ben Peacock, P.Eng, Kurt Boyko, P.Eng, Fernando Rodrigues, MMSAQP, and David Willms, P.Eng, each of whom is independent of the Company within the meaning of NI 43-101 and is a "Qualified Person" as such term is defined in NI 43-101.
Scientific and technical information concerning Juby is summarized, derived, or extracted from the Juby Technical Report entitled "Technical Report on the Updated Mineral Resource Estimate for the Juby Gold Project, Tyrrell Township, Shining Tree Area, Ontario" dated October 5, 2020 with an effective date of July 14, 2020. The Juby Technical Report was prepared by Joe Campbell, B.Sc., P.Geo., Alan Sexton, M.Sc., P.Geo., Duncan Studd, M.Sc., P.Geo. and Allan Armitage, Ph.D., P.Geo., each of whom is independent of the Company within the meaning of NI 43-101 and is a "Qualified Person" as such term is defined in NI 43-101.
The technical information in this news release was reviewed and approved by Pamela De Mark, P.Geo, Vice President Exploration of Aris Gold, who is a Qualified Person as defined by NI 43-101.
GCM Mining is a mid-tier gold producer with a proven track record of mine building and operating in Latin America. In Colombia, the Company is the leading high-grade underground gold and silver producer with several mines in operation at its Segovia Operations. Segovia produced 206,389 ounces of gold in 2021. In Guyana, the Company is advancing its fully funded Toroparu Project, one of the largest undeveloped gold/copper projects in the Americas, which is expected to commence production of more than 200,000 ounces of gold annually in 2024. GCM Mining has equity interests in Aris Gold Corporation (~44%; TSX: ARIS; Colombia – Marmato, Soto Norte; Canada - Juby), Denarius Metals Corp. (~32%; TSX-V: DSLV; Spain – Lomero-Poyatos and Colombia – Guia Antigua, Zancudo) and Western Atlas Resources Inc. (~26%; TSX-V: WA: Nunavut – Meadowbank).
Additional information on GCM Mining can be found at www.gcm-mining.com and www.sedar.com.
Mike Davies
Chief Financial Officer
e investorrelations@gcm-mining.com
t + 416.360.4653
Aris Gold is a Canadian mining company listed on the TSX under the symbol ARIS and on the OTCQX under the symbol ALLXF. The Company is led by an executive team with a demonstrated track record of creating value through building globally relevant gold mining companies. In Colombia, Aris Gold operates the 100%-owned Marmato mine, where a modernization and expansion program is under way, and as of April 12, 2022, operates the Soto Norte joint venture, where environmental licensing is advancing to develop a new gold mine. Aris Gold also owns the Juby project, an advanced exploration stage gold project in the Abitibi greenstone belt of Ontario, Canada. Aris Gold plans to pursue acquisition and other growth opportunities to unlock value creation from scale and diversification.
Additional information on Aris Gold can be found at www.arisgold.com and www.sedar.com.
Tyron Breytenbach
Senior Vice President, Capital Markets
Meghan Brown
Vice President, Investor Relations
e info@arisgold.com
t + 778.899.0518
This news release contains "forward-looking information" or forward-looking statements" within the meaning of Canadian securities legislation. All statements included herein are forward-looking, other than statements of historical fact, including without limitation statements relating to: the Transaction; the resulting entity of the Transaction, including its management, board of directors, assets, capitalization, strategy, plans and goals; the benefits of the Transaction; shareholder meetings, conference calls and webcasts in connection with the Transaction. Generally, the forward-looking information and forward looking statements can be identified by the use of forward looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", "will continue" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Statements concerning mineral resource estimates may also be deemed to constitute forward looking information to the extent that they involve estimates of the mineralization that will be encountered. The material factors or assumptions used to develop forward looking information or statements are disclosed throughout this news release.
Forward looking information and forward looking statements, while based on management's best estimates and assumptions, are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of GCM, Aris Gold and the resulting entity to be materially different from those expressed or implied by such forward-looking information or forward looking statements, including but not limited to: the completion and the timing of the Transaction; the ability of GCM and Aris Gold to receive, in a timely manner, the necessary regulatory, court, securityholder, stock exchange and other third-party approvals; the ability of GCM and Aris Gold to satisfy, in a timely manner, the other conditions to the closing of the Transaction; interloper risk; the ability to complete the Transaction on the terms contemplated by the arrangement agreement between GCM and Aris Gold and other agreements, including the voting support agreements, or at all; failure to achieve and sustain mine-building, operating and financial capacity; the ability of the combined group to realize the anticipated benefits of, and synergies from, the Transaction and the timing thereof; the timing of the commencement and completion of construction activities, first production and sales, if at all; the impacts of a changing risk profile and possible subjection to a credit rating review, which may result in a downgrade or negative outlook being assigned to the combined group or a portion thereof; the combined group's dividend policy; the potential exposure to political, economic or social instability related to the combined group's international operations; the consequences of not completing the Transaction, including the volatility of the share prices of GCM and Aris Gold, negative reactions from the investment community and the required payment of certain costs related to the Transaction; actions taken by government entities or others seeking to prevent or alter the terms of the Transaction; potential undisclosed liabilities unidentified during the due diligence process; the accuracy of the pro forma financial information of the combined group after the Transaction; the interpretation of the Transaction by tax authorities; the success of business integration; the focus of management's time and attention on the Transaction and other disruptions arising from the Transaction; the ability of the Aris Gold management team to successfully integrate with the current operations, risks related to international operations; risks related to general economic conditions; uncertainties relating to operations during the COVID-19 pandemic; actual results of current exploration activities; availability of quality assets that will add scale, diversification and complement the resulting entity's growth trajectory; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; the ability to convert mineral resources to mineral reserves; fluctuations in foreign currency exchange rates; increases in market prices of mining consumables; risks associated with holding derivative instruments (such as credit risks, market liquidity risk and mark-to-market risk); possible variations in mineral reserves, grade or recovery rates; failure of plant, equipment or processes to operate as anticipated; changes in national and local government legislation, taxation, controls, regulations, and political or economic developments in Canada, Colombia or Guyana; risks of the mining industry including, without limitation, accidents, operations, labour disputes, title disputes, claims and limitations on insurance coverage; delays in obtaining governmental approvals including obtaining required environmental and other licenses; the completion of development or construction activities; and those factors discussed in the section entitled "Risk Factors" in GCM's most recent AIF available on SEDAR at www.sedar.com and in the section entitled "Risk Factors" in Aris Gold's most recent AIF available on SEDAR at www.sedar.com.
Although GCM and Aris Gold have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information or statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information or statements. Each of GCM and Aris Gold has and continues to disclose in its Management's Discussion and Analysis and other publicly filed documents, changes to material factors or assumptions underlying the forward-looking information and forward-looking statements and to the validity of the information, in the period the changes occur. The forward-looking statements and forward-looking information are made as of the date hereof and each of GCM and Aris Gold disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements or forward-looking information contained herein to reflect future results. Accordingly, readers should not place undue reliance on forward-looking statements and information.
Although information provided by GCM for inclusion in this news release is believed by Aris Gold to be reliable, Aris Gold has not independently verified such information and cannot provide any assurance of its accuracy, currency, reliability or completeness. Although information provided by Aris Gold for inclusion in this news release is believed by GCM to be reliable, GCM has not independently verified such information and cannot provide any assurance of its accuracy, currency, reliability or completeness.
This announcement does not constitute an offer of securities for sale in the United States, nor may any securities referred to herein be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933 as amended (the "Securities Act") and the rules and regulations thereunder. The securities referred to herein have not been registered pursuant to the Securities Act and there is no intention to register any of the securities in the United States or to conduct a public offering of securities in the United States.
View original content:
SOURCE Aris Gold Corporation | https://www.mysuncoast.com/prnewswire/2022/07/25/aris-gold-gcm-mining-combine-create-leading-americas-gold-producer/ | 2022-07-25T11:01:22Z |
NEW YORK, June 28, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN)'s sale to Pfizer Inc. for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven's non-CGRP development stage pipeline compounds, per Biohaven common share. If you are a Biohaven shareholder, click here to learn more about your rights and options.
U.S. Well Services, Inc. (NASDAQ: USWS)'s sale to ProFrac Holding Corp. Under the terms of the merger agreement, USWS shareholders will receive 0.0561 shares of ProFrac Class A common stock for each share of USWS Class A common stock they own. If you are a USWS shareholder, click here to learn more about your rights and options.
Healthcare Realty Trust Inc. (NYSE: HR)'s merger with Healthcare Trust of America, Inc. If you are a Healthcare Realty shareholder, click here to learn more about your rights and options.
ServiceSource International, Inc. (NASDAQ: SREV)'s sale to Concentrix Corporation for $1.50 per share. If you are a ServiceSource shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:
SOURCE Halper Sadeh LLP | https://www.wibw.com/prnewswire/2022/06/28/investigation-notice-halper-sadeh-llp-investigates-bhvn-usws-hr-srev/ | 2022-06-28T16:01:00Z |
Partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
CENTER VALLEY, Pa., May 19, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today a strategic co-marketing agreement with Monroe Township, N.J.-based Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business. Through this agreement, Olympus and Bracco will work together to raise awareness of the role of endoscopic ultrasound (EUS) with contrast in the characterization of focal liver lesions. The contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) technology will open pathways for more innovative and timely diagnosis and treatment of liver disease.
Endo-Hepatology is an up-and-coming field in the world of GI, due to the rise of liver diseasei and many emerging applications for EUS such as EUS-guided liver biopsy, EUS-guided shear wave measurement and now contrast-enhanced harmonic EUS.
CH-EUS is comprised of a contrast agent containing microbubbles and an endoscopic ultrasound system designed to allow the detection of microbubbles within the vasculature, with the intent to provide a more detailed view of potential pathology. More detailed visualization during minimally invasive procedures can provide more information to physicians for use in diagnosis. Bracco Diagnostic Inc.'s Lumason ultrasound enhancing agent (sulfur hexafluoride lipid-type A microspheres), for injectable suspension and/or intravenous use or intravesical use, is the first and currently only contrast agent available for characterization of focal liver lesions in adults and pediatric patients.
Per the terms of the agreement, Olympus will co-market the Lumason® ultrasound enhancing agent with Bracco Diagnostics, Inc. Risks associated with the use of Lumason include headache and nausea. Serious cardiopulmonary reactions are possible in patients with hypersensitivity to sulfur hexafluoride lipid microsphere or its components, but they are uncommon. See full prescriptive information here. Risks associated with EUS include or are associated with perforation, hemorrhage, fiducial placement infection, and pancreatitis.i The benefits of CH-EUS are real-time imaging, avoidance of ionizing radiation and helping medical practices provide a full liver evaluation.
"Improving the characterization of lesions in the liver with CH-EUS may mean that patients receive a more accurate diagnosis and faster treatment," said Dr. Douglas Graham Adler, Professor of Medicine and Director, Center for Advanced Therapeutic Endoscopy (CATE), Centura Health, Porter Adventist Hospital, Denver, Co. "In addition, the patient may potentially avoid radiation and/or percutaneous or transjugular procedures to obtain tissue."
"We gain from this agreement an additional pathway to discuss with physicians the importance of better specificity in diagnosing liver malignancies. These discussions have the potential to build on the safety and clinical efficacy advantages that Olympus' current EUS-guided technologies already bring to physicians and their patients," said Richard Reynolds, President, Medical Systems Group, Olympus Corporation of the Americas. "We are looking forward to good synergies that will provide more options for the diagnosis of focal liver lesions."ii
Those interested can visit the Endo-Hepatology station at the Olympus booth #4323 during the upcoming Digestive Disease Week (DDW) held in San Diego, May 21-24, 2022.
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease.
As a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients and their safety. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications. For more information, visit medical.olympusamerica.com.
i ASGE Standards of Practice Committee, Forbes N, Coelho-Prabhu N, Al-Haddad MA, Kwon RS, Amateau SK, Buxbaum JL, Calderwood AH, Elhanafi SE, Fujii-Lau LL, Kohli DR, Pawa S, Storm AC, Thosani NC, Qumseya BJ. Adverse events associated with EUS and EUS-guided procedures. Gastrointest Endosc. 2022 Jan;95(1):16-26.e2. doi: 10.1016/j.gie.2021.09.009. Epub 2021 Oct 27. PMID: 34711402.
ii Samarasena, J., & Chang, K. J. (2018). Endo-hepatology: A new paradigm. Endoscopic ultrasound, 7(4), 219–222. https://doi.org/10.4103/eus.eus_30_18
View original content to download multimedia:
SOURCE Olympus | https://www.mysuncoast.com/prnewswire/2022/05/19/olympus-announces-exclusive-us-co-marketing-agreement-with-bracco-diagnostics-inc/ | 2022-05-19T15:37:04Z |
NEW YORK, May 27, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Oscar Health, Inc. (NYSE: OSCR).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/oscar-health-inc-loss-submission-form/?id=27766&from=4
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until July 11, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Oscar Health, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law | https://www.wibw.com/prnewswire/2022/05/27/oscr-shareholder-alert-jakubowitz-law-reminds-oscar-shareholders-lead-plaintiff-deadline-july-11-2022/ | 2022-05-27T11:42:00Z |
eXplore Lawrence launches 2022 Lawrence Bucket List passport
LAWRENCE, Kan. (WIBW) - eXplore Lawrence has officially launched the 2022 Lawrence Bucket List passport.
eXplore Lawrence, the official tourism organization for Lawrence, says it has officially launched the 2022 Lawrence Bucket List - a new program that aims to drive traffic and revenue toward local businesses.
The organization noted that the Lawrence Bucket List is a free program that visitors and locals can sign up for. With more than 60 businesses included, the passport showcases the best of Lawrence in an easy, mobile-friendly way.
eXplore Lawrence indicated that the first 100 users to check in at 10 participating locations will win a limited edition Unmistakably Lawrence Bucket Hat. Users can also earn an entry to win a Lawrence Bucket List Getaway Package after every 5 check-ins. A winner will randomly be drawn after the pass expires at the end of March 2023.
The group said the pass’s theme incorporates Lawrence’s basketball history and takes advantage of the buzz around the University of Kansas Men’s Basketball NCAA National Championship win in March.
“We were looking for a program that encourages visitation and spending at local businesses while making it fun for users to explore the city,” said Andrea Johnson, Director of Marketing and Communications at eXplore Lawrence. “The Lawrence Bucket List does just that. It’s simple to use and a fun way to introduce visitors and locals to things to see and do while they earn prizes.”
eXplore Lawrence noted that the conversation about mobile passports began in early 2022 and led it to reach out to a well-known tech company in the travel space - Bandwango. It said Bandwango technology is meant to support free and paid experiences created by destinations and is marketed to visitors and locals.
The organization said users can click HERE to sign up for their pass by providing their name, e-mail address, and mobile phone number. A link will then be sent to their mobile phone, which opens the passport and requires the user to add the button icon to their home screen where they can access it at any time.
eXplore Lawrence noted there is no download necessary so no bulky apps take up space on a user’s phone.
Once ready to use the pass, eXplore Lawrence said users simply check in through their mobile phone at the participating location. It said many participating businesses offer special deals to pass holders. To redeem deals, users just hand their phones over at the checkout counter to access savings.
Local restaurants, shops, attractions and hotels who wish to be a part of the pass can email marketing@explorelawrence.com for more information.
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/09/05/explore-lawrence-launches-2022-lawrence-bucket-list-passport/ | 2022-09-05T21:05:10Z |
NEW YORK, July 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GM, KSS, DVN, MU, and XOM.
Click a link below then choose between in-depth options trade idea report or a stock score report.
Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.
Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.
- GM: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=GM&prnumber=070120227
- KSS: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=KSS&prnumber=070120227
- DVN: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=DVN&prnumber=070120227
- MU: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=MU&prnumber=070120227
- XOM: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=XOM&prnumber=070120227
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:
SOURCE InvestorsObserver | https://www.kxii.com/prnewswire/2022/07/01/thinking-about-trading-options-or-stock-general-motors-kohls-devon-energy-micron-technology-or-exxon-mobil/ | 2022-07-01T16:08:13Z |
Conference call and webcast scheduled for 8:30 a.m. EDT
TORONTO, June 23, 2022 /PRNewswire/ -- Thomson Reuters (NYSE, TSX: TRI) announced today its second-quarter 2022 earnings will be issued via news release on Thursday, August 4, 2022.
Steve Hasker, president and chief executive officer, and Mike Eastwood, chief financial officer, will host a conference call and simultaneous webcast that morning at 8:30 a.m. EDT. Discussions may include forward-looking information.
You can access the webcast by visiting the "Investor Relations" section of the Thomson Reuters website. Registration for the webcast is now open. Additionally, an archive of the webcast will be available following the presentation.
Thomson Reuters
Thomson Reuters is a leading provider of business information services. Our products include highly specialized information-enabled software and tools for legal, tax, accounting and compliance professionals combined with the world's most global news service – Reuters. For more information on Thomson Reuters, visit tr.com and for the latest world news, reuters.com.
View original content to download multimedia:
SOURCE Thomson Reuters | https://www.wibw.com/prnewswire/2022/06/23/thomson-reuters-second-quarter-2022-earnings-announcement-webcast-scheduled-august-4-2022/ | 2022-06-23T16:28:00Z |
NORWALK, Conn., July 26, 2022 /PRNewswire/ -- RISMedia is now accepting nominations for its 6th annual Real Estate Newsmaker honors. This one-of-a-kind recognition program is designed to celebrate industry professionals from across the U.S. who are making headlines for their commitment and contributions to the real estate industry, as well as going the extra mile to positively impact their peers, colleagues, clients and communities.
The deadline to nominate a 2023 Newsmaker is Sept. 1, 2022.
The 2023 Real Estate Newsmakers will be chosen based on their outstanding accomplishment(s) in 2022. Please see the Real Estate Newsmaker categories below.
The "success stories" of those who have rocketed their business/company/brand to the top, with robust growth and marketing strategies, winning awards for top companies, multi-year strategies for success and more.
The "champions of a better way" who have a passion for a cause greater than themselves, from equal rights and REALTOR® safety, to disaster recovery, children's and women's causes, and so much more.
The "forward-thinkers" who are working to change the conversation focused on growth, stability and technology in an ever-changing real estate landscape to achieve new successes, profits and support.
The "thought leaders" in the industry who do the noble work of leading and inspiring innovation, creativity, strong leadership and success in business.
The "iconic leaders" such as founders, CEOs and executives who have dedicated their lives to the betterment of their companies, agents and the industry to reach new heights of success.
The "agents of change" for their contributions to moving the industry forward and improving agent-client relationships on every level through innovation, new technologies and more.
Do you or someone you know have what it takes to be a Real Estate Newsmaker? Nominate yourself or another real estate professional today!
The hundreds of industry professionals selected for RISMedia's 2023 Real Estate Newsmakers will be showcased in RISMedia's Real Estate magazine and online at RISMedia.com in early 2023. Check out RISMedia's 2022 Real Estate Newsmakers here! For any questions, please contact editorial@rismedia.com.
RISMedia, founded in 1980 by CEO and Publisher John E. Featherston is the residential real estate industry's definitive source for news and information, strategies and trends, and premier educational and networking events.
Contact: Paige Brown, pbrown@rismedia.com
View original content:
SOURCE RISMedia | https://www.wibw.com/prnewswire/2022/07/26/nominations-now-open-rismedias-2023-real-estate-newsmakers/ | 2022-07-26T18:15:13Z |
Transforming yet another office environment, @Ease 605 offers 28,000 square feet of meeting facilities, outdoor space, powered communal lounges, and hosts a unique NFT multi-media art exhibition all developed with Ease Hospitality's signature biophilic design at 605 3rd Avenue. @Ease's five-star integrated services along with its world-class technology systems create seamless integration for in-person, virtual, or hybrid events.
NEW YORK, June 22, 2022 /PRNewswire/ -- Ease Hospitality has opened their second physical amenity, meetings, and conference center location, @Ease 605. The luxury management specialists expanded their portfolio of solutions for modern events and office spaces, with first-class amenities that anticipate and exceed their guests' needs. @Ease 605 features powered communal lounge spaces, break-out, classroom or pod meeting and conferencing spaces, two generous outdoor terraces, and the second location of their signature Palm Rose Cafe with health-conscious and seasonal gourmet cuisine, all enhanced with the latest innovations in technology woven seamlessly throughout the space. @Ease 605 is home to a custom and revolving NFT art exhibition, "Masked Monolith: Journey into the Hybrid Jungle," by artist Kenneth Wayne Alexander. The exhibition, the first of its kind in Midtown, was unveiled last night during NFT.NYC week and is powered by digital art platform Blackdove. During the event, an NFT collection from international street muralist Vexta was also showcased on internal displays. Vexta's works of art were initially created as part of a mural and Augmented Reality experience overlay at Ease Hospitality's sponsored park experience at 1345 Avenue of the Americas.
"We are deeply aware of the importance of evolutionary technology in the workplace, balancing green and digital is a delicate dance. By adding this NFT exhibition that features an artist who is able to incorporate natural elements we stay true to our core and our future", says founder of Ease Hospitality Crystal Fisher. "We celebrate beauty in opening this location. The beauty of coming together to enjoy each other's company, the beauty of the space that is wrapped in greenscape, and the beauty of the artwork that we can now take home if we enjoy it thanks to world-class software like Blackdove. The modernity of this event alone is a beautiful moment in our cultural story, to be @Ease is to feel good and want to create at your highest level."
Ease Hospitality and Fisher Brother's changed the face of the modern workplace in February 2021 with the launch of @Ease 1345. This inaugural physical space effectively created an elevated practical lifestyle solution for commercial buildings offering a five-star, curated ecosystem that successfully blends the physical and digital experience. @Ease 605 opening its doors in the heart of Midtown expands the company's mission to fill a growing need to provide onsite world-class service and support to all functional areas of business, particularly as companies return post-pandemic. Most critically, today, the management company culture rests on "evolutionary technology", outfitting each location with state-of-the-art technology and global connectivity suited for in-person, hybrid, or virtual events. The company is prewired for future-proofing of pop-up and permanent installations like hosting a web-based art gallery, offering meditation minutes on-demand through the workplace app, and continually evaluating the role of the metaverse in today's workplace.
Blackdove has designed a custom NFT display in the space, the company's first permanent installation in New York City, showcasing 6 digital canvases – 6 x 65" LG screens. With the ability to rotate artists and works of art, the first artist to be displayed @Ease 605's Blackdove NFT gallery is multidisciplinary artist Kenneth Wayne Alexander. Kenneth uses mixed-media collages depicting imaginary worlds and a Surrealist style that contemplates serene yet deeply complex realities. Kenneth's digital art is an extension of Ease Hospitality's mission to redefine the future of the office and amenities market. Through a limitless approach to blending natural beauty and technology, the artwork enhances the experience and creates a more productive, rewarding, and healthy workplace. Events booked at @Ease 605 can also commission these digital canvases for integration of branding to create a custom and fully immersive experience.
"Blackdove is pleased to partner with Ease Hospitality to open Midtown's first permanent NFT gallery in a beautiful, modern space. Featuring Blackdove's Afro-Futurist digital artist Kenneth Wayne Alexander presented through our advanced technology and NFT Digital Canvases, this inaugural exhibition sets the perfect tone for the artistic experience that guests at @Ease 605 will encounter now and in the future," said Blackdove Gallery and Partnerships Manager Lara Binnet.
@Ease 605's 28,000 square feet of space is made up of multiple meetings, events, and conferencing facilities. The Oasis North, Oasis Mid, and Oasis South conference rooms combine to create the 3,070 square feet Oasis Assembly that can host 200 people. These three areas can be sectioned out to offer 700 square feet for 66 guests, 1670 square feet for 100 guests, and 700 feet for 66 guests respectively. Breakout meeting rooms or spaces designed for more intimate events include Bamboo North which boasts 1440 square feet and can host up to 100 guests, Bamboo South with 1000 square feet available for up to 72 guests, and the Maple Boardroom with 380 square feet for 14 guests. The Gallery reception area can host 190 people at a time with 1560 square feet of space to serve catering or convene during a meeting or event. Communal areas include a tenant lounge with powered, meeting desks and seating areas, access to individual private "Cove" drop-in rooms, a respite room, and access to grab & go food and beverage options plus the on-demand service of the Palm Rose Cafe. Two, much-coveted terrace spaces cover more than 4,300 square feet for outdoor convening and/or reprieving.
Ease Hospitality's signature design was developed, in collaboration with award-winning architect David Rockwell and Rockwell Group, throughout the development and inception of the inaugural location @Ease 1345 located at 1345 Avenue of the Americas. The brand standards carry over to @Ease 605, anchored in Biophilic principles and organic materials to promote both wellness and productivity in the working environment. Each location boasts unique standout features of green design and naturally formed elements like heavily veined dark marble in varying shades. From the largest terrarium in the Northeast to the more than 500 square feet of vertical green landscape, the biophilic intent is carried through the material and palette selection. There is no space left uncovered, even special moments like the tenant-only branded "selfie-booths" (private phone booths) are wrapped in themed faux florals and silk roses to remind guests of the importance of balancing both nature and artistic endeavors.
"We started Ease Hospitality to create a true connection with our tenants and guests. @Ease 605 is a testament to meeting a growing need and demonstrates our dedication to adding value to the workplace experience," says Crystal. "We have found, through challenging times, that the blending of the comforts of the physical space and the convenience of the digital landscape allows us to be at ease while we work. Adding the NFT exhibition, we are surging further into the realms of art and of technology to offer a truly unique experience for our guests. Technology changes every day, plants continue to grow and change color in the same fashion, and nothing good stays the same for too long. The Ease culture promotes innovation, adaptation, and communication. We believe we must continue to grow our offerings, our services, and the way we deliver them to our guests to remain at the forefront of hospitality."
Currently open to tenants of 605 3rd Avenue, select guests who have booked meetings and events in both locations, and a small pool of tenant referrals from the property, Ease Hospitality is piloting a VIP Membership Program with the intention to open its doors wider. The membership program will allow the company to host external guests wishing to book a day or weekly pass and grant access to use the tenant lounges, Palm Rose Cafes, meeting facilities, on-demand access to the NFT art exhibition, and more at their @Ease 1345 and @Ease 605 luxury amenities and powered workspaces.
Ease Hospitality is navigating a return to the office at a time when health and safety are of the utmost importance. The Ease team has taken every precaution to ensure a safe and controlled environment for tenants and guests. With a background in operations, Crystal says, "You cannot work well unless you live well, which is why we have undergone WELL certification across the Fisher Brother's portfolio, and continue to carry the message of healthy choices on site all day long as offered through our hospitality services."
As with @Ease 1345, @Ease 605 offers seamless integration and customization of daily programming onsite throughout from the curb of the building to a tenant's desk through the @Ease Workplace app. This app affords tenants a one-touch solution to a streamlined experience in the palm of their hands. Whether a tenant is programming the elevator recall as they arrive from the corner, ordering lunch from the cafe for one or one hundred guests through vertical catering, inquiring about meeting rooms, or looking to book a tailored wellness moment, from personal massage at @Ease 1345 to one-on-one Yoga at @Ease 605, tenants can effortlessly access all offerings through one tap of the workplace tile.
The custom @Ease Workplace app allows for touch-less entry and partners with Kastle Systems to provide virtual security screenings that help limit person-to-person contact. Through the pandemic Fisher was of the first landlords/operators to install commercial photo-hydro ionization units within the HVAC main system to eliminate unwanted VOCs and virtually eradicate airborne viruses including coronavirus, improving overall indoor air quality. The system runs all day and enhances air quality within each @Ease location, while MoonBeam3, @Ease's cleanliness choice technology, harnesses UV rays to disinfect all high-touch surfaces. Hand sanitizing stations with custom branded Palm Rose spread throughout the venue, masks available upon request, and beacons alert managers of densely populated areas allowing for better scheduling of on-demand cleaning and access control of crowds if/when needed. Distinguished, well-appointed, and WELL Certified, the @Ease 605 experience provides a personalized "finishing touch" creating a five-star experience for every meeting, conference, and event.
@Ease 605 is located on the 7th floor at 605 3rd Avenue. For additional information about Ease Hospitality, please visit easehospitality.com or follow @easehospitality on Instagram. To learn more about hosting a meeting, conference, or event, or to inquire about management services please email info@easehospitality.com.
View original content to download multimedia:
SOURCE Ease Hospitality | https://www.mysuncoast.com/prnewswire/2022/06/22/ease-hospitalitys-second-location-ease-605-is-now-open-with-nft-exhibition/ | 2022-06-22T21:31:35Z |
AALBORG, Denmark, July 13, 2022 /PRNewswire/ -- Asetek, sim racing gear innovator, and sports car championship-winning and esports leader Hardpoint announced an agreement whereby Asetek SimSports™ racing products will be available to try out in sim rigs at International Motor Sports Association (IMSA) endurance race events and will be available to try and purchase in the Hardpoint race shop. As part of the agreement, and as an official sponsor of the Hardpoint esports team, Asetek SimSports™ branding will be prominent during iRacing events.
"What André and the Asetek team have done is uncanny, and something other sim racing gear providers have struggled with – to bring a real racecar feel to sim racing," said Rob Ferriol, President and IMSA driver at Hardpoint. "I am pleased to have this collaboration to bring the experience of driving a real racecar to the racing community - whether sim racers wanting to reach their apex, or real racers training to improve lap speeds."
The racing simulators with Asetek SimSports™ Invicta™ pedals, will be available to try out this season at the IMSA WeatherTech Sportscar Championship race at Virginia International Raceway, Hardpoint's home track, August 26 - 28, and the 2022 Motul Petit Le Mans, held at Road Atlanta in Braselton, Georgia, October 7 - 9.
In addition to featuring the Invicta™ pedals, the Hardpoint sim rigs employ Asetek's premium liquid cooling technology to enable a cool stable system that stands the rigors of endless race sessions.
"It is exciting to have this cooperation with Rob and Hardpoint to bring our Invicta™ sim racing pedals to IMSA race events, starting with the WeatherTech Championship, one of the iconic races in the U.S.," said André Sloth Eriksen, founder and CEO of Asetek. "We specifically designed our Invicta™ pedals to provide a real racecar feel, so it is huge to have our pedals in Hardpoint sim rigs in the paddock at these major motorsports events in North America, and now customers can try out and buy our SimSports gear from the Hardpoint shop."
"Added to that, it will be a real thrill to all of us at Asetek to see Asetek SimSports™ kit being put through its paces by the Hardpoint esports team during iRacing events, and to know Asetek liquid cooling technology is enabling immersive experiences on the sim rigs," continued André Sloth Eriksen.
To learn more about Hardpoint Motorsports visit https://www.hardpoint.com/. To learn more about Asetek SimSports™ and Asetek liquid cooling visit https://www.asetek.com/simsports/.
About Hardpoint
Hardpoint was founded by Rob Ferriol in 2018 with the vision of combining his experience as a successful entrepreneur with his passion for racing. Headquartered at VIRginia International Raceway, the team captured the 2021 Porsche Carrera Cup North America Pro-Am championship in its inaugural season and competes full-time in the IMSA WeatherTech Sports Car Championship in the No. 99 GridRival Porsche 911 GT3 R with co-drivers Ferriol and Katherine Legge, joined by Stefan Wilson for Michelin Endurance Cup races. In 2022, Hardpoint has added the No. 22 Racing To End Alzheimer's Porsche 718 Cayman GT4 RS Clubsport driven by Nick Galante and Sean McAllister in IMSA Michelin Pilot Challenge Grand Sport (GS). More information on Hardpoint can be found at www.hardpoint.com or through its strong social media presence on Facebook, Instagram and Twitter.
About Asetek
Asetek (ASTK.OL), a global leader in mechatronic innovation, is a Danish garage-to-stock-exchange success story. Founded in 2000, Asetek established its innovative position as the leading OEM developer and producer of the all-in-one liquid cooler for all major PC & Enthusiast gaming brands. In 2013, Asetek went public while expanding into energy-efficient and environmentally friendly cooling solutions for data centers. In 2021, Asetek introduced its line of products for next- level immersive SimSports gaming experiences. Asetek is headquartered in Denmark and has operations in China, Taiwan, and the United States.
www.asetek.com
Media contacts
Margo Westfall
Asetek Sr. Marketing Manager
mwe@asetek.com
+1(408)644-5616
Reece White
Hardpoint Communications Manager
reece.white@hardpoint.com
+1(831)383-9426
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Asetek | https://www.wibw.com/prnewswire/2022/07/13/asetek-simsports-hardpoint-bring-invicta-pedals-sim-rigs-imsa-endurance-races-hardpoint-race-shop/ | 2022-07-13T07:54:37Z |
HealthWell's 2021 Year in Review Now Available
GERMANTOWN, Md., April 7, 2022 /PRNewswire/ -- The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is proud to announce that they have reached the milestone of providing financial assistance through more than 1.1 million grants. Since awarding their first grant in 2004, the HealthWell Foundation has served as a safety net to over 727,000 patients across more than 85 disease areas by providing over $2.7 billion in financial support to underinsured patients who would otherwise have forgone life-changing, often lifesaving, medical treatments simply because their health insurance was not enough.
HealthWell recently published its 2021 Year in Review illustrating its accomplishments. Highlights from 2021 include:
- Awarding over $818.4 million in medication copayment and insurance premium assistance to more than 175,000 underinsured Americans through close to 185,500 grants.
- Launching or re-opening 18 funds, including new funds to assist Medicare patients living with Myelodysplastic Syndromes, Neurocognitive Disease with Psychosis, Pancreatic Cancer and Pulmonary Hypertension.
- Continuing to compliantly operate over 60 funds in a variety of disease areas, including multiple funds in oncology, and special initiative funds in behavioral health and pediatrics.
- Receiving over $538* million in donations from the kindness of our corporate, non-profit, and individual supporters.
- Maintaining operational efficiency by programming grants with an overhead rate of less than 2.61% foundation-wide, while never using any donor dollars to pay administrative fees.
"We were honored to have achieved numerous milestones and to have been able to assist a record number of underinsured patients in 2021," said Krista Zodet, HealthWell Foundation President. "In addition, we were humbled by the dedicated support of our individual and corporate donors. Thanks to their continued generosity and unwavering trust, we were able to continue to carry out our mission to reduce financial barriers to care for underinsured patients with chronic or life-altering diseases. We do not take this support lightly, but believe that the trust our donors have placed in us is a direct result of the integrity and high standards with which we operate. Thank you for allowing the HealthWell Foundation to fill a critical, unmet need, for those who have nowhere else to turn."
The full version of our 2021 Year in Review can be viewed here. To learn more about HealthWell programs and our robust disease fund portfolio, visit our website at HealthWellFoundation.org.
About the HealthWell Foundation
A nationally recognized, independent non-profit organization founded in 2003, the HealthWell Foundation has served as a safety net across over 85 disease areas for more than 727,000 underinsured patients. Since its inception, HealthWell has provided over $2.7 billion in financial support through more than 1.1 million grants to access life-changing medical treatments patients otherwise would not be able to afford. HealthWell provides financial assistance to adults and children facing medical hardship resulting from gaps in their insurance that cause out-of-pocket medical expenses to escalate rapidly; HealthWell assists with the treatment-related cost-sharing obligations of these patients. HealthWell ranked 27th on the 2021 Forbes list of The 100 Largest U.S. Charities and was recognized for its 100 percent fundraising efficiency. For more information, visit www.HealthWellFoundation.org.
CONTACT:
Ginny Dunn
240-632-5309
ginny.dunn@healthwellfoundation.org
View original content to download multimedia:
SOURCE HealthWell Foundation | https://www.wibw.com/prnewswire/2022/04/07/healthwell-foundation-exceeds-1-million-grants-awarded-milestone/ | 2022-04-07T16:09:19Z |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.